Priority list of endemic diseases for the red meat industries by Lane, Joe et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
final report  
 
    
    
Project code: B.AHE.0010 
Prepared by: GHD Pty Ltd (Joe Lane) with Tristan 
Jubb, Richard Shephard, John 
Webb-Ware, Geoffry Fordyce 
 GHD Pty Ltd 
Date published: 20 March 2015 
ISBN: 9781741918946 
 
PUBLISHED BY 
Meat & Livestock Australia Limited 
Locked Bag 991 
NORTH SYDNEY NSW 2059 
ished by  
 
Meat & Livestock Australia acknowledges the matching funds provided by the Australian 
Government to support the research and development detailed in this publication. 
This publication is published by Meat & Livestock Australia Limited ABN 39 081 678 364 (MLA). Care is taken to 
ensure the accuracy of the information contained in this publication. However MLA cannot accept responsibility for 
the accuracy or completeness of the information or opinions contained in the publication. You should make your 
own enquiries before making decisions concerning your interests. Reproduction in whole or in part of this 
publication is prohibited without prior written consent of MLA. 
Priority list of endemic diseases for the red 
meat industries 
B.AHE.0010 Final Report: Priority list of endemic diseases for the red meat industries 
Page 2 of 282 
Abstract 
This report provides a systematic review of the most economically damaging endemic diseases and 
conditions for the Australian red meat industry (cattle, sheep and goats). A number of diseases for 
cattle, sheep and goats have been identified and were prioritised according to their prevalence, 
distribution, risk factors and mitigation. The economic cost of each disease as a result of production 
losses, preventive costs and treatment costs is estimated at the herd and flock level, then 
extrapolated to a national basis using herd/flock demographics from the 2010-11 Agricultural Census 
by the Australian Bureau of Statistics. Information shortfalls and recommendations for further 
research are also specified.  
A total of 17 cattle, 23 sheep and nine goat diseases were prioritised based on feedback received 
from producer, government and industry surveys, followed by discussions between the consultants 
and MLA. Assumptions of disease distribution, in-herd/flock prevalence, impacts on 
mortality/production and costs for prevention and treatment were obtained from the literature 
where available. Where these data were not available, the consultants used their own expertise to 
estimate the relevant measures for each disease. Levels of confidence in the assumptions for each 
disease were estimated, and gaps in knowledge identified.  
The assumptions were analysed using a specialised Excel model that estimated the per animal, 
herd/flock and national costs of each important disease. The report was peer reviewed and 
workshopped by the consultants and experts selected by MLA before being finalised. Consequently, 
this report is an important resource that will guide and prioritise future research, development and 
extension activities by a variety of stakeholders in the red meat industry. This report completes 
Phase I and Phase II of an overall four-Phase project initiative by MLA, with identified data gaps in 
this report potentially being addressed within the later phases. 
Modelling the economic costs using a consistent approach for each disease ensures that the derived 
estimates are transparent and can be refined if improved data on prevalence becomes available. This 
means that the report will be an enduring resource for developing policies and strategies for the 
management of endemic diseases within the Australian red meat industry. 
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Executive summary 
This report provides the results for Phase I (survey and shortlisting a priority list of endemic disease) 
and Phase II (review and assessment of diseases) of a four-phase survey of livestock diseases of 
interest to the Australian red meat industry. The results provide a comprehensive economic 
assessment of the most significant endemic diseases which currently affect the cattle, sheep and 
goat red meat industries. 
Since 2006, Meat & Livestock Australia Limited (MLA) and wider industry have relied on a report 
from project B.AHW.087 by Sackett et al. (2006), with its estimates of the economic cost of some 
common endemic cattle and sheep diseases, to guide research, development and extension (RD&E) 
activities. Aside from a number of shortcomings to this report such as the omission of goats, there 
has been an increasing need to provide a more up-to-date estimate of the economic impact of 
endemic diseases within the Australian red-meat industry. This is required so that MLA, livestock 
producers and their advisors can access a comprehensive and relevant document that more 
accurately informs and guides their understanding of the economic consequences of common or 
emerging diseases, hence decisions on RD&E activity. 
The priority list of diseases was developed from a variety of surveys conducted across key 
stakeholders affected by livestock diseases within the red meat industries. Surveys were specifically 
developed, for livestock producers, veterinarians, processors, animal health companies and Chief 
Veterinary Officers, to identify the most economically important diseases. Stakeholders were 
surveyed with a variety of methods, ranging from computer assisted telephone interviews to more 
detailed and structured face to face interviews.  
The results of the surveys were assessed by the project team, in a series of workshops, with the aim 
of establishing an agreed list of priority diseases. Prioritisation commenced with the list obtained 
from the producer survey (see Appendix) with the priority order modified and some additional 
diseases included based on information from the other surveys and the consultants’ opinions. 
The final list included 17 cattle, 23 sheep and nine goat diseases that were assessed as having the 
greatest economic impact. The identified diseases are listed in the tables below. 
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Cattle 
Cattle tick 
Pestivirus (Bovine viral diarrhoea) 
Buffalo fly 
Dystocia 
Neonatal mortalities 
Internal parasites 
Bloat 
Bovine ephemeral fever 
Botulism 
Grass tetany 
Calf scours complex 
Vibriosis  
Theileriosis 
Pinkeye  
Clostridial infection 
Tick fever 
Johne's disease 
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Sheep 
Neonatal mortalities 
Internal parasites  
Dystocia 
Weaner ill-thrift 
Flystrike - body & breech 
Perennial ryegrass staggers 
Lice 
Mastitis 
Footrot 
Arthritis 
Ovine Johne’s disease (OJD) 
Clostridial disease 
Liver fluke  
Pneumonia 
Caseous lymphadenitis (‘Cheesy gland’) 
Pregnancy toxaemia 
Hypocalcaemia 
Foot abscess 
Bacterial enteritis 
Pyrrolizidine alkaloid poisoning  
Sheep measles 
Campylobacter abortion 
Sarcocystis 
 
 
Goats 
Internal parasites  
Enterotoxaemia  
Lice 
Pregnancy toxaemia 
Caseous lymphadenitis (‘Cheesy gland’) 
Liver fluke  
Footrot 
Johne's disease 
Caprine arthritis-encephalitis (CAE) 
 
 
Assumptions for disease distribution, in-herd/flock prevalence, impacts on mortality/production and 
costs for prevention and control were obtained from the literature where available. In the absence 
of appropriate data, the consultants used pooled industry knowledge to estimate the various 
measures. A level of confidence in each assumption was provided. 
A specifically designed Excel model, encompassing the Australian beef cattle, sheep and goat 
industries, was developed to incorporate these measures to calculate the costs of each disease to 
each industry. Importantly, each model for cattle, sheep and goats was built on a ‘typical’ herd/flock 
structure assumption for each species by production region; north and south for cattle, high rainfall 
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zone, sheep/wheat zone and pastoral zone for sheep, and type of production for both sheep (wool, 
prime lambs, dual purpose) and goats (rangeland and farmed). 
The model provides an estimate of the cost per herd/flock at the farm level for each disease. Costs 
were calculated for treatment, prevention and production losses. These results have been 
extrapolated across the regions in which each disease occurs, in line with adopted herd and flock 
demographics from Australian Bureau of Statistics Agricultural Commodities Statistics for 2010-11 in 
order to provide a national total cost estimate. Prioritisation commenced with the list obtained from 
the producer survey (see Appendix) with the priority order modified and some additional diseases 
included based on information from the other surveys and the consultants’ opinions. 
The results of the estimated annual economic cost of the priority diseases for cattle, sheep and goats 
are shown in the following three graphs: 
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These results highlight a significant variation in the estimated economic costs of the priority diseases.  
Whilst the results in this report are not directly comparable with those in Sackett et al. (2006), nor 
are they striving to be, they provide a timely and up-to-date assessment of the most economically 
important endemic diseases for the cattle, sheep and goat industries. The estimated costs are based 
on assumptions of disease distributions and impacts for which information is sometimes lacking. 
Every attempt has been made to source data from existing research and surveillance reports of 
disease prevalence and impacts but such data are often incomplete. Expert opinion was used where 
possible to fill knowledge gaps. 
The report highlights the gaps in current knowledge and reviews the availability or effectiveness of 
preventive and treatment strategies currently available for each disease. Where information is 
lacking, further investigations as envisaged in Phase III and Phase IV of the wider livestock disease 
survey may be warranted to increase the confidence in and/or accuracy of the cost estimates.  
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Abbreviation Description 
BVDV Bovine viral diarrhoea virus 
BCS Body condition score 
BEF Bovine ephemeral fever 
BJD Bovine Johne’s Disease 
BW Bodyweight 
CAE Caprine arthritis encephalitis 
CFW Clean fleece weight 
CW Carcass weight 
FD Fibre diameter 
FEC Faecal egg count 
FECRT Faecal egg count reduction test 
HRZ High rainfall zone 
IGR Insect growth regulator 
kg Kilogram 
LW Live weight 
M Millions 
N/kTex Newtons per kilotex 
NSHMP National sheep health monitoring project 
PA Pyrrolizidine alkaloidosis 
PCR Polymerase chain reaction 
PI Persistent infection 
PRG Perennial rye grass 
PRGT Perennial rye grass toxicosis 
WEC Worm egg count 
YO Years old (refers to age of the animal) 
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1 Background 
Since 2006, MLA has used the final report of project B.AHW.087 by Sackett et al. (2006) with its 
estimates of the economic cost of endemic cattle and sheep diseases in Australia to guide research, 
development and extension (RD&E) investments. However, it is recognised that this report has a 
number of shortcomings, namely that it: 
 Was a desk-top study which relied on expert opinions and published literature. 
 Excluded goats. 
 Was unable to address problems perceived to be relatively localised in their impact. 
 Was completed before newly emerged bovine theileriosis became a problem in NSW and 
Victoria. 
The B.AHW.087 final report is now over eight years old and there is a need for an up-to-date, 
objective assessment of the most common endemic diseases for the red meat industries. In 
preparing this report, GHD referred to outputs from the Sackett et al. (2006) report, however the 
authors did not directly compare the cost outcomes or justify any differences that arose because of 
the differences in the methodology. These differences included the use of different economic 
modelling techniques, changes in livestock populations (including for sheep a shift in production 
from wool to prime lambs for meat) and changes in the geographic distribution of the livestock. As 
well, since 2006 there have been changes in the availability of products for prevention and 
treatment of diseases and the costs of these.  
In order to better define the parameters for a new livestock disease survey, MLA funded a scoping 
study (B.AHE.0226), which recommended that the survey be multi-phased with a number of steps 
grouped together to be delivered over four phases:  
 Phase I – Steps 1-3: survey of producers, veterinarians, processors and others; and review 
available data for compilation of a priority disease list. 
 Phase II – Step 4: review the available information on the diseases in the list and identify 
knowledge gaps with regard to prevalence, risk factors, mitigation steps and economic 
impact.  
 Phase III – Steps 5-6: conduct targeted field and abattoir surveys of diseases where 
knowledge is considered to be incomplete. 
 Phase IV – Steps 7-9: determine on-farm and abattoir costs for priority diseases and report 
on the results.  
This project encompasses Phase I and Phase II of the broader livestock disease survey for Australian 
red meat production (cattle, sheep and goats). The report considers diseases and conditions 
predominantly impacting on the grazing industries. A 2013 report prepared by Nigel Perkins 
(P.PSH.0547) provided up-to-date information on animal health of the Australian Feedlot Industry 
and a survey of the live export sector is the responsibility of LiveCorp rather than MLA. 
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2 Objectives 
The objectives of this report are to provide: 
1. A valid list of 20 to 40 of the most economically damaging endemic diseases of cattle, sheep 
and goats. 
2. A documented systematic review of each disease on the priority list with special emphasis on 
prevalence and distribution, risk factors, mitigation steps and economic impacts. 
3. For each disease, recommendations on further research requirements to define the nature, 
extent and importance of the disease. 
3 Methodology 
The project was completed by GHD Pty Ltd is association with the following sub-consultant 
veterinarians: Dr Tristan Jubb, Dr Richard Shephard, Dr Geoffry Fordyce and Dr John Webb-Ware 
(including other members of the Mackinnon Project). 
The project team completed the following activities to prioritise diseases and estimate their 
economic impacts.  
3.1 Surveys 
GHD conducted a range of surveys similar to those described in the B.AHE.0226 Endemic diseases 
scoping study Step 1. Surveys were designed and implemented at a number of different levels and 
using different methods appropriate to each survey. The surveys were used to gauge the level of 
diseases across different geographic regions and were designed to gain an understanding of the 
perceptions of different stakeholders about the extent of diseases. The surveys employed are 
described below. Appendix 1 and Appendix 2 (separate document) include copies of surveys and 
results.  
a) Livestock producers  
A phone survey of cattle, sheep and goat producers was completed using the Computer-assisted 
telephone interviewing (CATI) services of a commercial research company contracted by GHD.  The 
consultants designed a “producer friendly” questionnaire designed to explore producer perceptions 
of important livestock diseases in their locations (cost and effort for prevention and treatment, 
impacts on production and profit, ranking degree of importance). The survey was administered to a 
stratified random sample of cattle, sheep and goat producers compiled from the MLA producer 
member database. The sample frame captured producers of all species (cattle, sheep, goats), 
enterprise types (breeding, fattening, wool, lamb) and regions (north, southwest and southeast) in 
all states and territories. A total of 300 producer surveys were completed with Figure 1 providing a 
breakdown of survey results by state. Of the 300 producer surveys completed, 110 were with 
southern cattle producers, 70 with northern cattle producers, 90 with sheep producers and 30 with 
goat producers. These numbers broadly reflect the relative “grazing pressure” of the different 
livestock types within Australia. 
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Southern cattle Northern cattle 
  
Sheep Goats 
Figure 1 State breakdown of producer surveys by species 
  
B.AHE.0010 Final Report: Priority list of endemic diseases for the red meat industries 
Page 16 of 282 
Figure 2 below outlines the survey results by rainfall zone and the herd / flock size by survey 
respondents.   
  
Respondents by rainfall zone Respondents by size of cattle herd 
  
Respondents by size of sheep flock Respondents by size of goat flock 
Figure 2 Number of survey respondents broken down by rainfall and herd/flock size 
 
b) State Departments of Primary Industries 
The Chief Veterinary Officer (CVO) in each state and territory were contacted by MLA and requested 
to complete a survey of endemic diseases of importance within their jurisdictions with the following 
information requested:  
 The economic importance of each disease (high, medium or low) from the list provided for 
each species. 
 The extent to which more extension (awareness) of currently available treatment and 
prevention options could reduce economic impact. 
 The extent to which more research is required to identify better treatment and control 
options to reduce economic impact. 
 Any comments about the disease/condition/syndrome especially if it relates to any emerging 
trends that will require attention in the near future. 
In addition, CVOs were requested to provide summary data on diagnoses of diseases from specimens 
submitted to their animal health laboratories.  
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c) Livestock veterinarians 
Livestock veterinarians were requested to complete a survey similar to that prepared for the CVOs as 
outlined above. The request was emailed to members of the Australian Cattle Veterinarians (ACV) 
and Australian Sheep Veterinarians (ASV).  This email directed participants to a dedicated website 
which provided background on the project and links to download and complete the survey. Once 
completed the survey could either be returned via email or post.  
d) Processors  
A meeting was held in Sydney with a representative of the Australian Meat Industry Council (AMIC) 
which represents livestock processors to gain information on endemic diseases that impact on 
carcase and co-product yields and downgrades. In addition, AMIC completed a similar survey which 
identified those livestock conditions or diseases of medium or high economic importance to 
processors. Of particular importance to the processors are those diseases or conditions that lower 
the processing 'value' (by intrinsically lowering the value of the animal and/or increasing processing 
costs) of the animal product (e.g. increased dark cutters, increased meat inspection / trimming).  
e) Department of Agriculture and Animal Health Australia 
The Australian Department of Agriculture provided data on cattle, sheep and goat carcase 
condemnations that occurred at the processing stage from its Export Production and Condemnation 
Statistics (EPACS) database. 
Animal Health Australia (AHA) provided information from three of its livestock surveillance 
programs:  
 National Significant Disease Investigation Program. 
 Sheep Health Monitoring Program Abattoir surveillance. 
 National TSE Surveillance Program. 
Data from these were further analysed by GHD to assist in disease prioritisation. 
f) Animal health companies 
Key representatives from Animal health companies were also surveyed to assist in developing a list 
of priority diseases or conditions. This survey asked similar questions to that of livestock 
veterinarians and CVOs with additional questions as follows:  
 For the diseases and conditions listed, please state what product(s) your company has 
available for use in Australia. 
 For the products you provided above, what is the standard price per animal of the 
recommended dose or application rate? 
3.2 Project workshops and discussions 
The project team completed a number of teleconferences and two project team workshops to 
initially finalise the survey questionnaires and then, based on the results of those surveys, finalised 
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the list of priority diseases for further analysis. One major workshop was attended by MLA with the 
following outcomes: 
 Review of the disease or condition lists compiled from the above surveys. 
 Valid final list of livestock disease for cattle, sheep and goats agreed; and 
 Establish and agree on the framework for economic analysis and presentation of each 
disease. 
Attendees at the major workshop analysed the results of all the surveys and the outputs of the data 
provided by relevant agencies to prepare a condensed list of the main diseases for cattle, sheep and 
goats. The producer survey outcomes formed the initial priority list which was modified using the 
information from the other surveys and the consultants’ own experience in disease investigation. 
The final list of 17 cattle, 23 sheep and nine goat diseases was agreed in consultation with MLA.  
Team members sourced information on the prevalence and impacts of each disease from published 
literature and where necessary this was supplemented by informal approaches to colleagues known 
to be experts for particular diseases. Despite this level of investigation, knowledge gaps were 
identified and such gaps may require further investigation in the later phases of the broader disease 
project. Assumptions on disease prevalence and impacts were assembled for each disease and then 
adopted within an Excel spreadsheet to estimate economic impact (see below).   
For many variables that comprise economic impact there is a degree of uncertainty surrounding the 
assumptions adopted. This is represented in the reports for each disease by a rating scale that 
provides the degree of confidence for each assumption. The transparent list of assumptions adopted 
enables estimates to be easily refined in the future when more accurate data become available. 
3.3 Review and modelling 
An Excel spreadsheet model was constructed to quantify the economic impacts of each disease. The 
spreadsheet was based on defining a “typical” herd/flock structure for each species by region (north 
and south for cattle; high rainfall zone, sheep/wheat zone and pastoral zone for sheep) and type of 
production for sheep (wool, prime lambs, dual purpose) and goats (rangeland and farmed). 
The model included a range of variables associated with the economic cost of diseases (prevalence, 
mortality, reproductive loss, weight loss, product quality, costs for prevention and treatment). The 
final output is a cost per herd/flock for each disease which is then extrapolated across the regions of 
disease occurrence to provide a national economic total. The model also includes a calculation of the 
net gain from moving susceptible herds and flocks from the current prevalence level to the lowest 
level of disease. It should be noted that model inputs do not reflect all potential situations; e.g. 
though a disease may very occasionally be associated with mortality, the assumption of zero impact 
may be entered as this is very close to the overall effect for a region. This process captures the 
realisable gains from better disease management understanding that total elimination of disease is 
usually impossible or impractical. 
The Excel spreadsheet for each disease was provided to MLA to enable the ready updating of the 
costs of disease if more accurate data become available. The spreadsheet represents a standardised 
template for future assessments – allowing the capture of relative change in disease impacts to be 
followed over time – and could also be used as a valuable tool in scenario planning of the potential 
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outcomes of future RD&E proposals. Example screen shots of model inputs and outputs are provided 
in Appendix 3.  
It should be noted that the cost models were constructed with the aim of comparing each disease to 
enable the prioritisation process. It is envisaged that models could be further refined in Phases III 
and IV of this project and that such refinement would improve the accuracy of the economic costs of 
each disease.  
Herd and Flock Demographics 
The spreadsheets model adopted herd and flock demographics based on data from the Australian 
Bureau of Statistics (ABS) Agricultural Commodities (2012) data for 2010-11. These data were 
analysed at the Natural Resource Management (NRM) regions level which is also consistent with 
livestock numbers reported by MLA. Data on livestock numbers and average herd/flock sizes are 
shown in Table 3-1, Table 3-2, Table 3-3 and Table 3-4. 
 
The analysis examined the total livestock numbers and the total number of livestock enterprises 
which was then used to work out average herd and flock sizes. Cattle were split into northern and 
southern regions while sheep were split across pastoral, sheep/wheat and high rainfall zones.  
 
Table 3-1 Cattle and sheep numbers 
Cattle  NSW Vic Qld SA WA Tas NT ACT Total 
Northern 
  
12,449,623 
 
1,059,821 
 
2,197,359 - 15,706,803 
Southern 5,383,931 2,365,851 - 1,109,640 894,561 466,583 - 8,807 10,229,373 
Total 5,383,931 2,365,851 12,449,623 1,109,640 1,954,382 466,583 2,197,359 8,807 25,936,176 
 
Sheep NSW Vic Qld SA WA Tas NT ACT Total 
Pastoral 3,251,045 493,416 3,653,238 1,128,932 364,994 - 1,855 - 8,893,480 
Sheep/ 
Wheat 
21,070,130 6,957,062 - 3,381,602 6,018,036 - - 54,092 37,480,922 
High 
rainfall 
2,503,522 7,761,539 - 6,498,008 7,616,824 2,344,469 - - 26,724,362 
Total 26,824,697 15,212,017 3,653,238 11,008,542 13,999,854 2,344,469 1,855 54,092 73,098,764 
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Table 3-2 Number of cattle and sheep businesses 
Cattle  NSW Vic Qld SA WA Tas NT ACT Total 
Northern - - 19,226 - 263 - 254 - 19,743 
Southern 27,164 16,020 - 4,628 4,265 2,602 - 51 54,730 
Total 27,164 16,020 19,226 4,628 4,528 2,602 254 51 74,473 
 
Sheep NSW Vic Qld SA WA Tas NT ACT Total 
Pastoral 743 565 1,818 103 98 - 3 - 3,330 
Sheep/ 
Wheat 
13,356 5,714 - 2,370 2,795 - - 32 24,267 
High 
rainfall 
2,319 4,691 - 4,339 3,330 1,552 - - 16,231 
Total 16,418 10,970 1,818 6,812 6,223 1,552 3 32 43,828 
 
Table 3-3 Cattle and sheep average herd sizes 
Cattle  Average Herd Size 
Northern 796 
Southern 187 
 
Sheep Average Herd Size 
Pastoral 2671 
Sheep/Wheat 1545 
High rainfall 1647 
 
The current demographics of Australian goats were extrapolated from the Australian Bureau of 
Statistics (ABS) Agricultural Commodities (2012) data for 2010-11 and a consultant’s report prepared 
for MLA (BCS Agribusiness 2011). 
A final figure of 4 million rangeland and 250,000 farmed meat goats and 150,000 farmed fibre goats 
(99% mohair) was decided with the 400,000 farmed goats split 10%, 20% and 70% into the high 
rainfall, sheep-wheat and pastoral zones respectively. 
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It is estimated that there are possibly 25,000 dairy goats in Australia. In 2009 there were 
approximately 65 commercial dairy goat farms, carrying close to 12,000 goats (BCS Agribusiness 
2011) and there are many small herds with less than 10 animals (GICA 2014).  Dairy goats have not 
been considered in this study. 
Table 3-4 Goat numbers 
Goats Total 
Rangeland 4,000,000  
Meat 250,000 
Fibre 150,000  
Total 4,400,000  
 
3.4 Priority diseases for modelling 
The priority lists of diseases for cattle, sheep and goats adopted by the consultants are shown below. 
The lists were derived from an analysis of the survey results (see Appendix 2 for these results) and 
were initially primarily ranked according to the opinions of the livestock producers surveyed. Final 
lists were derived at a workshop with the consultants at which an MLA representative attended and 
assented to the list. Those diseases that were considered but were not included in the priority list are 
provided in section 0.  
Cattle 
Cattle tick 
Pestivirus (Bovine viral diarrhoea) 
Buffalo fly 
Dystocia  
Neonatal mortalities  
Internal parasites  
Bloat  
Bovine ephemeral fever 
Botulism 
Grass tetany 
Calf scours complex 
Vibriosis 
Theileria 
Pinkeye  
Clostridial infection 
Tick fever 
Johne's disease 
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Sheep 
Neonatal mortalities 
Internal parasites  
Dystocia 
Weaner ill-thrift 
Flystrike - body & breech 
Perennial ryegrass staggers 
Lice 
Mastitis 
Footrot 
Arthritis 
Ovine Johne’s disease (OJD) 
Clostridial disease 
Liver fluke  
Pneumonia 
Caseous lymphadenitis 
Pregnancy toxaemia 
Hypocalcaemia 
Foot abscess 
Bacterial enteritis 
Pyrrolizidine alkaloidosis  
Sheep measles 
Campylobacter abortion 
Sarcocystis 
 
Goats 
Internal parasites  
Enterotoxaemia  
Lice 
Pregnancy toxaemia 
Caseous lymphadenitis 
Liver fluke  
Footrot 
Johne's disease 
Caprine arthritis-encephalitis (CAE) 
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3.5 Other diseases considered 
The following diseases were also nominated from the range of surveys as being of importance to the 
livestock industries. However, the consultants did not include these in a priority list for further 
systematic review for the following reasons (note that no additional goat diseases were provided 
from the survey results): 
 Covered in the priority list (e.g. blackleg included in clostridial diseases) 
 More relevant to other livestock sectors (e.g. dairy, feedlots, live exports) 
 Considered to be episodic with well-known aetiology, prevention and treatment options (e.g. 
anthrax) 
 While some diseases were important in certain regions, the analysis was conducted at the 
industry level 
 Considered to be of lower priority within a time and budget constrained project setting.  
Cattle diseases not included in priority list 
Blackleg 
Leptospirosis 
Liver fluke (fascioliasis) 
Enterotoxaemia 
Footrot 
Tetanus 
Mastitis 
Milk fever (Hypocalcaemia) 
Plant poisoning 
Abortion 
Acaracide resistance  
Lantana poisoning 
Perennial ryegrass toxicosis 
Micro-nutrients  
Anthrax 
Neospora 
Annual ryegrass toxicity 
Pregnancy toxaemia (fatty liver disease) 
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Sheep diseases not included in priority list 
Brucella ovis (Brucellosis) 
Scabby mouth 
Cancer 
Copper deficiency 
Mastitis 
Pinkeye 
Annual ryegrass toxicity 
Selenium + Vitamin E deficiency 
Cobalt deficiency 
Iodine deficiency 
Toxoplasmosis 
Campylobacter abortion 
Prolapse 
Acidosis 
Clover disease 
Dermatophilosis 
Fleece rot 
Lupinosis 
Pizzle rot 
Phalaris staggers 
Phalaris sudden death 
Mycoplasma ovis 
 
Sections 0, 5 and 6 provide a description of each of the diseases, the assumptions adopted including 
for distribution, prevalence and production impacts, and the estimated the economic impacts 
calculated by using the spreadsheet model. The economic impacts are calculated at a herd/flock and 
national level. A draft of the report with the economic impacts was peer reviewed by veterinary 
consultants selected by MLA. In addition, these reviewers, the project team members and MLA staff 
conducted a workshop to review model input assumptions prior to finalising the economic costs 
presented in this report.    
3.6 Presentation of results 
The diseases for cattle, sheep and goats are presented in order of the estimated cost of the disease. 
For each disease, a brief introduction on its aetiology is provided, followed by a description (with 
evidence) of its prevention, treatment, distribution and prevalence. For each of these attributes, the 
consultants provide a summary of the current level of knowledge using a 10-point scale (e.g. for 
prevention, the scale ranges from “low efficacy/ unproven treatments available” through to 
“effective treatments available”). 
The economic impact of each disease is then informed by assumptions that are summarised in a 
table of relevant variables. The value adopted for each variable includes a confidence rating (from 
“*” = low confidence, to “***” = high confidence). To limit the space required, the assumptions 
tables include abbreviations for the respective variables. A description of the abbreviations is 
provided in the table on page 12. 
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Finally, for each disease a summary table of the costs for treatment, prevention, production losses 
and the total for these is provided at an animal, herd/flock and national level based on outputs from 
the economic model. Note that total costs for each disease are not necessarily mutually exclusive. 
For example, the costs of neonatal mortalities in sheep include production losses associated with 
dystocia and mastitis which are also separately reported. An explanation is provided in these cases.  
Section 7 includes summaries of the diseases in priority order based on estimated costs to the 
industry. Included in the summaries is an analysis of the gaps in knowledge in relation to aetiology, 
distribution and prevalence of each disease, and commentary on the availability of products and/or 
management opportunities to effectively prevent or treat the disease. An overall score that 
combines current knowledge (aetiology, distribution and prevalence) and the ability to manage the 
disease (availability of effective preventive and treatment agents) is also calculated to provide 
guidance on those aspects of the diseases that will most benefit from future research, development 
and/or extension.  
It should be noted that the calculated overall score is largely based on subjective assessments by the 
consultants – it is more a qualitative ranking than an absolute measure – and should be used as such 
to assist in guiding decision making and to enable MLA to consider the most appropriate research, 
development or extension strategy to assist the livestock industries to better manage diseases. Care 
is needed if this score is to be used, recognising its limitations as a definitive metric for decision 
making.   
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4 Results – Cattle diseases 
4.1 Cattle tick 
The disease 
The cattle tick, Rhipicephalus microplus, causes anaemia by virtue of blood sucking.  As well, it is the 
vector for three tick fever organisms in Australia.  Ticks favour warm moist conditions in their non-
parasitic stage which is between when the engorged female leaves its host to lay eggs, and when 
larval ticks reattach for their 21-day feeding period.  The non-parasitic stage can be as long as 7 
months.  Increasing Bos indicus content is associated with higher resistance to tick attachment, but 
within level of (0-100%) Bos indicus there is substantial variation in resistance; the heritability is 34% 
(Mackinnon et al. 1991).  Cattle ticks can also parasitise a wide range of other animal species, 
including horses. Holroyd et al. (1988) reported that in years with highest tick burdens, 
Droughtmaster cattle in a dry topical environment were up to 25kg heavier through a reproductive 
cycle, had conceptions rates up to 30% higher and weaned calves up to 24 kg heavier when tick 
infestation was fully controlled.  Johnston et al. (1981) had previously found average annual live 
weight effects of <10 kg and no effect on conception rates.  Tick control increases annual growth of 
Brahman cross heifers from weaning to the end of mating at 2.5 years of age by >10 kg without 
affecting maiden pregnancy rates (Holroyd and Dunster 1978; Johnston et al. 1981).  Heifer 
pregnancies were unaffected by tick control in either study. 
 
Unknown aetiology Known aetiology 
        X  
 
Prevention 
In addition to breed and within breed selection, acaracides are the most frequently used control 
method.  There is a long history of ticks developing resistance to these chemicals, which has led to 
research for an effective tick vaccine.  An efficacious first-generation vaccine was available for a 
short period in the 1990s, but no new vaccine has become commercially available (Willadsen 2008).  
White et al. (2003) estimated that the effect of ticks on live weight production could be reduced by 
60% in Australia by genetic changes alone. The shift away from high percentage Brahman cattle is 
increasing the need for efficacious preventative measures such as vaccine and genetic change. 
Sackett et al. (2006) stated the annual quarantine cost to NSW and Queensland to be $2-7M and 
<$2M, respectively. 
Low efficacy/ unproven preventives available Effective preventives available 
       X   
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Treatment 
O’Rourke et al. (1992) reported that 78% of cattle in high-rainfall regions were treated for ticks, and 
~48% of cattle in the balance of the tick zone of northern Australia were treated, with approximately 
5% across both regions not treated.  Playford (2005) reported that $16.8M was spent on acaracides 
in 2003. Some labour is associated with all treatments. Hide values, currently ~$30, can be reduced 
by 25% with an average of 20% affected (Playford 2005). While treatment is an option it is not 
considered to be cost effective. 
Low efficacy/ unproven treatments available Effective treatments available 
      X    
 
Distribution 
Dry and cool climate areas combined with tick-free zones restricts the tick and thus the disease to 
eastern and northern areas of Queensland, Northern Territory and Western Australia. 
Distribution contracting Distribution stable Distribution increasing 
    X      
 
Prevalence 
Approximately 45% of Queensland’s cattle are within the regulated tick-free zone, no regulated zone 
exists in either the NT or WA. There is a low prevalence of ticks in Queensland’s endemic tick zones 
beyond 200 km from the coast following droughts in the 1990’s, 2000’s and current, where 
approximately 40% of cattle are reared.  There has been limited resurgence of ticks during wetter 
years where dry seasonal conditions have eliminated them. 
Prevalence decreasing Prevalence increasing 
    X      
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Economics 
Assumptions: Cattle tick (southern) 
As tick is restricted to northern Australia, the annual cost of tick in southern Australia is limited to 
the assumed cost of quarantine of $5M. 
 
Assumptions: Cattle tick (northern) 
Table 4-1 Assumptions: cattle tick (northern) 
Variable Value adopted Confidence 
Regional Extent 15%, 15%, 35% and 35% of herds with a high, medium, low and 
nil incidence 
*** 
% herds infected 
Infestations of clinical significance occur every year, 2 in 3 years, 
and in one year in three in high, medium and low incidence 
regions. 
** 
Mortalities 
The model assumes no mortalities are caused by the tick. Note 
that tick fever causes loss, and most producers institute 
treatment to minimise tick impacts. 
** 
Weight loss 
Annual weight deficit due to ticks in untreated clinically-affected 
cattle averages 15 kg. 
* 
Fertility Conception rates are reduced by 10% in clinically-affected cattle. * 
Market avoidance 
Clearing of ticks for market access is covered under treatment. 
25% of hides have values reduced by 25%. 
** 
Movement 
restrictions 
Quarantine zones are in place and cost $1.7M annually to 
manage in Queensland 
** 
Treatment 
75%, 50% and 50% of clinically-affected cattle are treated in 
high, medium and low incidence regions, respectively. 
** 
Prevention 
No specific cost as use of tropically-adapted breeds is primarily 
based on production potential rather than tick resistance 
specifically. Some costs associated with strategic prevention are 
included as treatment costs. 
*** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of cattle tick in northern Australia at $156.0M (Table 4-2). 
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Table 4-2 Economic cost of cattle tick – northern 
 Treatment Prevention Production Total 
 H M L H M L H M L H M L 
Per 
Cattle 
$5.03 $2.22 $1.11 $0.17 $0.17 $0.17 $21.34 $15.90 $7.95 $26.54 $18.28 $9.22 
Per 
Herd 
$3,998 $1,759 $879 $133 $133 $133 $16,941 $12,621 $6,311 $21,072 $14,513 $7,323 
Total $23.1M $1.7M $131.2M $156.0M 
 
Total cost of disease 
The total cost for cattle across Australia at the current prevalence of disease is estimated at $161.0M 
per annum. The net gain from moving all herds experiencing tick infestation to the lowest level of 
disease is estimated at $62.0M. 
 
4.2 Bovine viral diarrhoea virus (BVDV or pestivirus) 
The disease 
Various strains of Type 1 BVDV (a pestivirus) in Australia impact on reproduction and mortality in 
grazing beef cattle.  The virus is mainly spread by direct contact with persistently-infected (PI) 
animals.  The major problems are conception failure, early-pregnancy abortion, and mortality of PI 
calves of which approximately 50% die by weaning age, and approximately 50% of surviving calves 
die annually thereafter (McGowan et al. 1993a; McGowan et al. 1993b; Kirkland et al. 1990).  The 
virus also has a predilection for the immune system, and this may increase the incidence of other 
diseases when animals are experiencing transient infection. McGowan et al. (2014) reported that the 
average percent cattle pregnant within 4 months of calving was 57%, 43% and 34% in north 
Australian herds with <20%,  20-80%  and >80% of cows sero-positive to BVDV, respectively. 
Prevalence of >30% of recent BVDV infection in early-mid pregnant cows was associated with almost 
10% higher foetal and calf loss than in herds with <10% prevalence of recent infection, also reported 
by Kirkland et al. (2012) and Morton et al. (2013). Modelling that uses an understanding of BVDV 
epidemiology in Australia and the known incidence of PI animals suggests that, depending on the 
relative prevalence of BVDV strains with varying abortigenic effect, weaning rate is conservatively 
estimated to be lower by between 1% and 4.5% as a result of between 3% and 7% of cows being 
infected in early pregnancy each year.  Some live export market protocols require freedom from 
BVDV and/or no evidence of this disease being recently transmitted within the source herd. 
Unknown aetiology Known aetiology 
         X 
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Prevention 
A range of strategies is used to control infection and impacts.  These include control and eradication 
through identifying immune animals and PIs using the large range of diagnostic tests available, 
biosecurity to prevent movement of PIs and or to identify movement of unborn PIs, and strategic use 
of a killed vaccine with efficacy of ~80% which is registered for use in Australia (Bergman and Reichel 
2014).  The vaccine, which can increase pregnancy rates by 15% in endemically-infected herds 
(Bergman and Reichel 2014), has a retail cost of $4-5/dose, requires two initial injections, and may 
be recommended for annual use in some herds. An average of ~0.5M and ~1M doses of vaccine were 
sold annually in northern and southern Australia in 2012-13 (Zoetis, pers comm). 
Low efficacy/ unproven preventives available Effective preventives available 
      X    
 
Treatment 
No specific treatment exists for BVDV. 
Low efficacy/ unproven treatments available Effective treatments available 
X          
 
Distribution 
Recent data from >37,000 cattle that were mostly 1-2 years of age and destined for live export 
showed there is very little variation in >1% prevalence of cattle being BVDV antigen positive across 
Australia (Dr Peter Kirkland, Elizabeth McArthur Agricultural Institute, NSW, personal 
communication).  Extensive testing of steers of a similar average age at feedlot entry in Australia has 
found that ~0.5% are PI cattle (MR McGowan, UQ, personal communication). 
Distribution contracting Distribution stable Distribution increasing 
    X      
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Prevalence 
McGowan et al. (2014) reported that 15-21%, 39-50% and 35-40% of north Australian cow herds had 
prevalence of cows sero-positive to BVDV of <20%,  20-80%  and >80%, respectively; recent infection 
was found in 4-16% of cow herds. St George et al. (1967) had previously reported that 61% of 
Australian cattle were seropositive and 79% of herds infected, indicating little change in prevalence 
in 45 years. Both Kirkland et al. (2012) and Morton et al. (2013) also reported a low proportion of 
cattle herds having recent BVDV infection. Both groups reported that half the herds they studied had 
0-30% sero-positive animals, indicating high susceptibility to the virus. 
Prevalence decreasing Prevalence increasing 
     X     
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Economics 
Assumptions: Bovine viral diarrhoea virus – southern 
Table 4-3 Assumptions: Bovine viral diarrhoea virus – southern 
Variable Value adopted Confidence 
Regional 
Extent 
10%, 25%, 45% and 20% of herds with a high, medium, low 
and nil incidence rate 
** 
% herds 
infected 
An average of 20% of cows are transiently infected in high-
incidence herds in a year with 7% of calves born as PIs, 
contributing to a national prevalence of 0.5% PIs as 
yearlings. 
Rates are set at 50% and 5% of this in moderately- and 
lowly-affected herds. 
** 
Mortalities 50% mortality of PIs as weaners and then annually *** 
Weight loss No temporary weight loss *** 
Fertility 
Half of the cows infected in the first trimester abort. As many 
infected cows are culled because they are non-pregnant, the 
reduction in pregnancy rate is set at 2% in high-incidence 
herds. 
*** 
Market 
avoidance 
No PIs exported for breeding *** 
Movement 
restrictions 
Nil *** 
Treatment No treatment available *** 
Prevention 
Vaccination of all cattle in 20% of low-incidence herds where 
30% of heifers are vaccinated. As many infected cows are 
culled because they are non-pregnant, the reduction in 
pregnancy rate is set at 2% in high-incidence herds. 
** 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of BVDV in cattle in southern Australia at $63.5M (Table 4-4).  
 
  
B.AHE.0010 Final Report: Priority list of endemic diseases for the red meat industries 
Page 33 of 282 
Table 4-4 Economic cost of bovine viral diarrhoea virus – southern  
 Treatment Prevention Production Total 
 H M L H M L H M L H M L 
Per Cattle $0 $0 $0 $0 $0 $1.08 $19.14 $9.61 $2.99 $19.23 $9.69 $4.13 
Per Herd $0 $0 $0 $0 $0 $201 $3,578 $1,797 $560 $3,596 $1,812 $772 
Total $0M $5.0M $58.5M $63.5M 
 
The net gain from moving all southern herds experiencing BVDV to the lowest level of disease is 
estimated at $29.7M. 
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Assumptions: Bovine viral diarrhoea virus – northern 
Table 4-5 Assumptions: bovine viral diarrhoea virus – northern (cattle) 
Variable Value adopted Confidence 
Regional 
Extent 
10%, 30%, 40% and 20% of herds with a high, medium, low 
and nil prevalence rate 
** 
% herds 
infected 
An average of 20% of cows are infected in high-incidence 
herds in a year with 7% of calves born as PIs, resulting in 
national prevalence of 0.5% PIs as yearlings. Rates are set 
at 50% and 5% of this in moderately- and lowly-affected 
herds. 
** 
Mortalities 50% mortality of PIs as weaners and then annually *** 
Weight loss No temporary weight loss *** 
Fertility 
Half of the cows infected in the first trimester abort. As many 
infected cows are culled because they are non-pregnant, the 
reduction in pregnancy rate is set at 2% in high-incidence 
herds. 
*** 
Market 
avoidance 
No PIs exported for breeding *** 
Movement 
restrictions 
Nil *** 
Treatment No treatment available *** 
Prevention 
Vaccination of all cattle in 5% of low-incidence herds with 
30% of heifers only in these herds. vaccinated in 15% of 
herds. All rates are reduced for the proportion of cows 
vaccinated with 80% vaccination efficacy. 
** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of BVDV in cattle in northern Australia at $50.9M (Table 4-6).  
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Table 4-6 Economic cost of bovine viral diarrhoea virus – northern (cattle) 
 Treatment Prevention Production Total 
 H M L H M L H M L H M L 
Per Cattle $0 $0 $0 $0.00 $0.00 $0.44 $11.54 $5.87 $0.44 $11.57 $5.89 $0.89 
Per Herd $0 $0 $0 $0 $0 $343 $9,073 $4,614 $343 $9,069 $4,631 $701 
Total $0M $2.7M $48.2M $50.9M 
 
The net gain from moving all northern herds experiencing BVDV to the lowest level of disease is 
estimated at $39.9M. 
Total cost of disease 
The total cost of BVDV in cattle across Australia at the current prevalence of disease is estimated at 
$114.4M per annum, which is higher than the estimate of $49.1M by Lanyon et al. (2011). The net 
gain from moving all herds experiencing BVDV to the lowest level of disease is estimated at $98.5M. 
Note that the estimated costs are averaged across all herds and as such do not recognise the 
episodic fashion in which BVDV impacts on individual herds; very few herds experience this ‘average’ 
loss in any given year. 
This estimate of BVDV impact substantially exceeds the perceptions of many beef producers and 
veterinarians. Much of this perception is derived from the apparent low visibility of the PI mortality 
rate and impacts on pregnancy rates that have been reported in domestic and international studies. 
BVD is a complex and insidious disease.  There are limited data that provide a national perspective, 
and because of this, some inputs may have been incorrectly assigned in modelling the impacts of 
BVDV impact.  Further impacts research is indicated. 
 
  
B.AHE.0010 Final Report: Priority list of endemic diseases for the red meat industries 
Page 36 of 282 
4.3 Buffalo fly 
The disease 
Haematobia irritans exigua is a blood sucking fly that can only survive by 10-40 daily feeds (Meat & 
Livestock Australia 2005).  It reproduces in cattle dung and populations may therefore be impacted 
by the presence or absence of dung beetles.  Populations are highest during warm wet conditions 
and can average 1,000 per animal (Holroyd et al. 1984).  Growth advantages from efficacious fly 
control have been reported by several authors (Meat & Livestock Australia 2005) and may average 
about 10%.  Some cattle are sensitive to flies or to the skin-residing parasite they transmit, 
Stephanofilaria sp., resulting in intense irritation causing skin lesions that may affect hide values and 
suitability for live export.  This sensitivity is lowly heritable. Flies are a welfare issue as cattle seek 
treatments they have learned to be associated with relief from infestation. 
Unknown aetiology Known aetiology 
       X   
 
Prevention 
Any treatment is expected to have welfare benefits.  A well-controlled study showed that live weight 
impacts can only be achieved through sustained, highly-efficacious chemical fly control (Holroyd et 
al. 1984).  Occasional treatment is unlikely to have a long-term live weight impact despite obvious 
effects on welfare on the animals.  Fly control also eliminates skin lesions (Holroyd et al. 1984). 
Low efficacy/ unproven preventives available Effective preventives available 
   X    X   
 
Treatment 
O’Rourke et al. (1991) reported that 67% of north Australian producers applied buffalo fly 
prevention, and a further 5% whose cattle experienced infestation applied no treatment.  A range of 
insecticide treatments are available with an estimated $4-6M spent annually on chemical control 
(Meat & Livestock Australia 2005).  Other treatments such as fly traps are very expensive and few are 
in use. 
Low efficacy/ unproven treatments available Effective treatments available 
       X   
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Distribution 
The fly is mainly distributed in eastern Queensland, the northern areas of the NT and WA, and the NE 
corner of NSW (Meat & Livestock Australia 2005). However the fly has also been recorded in Victoria 
and in Alice Springs. 
Distribution contracting Distribution stable Distribution increasing 
    X      
 
Prevalence 
Prevalence is affected by seasonal conditions.  Particularly under early wet season conditions, high 
fly populations can occur very quickly as the life cycle can be less than 2 weeks (Meat & Livestock 
Australia 2005).  Populations are highest in near-coastal regions of northern Australia where 
humidity is highest.  Populations become very low under dry or cool conditions. Where flies are 
persistent, populations sufficient to affect live weight production may persist for 2-6 months 
annually. 
Prevalence decreasing Prevalence increasing 
    X      
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Economics 
Assumptions: Buffalo fly – southern 
Table 4-7 Assumptions: buffalo fly – southern (cattle) 
Variable Value adopted Confidence 
Regional 
Extent 
0%, 5% and 10% of herds with high, medium and low 
incidence 
** 
% herds 
infected 
Entire herds are infested, but an average of 33% and 10% 
of the year in medium and low incidence herds, respectively 
** 
Mortalities No mortalities caused *** 
Weight loss 
Where prevention is applied during infestation, in 25% of 
these situations there is effective prevention of permanent 
weight loss, which is 10% over the infestation period 
* 
Fertility Nil effect * 
Market 
avoidance 
Skin lesions cause 5% and 2% of cattle in medium and low 
incidence herds, respectively, to have net market value 
reduced by $0.10/kg 
* 
Movement 
restrictions 
Nil *** 
Treatment As for prevention ** 
Prevention 
70% of cattle in affected areas have some form of control 
applied.  An average of $1/animal/month is required for full 
control. Partial control costs half this. 
** 
Based on the adopted prevalence and impacts of buffalo fly on the classes of animals affected, GHD 
has calculated the annual cost of buffalo fly in cattle in southern Australia at $4.1M (Table 4-8). 
 
Table 4-8 Economic cost of buffalo fly – southern (cattle) 
 Treatment Prevention Production Total 
 H M L H M L H M L H M L 
Per Cattle $0 $0 $0 $0.03 $2.04 $0.44 $0 $4.27 $0.41 $0.03 $6.31 $0.85 
Per Herd $0 $0 $0 $5 $384 $83 $0 $802 $77 $5 $1,186 $160 
Total $0M $1.5M $2.6M $4.1M 
 
The net gain from moving all southern herds experiencing buffalo fly to the lowest level of disease is 
estimated at $2.8M. 
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Assumptions: Buffalo fly – northern 
Table 4-9 Assumptions: buffalo fly – northern (cattle) 
Variable Value adopted Confidence 
Regional 
Extent 
10%, 50% and 30% of herds with high, medium and low 
incidence 
** 
% herds 
infected 
Entire herds are infested, but an average of 80%, 33% and 
10% of the year in high, medium and low incidence herds, 
respectively 
** 
Mortalities No mortalities caused *** 
Weight loss 
Where prevention is applied during infestation, in 25% of 
these situations there is effective prevention of permanent 
weight loss, which is 10% over the infestation period 
* 
Fertility Nil effect * 
Market 
avoidance 
Skin lesions cause 10%, 5% and 2% of cattle in high, 
medium and low incidence herds, respectively, to have net 
market value reduced by $0.20/kg 
* 
Movement 
restrictions 
Nil *** 
Treatment As for prevention ** 
Prevention 
70% of cattle have some form of control applied.  An 
average of $1/animal/month is required for full control. 
Partial control costs half this. 
** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of buffalo fly in cattle in northern Australia at $94.6M (Table 4-10). 
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Table 4-10 Economic cost of buffalo fly – northern (cattle) 
 Treatment Prevention Production Total 
 H M L H M L H M L H M L 
Per Cattle $0 $0 $0 $7.59 $1.95 $0.42 $26.34 $2.91 $0.28 $33.93 $4.86 $0.7 
Per Herd $0 $0 $0 $6,026 $1,547 $335 $20,915 $2,311 $223 $26,941 $3,858 $558 
Total $0M $29.1M $65.4M $94.6M 
 
The net gain from moving all northern herds experiencing buffalo fly to the lowest level of 
infestation is estimated at $84.9M. 
 
Total cost of disease 
The total cost of buffalo fly in cattle across Australia at current prevalence is estimated at $98.7M 
per annum. The net gain from moving all herds to the lowest level of infestation is estimated at 
$87.7M. 
 
4.4 Dystocia 
The disease 
Dystocia is most commonly due to foetal-maternal incompatibility – foetus is relatively or absolutely 
too large to fit through the maternal pelvis – but may also occur due to malpresentation of the 
foetus. Less commonly dystocia can occur secondary to other disease such as milk fever and 
malformation of the calf.  Foetal-maternal incompatibility is the most important cause of dystocia in 
Australia occurring predominately in primiparous heifers and arising due to mismating (heifer too 
small, poor bull selection), overlong gestations and/or (most commonly) inadequate nutrition in 
growing pregnant heifers.  
A 2000 survey of dystocia in Angus heifers reported an incidence of around 5.0% in heifers enrolled 
in controlled (growth-rate selective) breeding programs and an incidence of approximately 10.0% in 
uncontrolled matings. The incidence of dystocia in mature cows is low – an estimated maximum of 
2% is assumed. The survival of calves to weaning following a difficult calving has been estimated to 
be 12% less than calves born normally.  
For northern Australia we have assumed a lower incidence of dystocia – averaging at 2.0% of heifers 
and 0.3% of cows. We have assumed fewer inspections of calving cows in the northern industry and 
subsequently all dystocic calves and around 25% of dams die following unaided dystocia.   
The cause of the disease and predisposing risk factors are well known. Viral and other causes of 
arthrogryposis can result in malpresentation vary in incidence and distribution from year to year but 
are generally minor causes. Nutrition of the dam – especially yearlings and heifers – and during late 
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gestation strongly influences maternal-foetal mismatch. Under-nutrition is the major predisposing 
factor for dystocia in northern animals. 
Unknown aetiology Known aetiology 
        X  
 
Prevention 
Prevention of the majority of dystocia due to foetal-maternal mismatch is well known. Mating well-
grown heifers to low birthweight bulls combined with adequate supervised nutrition throughout 
pregnancy and at calving is essential. Foetal-maternal mismatch provides significant animal welfare 
challenges. The cost of preventing dystocia through selective genetics and better nutrition has not 
been assigned as the benefits from these practices extend beyond just dystocia prevention. Dystocia 
due to foetal-maternal mismatch can be controlled by good management. Access and ability to 
effectively monitor calving stock is markedly different between the southern more intensive and the 
northern more extensive industries. This is reflected in different labour costs and survival rates for 
dystocic cows and their calves between the two industries. 
Low efficacy/ unproven preventives available Effective preventives available 
       X X  
 
Treatment 
Regular inspection of calving cattle combined with judicious assistance is an essential component of 
good animal husbandry. Veterinary assistance is occasionally required. A daily inspection cost at 
calving has been assigned to prevention. Assistance should be administered early enough to ensure a 
live calf can be delivered. This needs to be balanced against not intervening too early, especially in 
heifers. 
Low efficacy/ unproven treatments available Effective treatments available 
       X   
 
Distribution 
All beef cattle are at risk of dystocia. Intensification of production systems is leading to more disease. 
Distribution contracting Distribution stable Distribution increasing 
    X      
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Prevalence 
The average prevalence of dystocia is assumed at 5% for heifers and <1% for cows. Of these 
assistance is required in one in ten cases. Mortality of calves born to difficult calving is assumed to be 
12% greater than background mortalities. Mortality in the dam is assumed at 0.5% of cases. 
Prevalence decreasing Prevalence increasing 
    X      
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Economics 
Assumptions: Dystocia – southern 
Table 4-11 Assumptions: dystocia – southern (cattle) 
Variable Value adopted Confidence 
Regional 
Extent 
All beef herds are at risk of dystocia – malpresentation can occur in 
any animal 
*** 
% herds 
infected 
5% of southern herds experience large-scale dystocia problems: up 
to 25% of heifers and 2% of mature cows experiencing dystocia 
10% of southern herds experience moderate problems: up to 10% of 
heifers and 1% of mature cows experiencing dystocia 
85% of southern herds experience minor problems: up to 5% of 
heifers and 0.5% of mature cows experiencing dystocia 
** 
Mortalities 
A 1% cow mortality rate is assumed. The mortality rate of calves 
born to dystocic births is 12% higher than for non-dystocic births. 
** 
Weight loss 
A 10kg and 5kg average temporary weight loss is assumed in 
dystocic heifers and cows respectively. There is an additional 5 kg 
weight loss assumed for dystocic heifers. 
* 
Fertility No further impacts beyond direct mortalities listed above * 
Market 
avoidance 
Nil *** 
Movement 
restrictions 
Nil *** 
Treatment 
Treatment is by manual assistance to calve by the farmer (pull – 
costed at $50) with a 10% of cases being serviced by veterinarians 
(costed at $350). This provides an average cost of $80 per assisted 
dystocia with 90% of southern cattle experiencing dystocia being 
detected and assisted. 
** 
Prevention 
Daily inspections costs have been assigned to prevention. Twice 
daily inspection at calving is assumed for herds with severe 
problems and once daily for others. 
** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of dystocia in cattle in southern Australia at $59.6M (Table4-12)  
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Table 4-12 Economic cost of dystocia – southern (cattle) 
 Treatment Prevention Production Total 
 H M L H M L H M L H M L 
Per 
Cattle 
$3.24 $1.35 $0.67 $8.76 $4.38 $3.41 $4.21 $1.73 $0.86 $16.22 $7.46 $4.95 
Per 
Herd 
$613 $255 $127 $1,656 $828 $644 $796 $327 $163 $3,065 $1,410 $935 
Total $9.0M $39.0M $11.6M $59.6M 
 
The net gain from moving all southern herds to the lowest dystocia prevalence band is estimated at 
$8.4M per annum.  
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Assumptions: Dystocia – northern 
Table 4-13 Assumptions: dystocia – northern (cattle) 
Variable Value adopted Confidence 
Regional 
Extent 
All beef herds are at risk of dystocia – malpresentation can occur in 
any animal 
*** 
% herds 
infected 
5% of northern herds experience large-scale dystocia problems: up 
to 20% of heifers and 2% of mature cows experiencing dystocia 
15% of northern herds experience moderate problems: up to 10% of 
heifers and 1% of mature cows experiencing dystocia 
85% of northern herds experience minor problems: up to 5% of 
heifers and 0.5% of mature cows experiencing dystocia 
* 
Mortalities 
A 25% heifer and 10% cow mortality rates are assumed. The 
mortality rate of calves born to dystocic births is assumed twice that 
of southern herds due to the lower assistance rate in the north (24% 
higher than for non-dystocic births).  
* 
Weight loss 
An average of 5kg temporary and 5kg permanent weight loss is 
assumed in dystocic heifers that survive. No weight loss is assumed 
for dystocic cows that survive. 
* 
Fertility No further impacts beyond direct calf mortalities listed above * 
Market 
avoidance 
Nil *** 
Movement 
restrictions 
Nil *** 
Treatment 
Treatment is by manual assistance by the farmer or veterinarian. An 
average cost of $50 per dystocia is assumed (non-veterinary ‘pulls’ 
only) but only 5% (severe), 2% (moderate) and 1% (low) of dystocia 
cases are detected and/or assisted in each of the three herd 
prevalence levels in the north. 
* 
Prevention 
Daily inspections costs have been assigned to prevention. Twice 
daily inspection at calving is assumed for herds with severe 
problems and once daily for others. However, only 10% (severe), 3% 
(moderate) and 1% (low) affected herds use once daily inspections.  
** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of dystocia in cattle in northern Australia at $38.2M (Table 4-14). 
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Table 4-14 Economic cost of dystocia – northern (cattle) 
 Treatment Prevention Production Total 
 H M L H M L H M L H M L 
Per 
Cattle 
$0.11 $0.02 $0.00 $0.51 $0.15 $0.03 $9.42 $3.88 $1.94 $10.04 $4.05 $1.97 
Per 
Herd 
$79 $13 $2 $382 $115 $19 $7,066 $2910 $1,455 $7,528 $3,037 $1,476 
Total $0.1M $0.9M $37.1M $38.2M 
 
The net gain from moving all northern herds to the lowest dystocia prevalence band is estimated at 
$9.1M; although this may not be practically achieved due to difficulties of inspection and handling of 
the majority of dystocic animals in the northern environment. 
Total cost of disease 
The total cost of dystocia in cattle across Australia at the current prevalence of disease is estimated 
at $97.8M per annum. The net gain from moving all herds (northern and southern) to the lowest 
dystocia prevalence band is estimated at $17.8M. 
 
4.5 Neonatal calf mortality of unknown cause 
The disease 
Recent Beef CRC data confirmed that in northern Australia, about 2/3rd of reproductive loss occurs as 
calf loss within the neonatal period up to a week after birth (Bunter et al. 2014), but 1/3rd in 
southern Australia (Copping et al.: In press).  The aetiology of several percentage units is known and 
some are discussed elsewhere in this report. It includes: reproductive diseases such as vibriosis and 
BVDV (Fordyce et al. 2014) across Australia, and Neosporosis in southern Australia (Atkinson et al. 
2000); animal factors such as udder conformation (Bunter et al. 2014) and dystocia, especially in 
heifers; losses associated with cow mortality which is primarily associated with available nutrition 
and the physiological state of the cow as reflected in body condition and stage of the reproductive 
cycle (Fordyce et al. 2014).  The aetiology of neonatal loss in excess of ~5-10% has remained largely 
unknown in northern Australia, though recent research has shown the major risk factors to be 
behavioural, nutritional, managerial and environmental (Fordyce et al. 2014).  Insufficient milk 
production and delivery and inadequate calf suckling are hypothesised to be how these risk factors 
mediate their effect. 
Unknown aetiology Known aetiology 
 X         
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Prevention 
Prevention of high neonatal calf mortality rates with unknown cause may be achieved through 
managing nutritional and environmental factors, but this has not been demonstrated. 
Low efficacy/ unproven preventives available Effective preventives available 
 X      X   
 
Treatment 
A small percentage of these calves are rescued and are hand-reared. 
Low efficacy/ unproven treatments available Effective treatments available 
    X      
 
Distribution 
Calf loss of unknown cause is probably widespread, matching the prevalence of the risk factors, but 
has rarely been measured as it was in the Beef CRC and Cash Cow projects. 
Distribution contracting Distribution stable Distribution increasing 
    X      
Prevalence 
In addition to losses due to cow mortality, median reproductive wastage between confirmed early 
pregnancy and weaning (two thirds of which occurs in the neonatal period) in northern Australia 
varies from 5-16% depending on region and cow age (Fordyce et al. 2014).  These authors 
demonstrated that loss is regularly as high as 15% in regions of high soil fertility but as high as 30% in 
areas with low soil fertility. Data from southern Australia (Copping et al.: In press) suggests that calf 
loss levels and variation may not be dissimilar to that in Queensland’s southern forest. 
Prevalence decreasing Prevalence increasing 
    X      
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Economics 
Assumptions: Neonatal calf mortality of unknown cause - southern 
Table 4-15 Assumptions: neonatal calf mortality of unknown cause – southern (cattle) 
Variable Value adopted Confidence 
Regional 
Extent 100% of herds with a low prevalence rate ** 
% herds 
infected 
An average of 2% of pregnancies are affected annually * 
Mortalities Calf mortality is associated with each incident *** 
Weight loss No temporary weight loss *** 
Fertility Affected cows have usual re-conception rates *** 
Market 
avoidance 
No market impact *** 
Movement 
restrictions 
Nil *** 
Treatment Treatment rarely used *** 
Prevention No controls have been developed *** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of neonatal calf mortality of unknown cause in cattle in southern 
Australia at $21.1M (Table 4-16).  
 
Table 4-16 Economic cost of neonatal calf mortality of unknown cause – southern (cattle) 
 Treatment Prevention Production Total 
 H M L H M L H M L H M L 
Per Cattle $0 $0 $0 $0 $0 $0 $0 $0 $4.11 $0 $0 $4.11 
Per Herd $0 $0 $0 $0 $0 $0 $0 $0 $772 $0 $0 $772 
Total $0M $0M $42.2M $42.2M 
 
There is no predicted net gain from moving all southern herds experiencing neonatal calf mortality of 
unknown cause to the lowest level of disease. 
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Assumptions: Neonatal calf mortality of unknown cause – northern 
Table 4-17 Assumptions: neonatal calf mortality of unknown cause – northern (cattle) 
Variable Value adopted Confidence 
Regional 
Extent 
30%, 20% and 50% of herds with a high, medium and low 
prevalence rate 
*** 
% herds 
infected 
An average of 4.2%, 3.3%, and 2.4% of pregnancies are 
affected annually in high, medium and low incidence herds, 
respectively 
*** 
Mortalities Calf mortality is associated with each incident *** 
Weight loss No temporary weight loss *** 
Fertility 
90% of affected cows reconceive, which is often higher than 
usual rates 
*** 
Market 
avoidance 
No market impact *** 
Movement 
restrictions 
Nil *** 
Treatment Treatment rarely used *** 
Prevention No controls have been developed *** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of neonatal calf mortality of unknown cause in cattle in northern 
Australia at $53.9M (Table 4-18). 
Table 4-18 Economic cost of neonatal calf mortality of unknown cause – northern (cattle) 
 Treatment Prevention Production Total 
 H M L H M L H M L H M L 
Per Cattle $0 $0 $0 $0 $0 $0 $4.74 $3.72 $2.71 $4.74 $3.72 $2.71 
Per Herd $0 $0 $0 $0 $0 $0 $3,677 $2,889 $2,101 $3,677 $2,889 $2,101 
Total $0M $0M $53.9M $53.9M 
 
The net gain from moving all northern herds experiencing neonatal calf mortality of unknown cause 
to the lowest level of disease is estimated at $12.4M. 
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Total cost of disease 
The total cost of calf mortality of unknown cause in cattle across Australia at the current prevalence 
is estimated at $96.2M per annum. The net gain from moving all northern herds to the lowest level 
of disease is estimated at $12.4M. Note that the economic loss is in addition to the costs of other 
reproductive losses considered elsewhere in this report, including dystocia, BVDV, vibriosis and calf 
scours. 
 
4.6 Internal parasites 
The disease 
Internal parasites in cattle are primarily a problem up to the age of 2 years, from which time 
acquired immunity generally suppresses clinical disease. There has been little published work on 
production responses following the internal parasite controlled study of Smeal (1981) that was 
discussed in the Sackett report. They reported an average (but variable) 20-30 kg greater liveweight 
in 16-20 month animals after a suppressive parasite treatment program (since weaning) when 
compared to untreated controls. This value is likely to be representative of the maximum gain from 
effective internal parasite control in high rainfall southern regions compared to no control. 
We estimate that 60% of southern beef cattle are in higher rainfall areas (and therefore under 
similar parasite challenge to the Smeal study) with 10% in the pastoral zone (and therefore under 
very low parasite challenge). The equivalent figures for northern Australia are 3% (wet tropics) and 
12% in moderate rainfall (parasite non conducive) regions. The remaining cattle in each region are in 
low rainfall areas and are typically subject to moderate challenge by internal parasites in most years.  
Since the work of Smeal and colleagues in the 1980s there has been increased use and reliance on 
mectin-based drenches. This has provided greater efficacy in general but may have also hastened the 
emergence of resistance to this chemical group. Rendell (2010) recently reported resistance in at 
least one strongyle species to benzimadazoles, levamisole and ivermectin on 54%, 100% and 62% of 
investigated properties in south west Victoria. Ostertagia species demonstrated the greatest 
resistance across the chemical groups. The emergence of chemical resistance may reduce the 
efficacy of drenching programs. 
Approximately $50-60 million of drench product for cattle is sold each year. Whilst most product is 
used effectively, a proportion appears to be used inappropriately – either in the wrong class of stock 
or when a drench is not required. There is also an increasing level of drench resistance reducing 
drench efficacy and promoting increased drenching frequency. 
While aetiology of the disease is quite well known, the methods (and importance) of managing 
refugia in internal parasite control programs and the emergence and spread of drench resistance are 
developing. 
Unknown aetiology Known aetiology 
       X   
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Prevention 
Eliminating worms and preventing re-introduction is not feasible in most high rainfall regions. The 
parasite challenge is reasonably predictable within regions although preventing the introduction of 
drench resistance is an emerging challenge for cattle producers. This can be achieved by careful 
selection of introductions, quarantine and treatment (with effective products) on entry. Strategic 
worm control programs have been developed and continue to be refined for regions and production 
systems. While benefits of anthelmintics are clear from weaning age and 6-8 months beyond, less 
evidence is available on the need and effectiveness for control in older animals. Monitoring worm 
burdens using faecal egg counts is a practical way to assist disease management, however faecal egg 
count testing in cattle is not considered to be a reliable tool. Resistance/drench failure (partial or 
complete) is becoming a more important problem. 
Low efficacy/ unproven preventives available Effective preventives available 
      X    
 
Treatment 
There is a range of anthelmintic products however no new chemical group has been identified for 
cattle  in the past few decades. Resistance is an emerging problem – primarily of intensification – and 
combination drenches and/or effective drench rotation systems are required on many properties. 
There is greater need for monitoring systems to support calendar-based drenching programs. 
Low efficacy/ unproven treatments available Effective treatments available 
      X    
 
Distribution 
Most internal parasite problems occur in higher rainfall areas and under more intensive stocking 
rates. The year-on-year distribution of worms tends to be constant although Haemonchus can 
extend or shrink in distribution each year depending on seasonal temperature and rainfall. While the 
distribution of parasites is constant, resistant strains may be emerging and expanding. There is a lack 
of information of the boundaries where diseases is problematic (e.g. between wet and dry tropics in 
the north, and between eastern and western areas in south-eastern Australia). 
Distribution contracting Distribution stable Distribution increasing 
     X     
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Prevalence 
The within-herd challenge by internal parasites is a function of region, climate and rainfall, 
production enterprise, stocking rate and efficacy (including resistance) of drenching program 
system(s) used. This challenge is stable and predictable on the majority of properties. 
Prevalence decreasing Prevalence increasing 
    X      
 
Economics 
Assumptions: Internal parasites – southern 
Table 4-19 Assumptions: internal parasites – southern (cattle) 
Variable Value adopted Confidence 
Regional 
Extent 
60% of southern cattle are on properties in higher rainfall regions 
(> 600 mm per annum) with 10% in the pastoral zone (no 
requirement for worm control in most years) 
*** 
% herds 
infected 
10% of properties experience high levels of disease and 
production impacts  
60% of properties experience moderate levels of disease and 
production impacts  
30% of properties experience low levels of disease and 
production impacts  
** 
Mortalities 1% in clinical young stock ** 
Weight loss 
Highly affected: up to 20 kg weight loss in young stock – 10 kg 
permanent; and 10 kg weight loss in yearlings – 5 kg permanent 
Moderately affected: up to 10 kg weight loss in young stock – 5 
kg permanent; no weight loss in yearlings or older 
Lowly affected: up to 4 kg weight loss in young stock – 2 kg 
permanent; no weight loss in yearlings or older 
* 
Fertility No impact ** 
Market 
avoidance 
Nil *** 
Movement 
restrictions 
Nil *** 
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Variable Value adopted Confidence 
Treatment 
Individual animal treatment not generally practised with control 
via seasonal prevention programs (see below) 
** 
Prevention 
Effective control programs require 2 to 3 drenches from weaning 
to adulthood. Adults do not require drenching. 
95% of highly affected properties average 4 drenches per year in 
young stock 
75% of moderately affected properties average 4 drenches per 
year in young stock 
30% of lowly affected properties average 1-2 drenches per year 
in young stock 
*** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of internal parasites in cattle in southern Australia at $82.0M (Table 
4-20).  
 
Table 4-20 Economic cost of internal parasites – southern (cattle) 
 
 Treatment1 Prevention Production Total 
 H M L H M L H M L H M L 
Per Cattle 
$0 $0 $0 $6.84 $5.40 
$0.6
6 
$5.10 $3.88 $3.37 
$11.9
4 
$9.28 $4.03 
Per Herd 
$0 $0 $0 
$1,28
6 
$1,01
6 
$124 $959 $729 $634 
$2,24
5 
$1,74
4 
$758 
Total $0M $42.4M $39.6M $82.0M 
 
The net gain from moving all southern herds to the lowest level of disease is estimated at $40.5M. 
 
  
                                                          
1 All costs have been assigned to prevention 
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Assumptions: Internal parasites - northern 
Table 4-21  Assumptions: internal parasites – northern (cattle) 
Variable Value adopted Confidence 
Regional 
Extent 
15% of northern cattle are on properties in higher rainfall regions (> 
600 mm per annum) with 85% in the low-rainfall zone (no 
requirement for worm control in most years) 
*** 
% herds 
infected 
3% of properties experience high levels of disease and production 
impacts  
12% of properties experience moderate levels of disease and 
production impacts  
85% of properties experience low levels of disease and no significant 
production impacts  
** 
Mortalities 0.5% in clinically-affected young stock ** 
Weight loss 
Highly affected: up to 20 kg weight loss in young stock – 10 kg 
permanent; and 10 kg weight loss in yearlings – 5 kg permanent 
Moderately affected: up to 10 kg weight loss in young stock – 5 kg 
permanent; no weight loss in yearlings or older 
Lowly affected: no effect 
* 
Fertility No impact ** 
Market 
avoidance 
Nil *** 
Movement 
restrictions 
Nil *** 
Treatment 
Individual animal treatment not generally practised with control via 
seasonal prevention programs (see below) 
** 
Prevention 
Effective control programs require 4 to 6 drenches from weaning to 
adulthood. Adults do not require drenching. 
80% of highly affected properties average 4 drenches per year in 
young stock 
65% of moderately affected properties average 4 drenches per year 
in young stock 
50% of lowly affected properties average 1-2 drenches per year in 
young stock – despite no scientific evidence that they are required 
*** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of internal parasites in cattle in northern Australia at $11.6M (Table 
4-22). 
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Table 4-22 Economic cost of internal parasites – northern (cattle) 
 Treatment2 Prevention Production Total 
 H M L H M L H M L H M L 
Per Cattle $0 $0 $0 $1.39 $1.01 $0.39 $2.20 $1.09 $0.05 $3.59 $2.11 $0.44 
Per Herd $0 $0 $0 $1,104 $806 $310 $1,755 $870 $42 $2,859 $1,676 $352 
Total  $0M $7.8M $3.8M $11.6M 
 
The net gain from moving all northern herds to the lowest level of disease is estimated at $6.3M. 
Total cost of disease 
The total cost of internal parasites in cattle across Australia at the current prevalence of disease is 
estimated at $93.6M per annum. The net gain from moving all Australian herds to the lowest level of 
disease is estimated at $46.8M with most of this potential gain in southern Australia.  
It should be noted that over-treatment of stock (resulting in financial losses from excess drench 
costs) appears likely. The total cost of disease to the industry is only slightly more than the total 
spent on drench by producers. The amount spent on drench is also in excess of the achievable gains 
from better parasite control; much expenditure on anthelmintics appears unnecessary. 
 
4.7 Bloat (southern) 
The Disease 
Bloat is the excessive accumulation of gases of fermentation in the rumen. This, if unable to be 
eructated, can lead to abdominal distension and development of clinical signs of pain, respiratory 
and circulatory distress, collapse and in severe cases death. The most common cause of bloat in 
pastured cattle is due to formation of a stable froth in the rumen following rapid digestion of lush 
legumes with high digestible protein and low fibre (frothy bloat). Bloat is a disease of intensification 
– improved clover-based pastures and leguminous crops such as lucerne are risk factors. 
High rainfall regions are most prone to bloat. Approximately half of southern cattle are held in 
regions that can produce pasture bloat under the right circumstances. A survey of a high risk region 
found an annual prevalence of 3%. 
Unknown aetiology Known aetiology 
        X  
 
                                                          
2 All costs have been assigned to prevention 
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Prevention 
Controlling access to at-risk pastures (strip grazing, hay supplementation etc.), use of bloat capsules 
(when available in the market) and vigilance all contribute to control. However outbreaks can occur 
suddenly and losses can be heavy. Furthermore, bloat capsules have not been available in the 
Australian market for the past two years. 
Low efficacy/ unproven preventives available Effective preventives available 
      X    
 
Treatment 
Treatment requires release of rumen gases – by natural means, stomach tube or rumen incision. 
Mild cases may be treated by gently walking to safe pastures. However, treatment is generally not 
possible as most severe cases are found dead. Treatment is also costly and time consuming. 
Low efficacy/ unproven treatments available Effective treatments available 
 X         
 
Distribution 
High rainfall areas with leguminous and productive pastures are high risk. Approximately 50% of 
southern cattle are in high rainfall regions. 
Distribution contracting Distribution stable Distribution increasing 
    X      
 
Prevalence 
Prevalence is generally constant – but is influenced by season (and availability of bloat capsules). 
Prevalence decreasing Prevalence increasing 
    X      
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Economics 
Assumptions: Bloat – southern 
Table 4-23 Assumptions: bloat – southern  
Variable Value adopted Confidence 
Regional 
Extent 
50% of southern beef herds are within the high rainfall area affected 
by bloat 
** 
% herds 
infected 
5% of southern herds experience large-scale outbreaks: up to 15% of 
ruminants affected (not unweaned calves). 
10% of southern herds experience moderate outbreaks: up to 5% of 
ruminants affected (not unweaned calves). 
35% of southern herds experience minor outbreaks: up to 3% of 
ruminants affected (not unweaned calves).  
50% of southern herds experience no disease 
** 
Mortalities A 25% mortality rate has been assumed for clinical bloat ** 
Weight loss 
No weight loss, fertility or other production effects are assumed; all 
production losses are due to deaths. 
* 
Fertility Nil *** 
Market 
avoidance 
Nil *** 
Movement 
restrictions 
Nil *** 
Treatment 
Treatment is by movement of moderately affected animals to safe 
pasture, stomach tubing/stabbing of severe cases; veterinary 
assistance is required for some stabbed cases. Only 50%, 25% and 
10% of cases on severe, moderate and lowly affected herds are 
found and treated before death or self-resolution. An average cost 
of $50 per treated case has been assumed. 
*** 
Prevention 
Prevention is by hay feeding and grazing management. Bloat 
capsules (when available) are used in a proportion of herds. An 
annual prevention cost of $25/ dose is assumed with 75%, 50% and 
25% of highly, moderately and lowly affected herds applying active 
prevention. We have not costed losses from forced avoidance of 
high-risk pastures/crops. These are too difficult to estimate with 
accuracy and lead to questions of suitability of the farming system. 
*** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of bloat in cattle in Australia at $76.8M (Table 4-24).  
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Table 4-24 Economic cost of bloat – southern (cattle) 
 Treatment Prevention Production Total 
 H M L H M L H M L H M L 
Per 
Cattle 
$3.75 $0.63 $0.15 $18.75 $6.25 $2.50 $30.96 $10.35 $6.24 $53.46 $17.24 $8.89 
Per 
Herd 
$701 $118 $29 $3,506 $1,169 $468 $5,789 $1,936 $1,166 $9,996 $3,223 $1,662 
Total $3.1M $24.9M $48.8M $76.8M 
 
The net gain from moving all southern herds experiencing bloat to the lowest level of disease is 
estimated at $31.3M. 
 
4.8 Bovine ephemeral fever (three-day sickness) 
The disease 
Bovine ephemeral fever (BEF), or three-day sickness as it is more commonly known, is caused by a 
virus that is spread between cattle by biting insects.  The primary clinical signs are ephemeral high 
fever and lameness.  Because of its high prevalence, clinical infection mostly occurs in cattle up to 2 
years of age, except following successive dry years when insect vector populations are insufficient to 
achieve high sero-conversion rates in young cattle (Uren 1989).  An average of approximately one 
third of cattle in a group will be affected in a typical outbreak and mortality rate in affected cattle 
may be ~0.5% (McGown et al. 2010).  Permanent weight loss in affected animals is thought to 
average 10 kg (Walker and Cybinski 1989). Fordyce et al. (2009) reported pregnancy rates per cycle 
to halve in an outbreak in 2-year-old heifers during their maiden mating.  The high fever associated 
with BEF can cause temporary sub-fertility in bulls and abortion.  No published data is available on 
the effect on calf output, which is debatable, as: temporary bull sub-fertility is usually only likely to 
affect single-sire matings (not usual practice); and, though abortion due to high fever is a possible 
outcome, the evidence for significant loss due to fever associated with BEF is lacking. 
Unknown aetiology Known aetiology 
       X   
 
Prevention 
A vaccine given as two initial injections with annual boosters is available and can achieve a six-fold 
reduction in the incidence of clinical effects.  A large north Australian trial with male and female 
cattle failed to show any significant benefits from vaccinating (McGown et al. 2010).  The disease 
was noted to occur during the study, but the period (2003-2009) was noted as of generally low-
incidence.  In a subsequent larger study with female cattle aged 2 years and older conducted during 
generally wetter years, BEF prevalence had no effect on fertility (McGowan et al. 2014).  In this 
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study, a quarter of northern beef producers vaccinated bulls, and virtually none vaccinated female 
cattle. 
Low efficacy/ unproven preventives available Effective preventives available 
   X    X   
 
Treatment 
Injectable analgesics and anti-pyretic drugs prescribed and or administered by veterinarians are used 
in treating acutely-affected cattle.  Such animals are usually heavy, well-conditioned and older than 2 
years. O’Rourke et al. (1991) reported that 14% of north Australian producers treated or vaccinated 
animals with BEF, with a further 12% were aware that BEF caused disease that they did not treat. 
Low efficacy/ unproven treatments available Effective treatments available 
       X   
 
Distribution 
The disease mainly occurs in northern Australia, but has progressed down eastern Australia as far as 
Victoria in some years. 
Distribution contracting Distribution stable Distribution increasing 
    X      
 
Prevalence 
Across northern Australia McGowan et al. (2014) found that ~8% of all heifer (aged 2-3 years) and 
cow groups and >10% of cattle tested had experienced recent infection.  At least 70% of herds had 
high sero-prevalence, and ~90% of cattle were sero-positive.  No herd had <20% sero-positive 
animals. 
Prevalence decreasing Prevalence increasing 
    X      
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Economics 
Assumptions: Bovine ephemeral fever (three-day sickness) – southern 
Table 4-25 Assumptions: bovine ephemeral fever (three-day sickness) – southern  
Variable Value adopted Confidence 
Regional 
Extent 
Infection usually only occurs under moist hot conditions 
every few years 
*** 
% herds 
infected 
5% of the cattle in this region are exposed every 5 years ** 
Mortalities 0.5% mortality in affected cattle * 
Weight loss Temporary weight loss of 10 kg in affected cattle ** 
Fertility 
50% chance of outbreak occurring during mating with 
pregnancy rates down by 20% 
* 
Market 
avoidance 
10% of affected steers have market value reduced by 
$0.20/kg 
* 
Movement 
restrictions 
Nil *** 
Treatment 10% of affected animals may be treated * 
Prevention No significant vaccination occurs *** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD has 
calculated the annual cost of BEF in cattle in southern Australia at $0.1M (Table 4-26). 
 
Table 4-26 Economic cost of bovine ephemeral fever (three-day sickness) – southern  
 Treatment Prevention Production Total 
 H M L H M L H M L H M L 
Per Cattle $0 $0 $0.02 $0 $0 $0 $0 $0 $0.21 $0 $0 $0.23 
Per Herd $0 $0 $4 $0 $0 $0 $0 $0 $39 $0 $0 $43 
Total $0M $0M $0.1M $0.1M 
No net gain is expected from moving all southern herds experiencing BEF to the lowest level of 
disease. 
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Assumptions: Bovine ephemeral fever (three-day sickness) – northern 
Table 4-27 Assumptions: bovine ephemeral fever (three-day sickness) – northern (cattle) 
Variable Value adopted Confidence 
Regional 
Extent Occurs across north Australia *** 
% herds 
infected 
40% of the cattle in this region are exposed every year; 
50% of cattle are affected every 3 years, and 10% of cattle 
every 5 years 
* 
Mortalities 0.5% mortality in affected cattle * 
Weight loss Temporary weight loss of 10 kg in affected cattle ** 
Fertility 
50% chance of outbreak occurring during mating in 
moderate- and low-incidence regions with pregnancy rates 
down by 20% 
* 
Market 
avoidance 
Nil * 
Movement 
restrictions 
Nil * 
Treatment 5% of affected animals may be treated * 
Prevention 
25% of bulls vaccinated, with little vaccination of other cattle 
classes 
** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of BEF in cattle in northern Australia at $59.7M (Table 4-28). 
 
Table 4-28 Economic cost of bovine ephemeral fever (three-day sickness) – northern (cattle) 
 Treatment Prevention Production Total 
 H M L H M L H M L H M L 
Per Cattle $0 $0.32 $0.23 $0 $0 $0 $2.59 $4.46 $3.45 $2.60 $4.79 $3.68 
Per Herd $0 $256 $184 $8 $8 $8 $2,060 $3,542 $2,738 $2,063 $3,800 $2,925 
Total $2.9M $0.1M $56.6M $59.7M 
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The net gain from moving all northern herds experiencing BEF to the lowest level of disease is 
estimated at $1.8M. 
Total cost of disease 
The total cost of BEF in cattle across Australia at the current prevalence of disease is estimated at 
$59.8M per annum. The net gain from moving only northern herds experiencing BEF to the lowest 
level of disease is estimated at $1.8M. The costs reflect what occurs on average but do not take into 
account that this is a “spiking” disease with catastrophic consequences to individual at-risk herds 
when challenged by the required combination of predisposing causes. 
 
4.9 Botulism 
The disease 
Botulism is caused by a clostridial bacterium that produces an extremely powerful toxin under low-
oxygen conditions.  Both C and D types are widely distributed. Cattle of all ages and gender are most 
susceptible when they eat carcasses or residues when attempting to overcome nutrient deficiencies, 
especially of protein and phosphorus, or when rotting carcasses are accidentally included in food or 
water.  Deficient appetites are common in north Australia where vast areas have low soil and pasture 
phosphorus (McCosker and Winks 1994). Most clinically-affected cattle die from flaccid paralysis, 
though sub-clinical toxin challenge appears regular. 
There is no evidence that non-lethal botulism has significant impacts of annual live weight gain. 
Henderson et al. (2013) reported that herds not vaccinated against botulism had about 5% higher 
(not significant) female cattle annual mortality rates in a study of 36 northern herds, of which only 
two did not vaccinate.  
Severe outbreaks in which 40% of cattle in a herd die have been reported (Trueman et al. 1992). 
Reproductive losses occur in association with cow mortality.  In addition, suckling calves are 
susceptible between when immunity is provided in colostrum of vaccinated cows and when the 
calves are vaccinated, usually at branding or weaning.  Losses of such calves usually only occurs in 
extremely poor seasons and rates are very low. There is no evidence that incidence of botulism has 
any impact on market access or values. The cattle disease is not a zoonosis and poses no food safety 
issues.  
Unknown aetiology Known aetiology 
      X    
 
Prevention 
O’Rourke et al. (1992) reported that 19% of north Australian beef producers in 1990 vaccinated 
cattle against botulism, with 42-74% vaccinating in most northern forest regions of Queensland; 1% 
of producers were aware of botulism presence but did not vaccinate. Bortolussi et al. (2005) 
reported that 60-84% of cattle were being vaccinated against botulism in tropical Australia in 1996-
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97, with 5-33% of properties vaccinating in central Queensland.  A more recent estimate for vaccine 
use suggests an average of 44% across northern Australia (Levantis and Hooper 2009).  Suggested 
levels (moderate confidence) are 80% in the northern forest, 50% on northern downs, 10% in sub-
tropical regions, and 1% in southern Australia.  Most vaccination outside tropical regions is in 
response to diagnosed outbreaks, or when susceptibility increases in line with poor seasonal 
conditions.  A range of highly efficacious vaccines is available, with average cost/animal/year of 
protection at about $1.50, including some labour. 
Low efficacy/ unproven preventives available Effective preventives available 
         X 
 
Treatment 
No specific treatment exists for botulism. Rare sub-lethal clinical cases can be nursed back to full 
health over approximately one month. 
Low efficacy/ unproven treatments available Effective treatments available 
X          
 
Distribution 
In the absence of verifying data, professional opinion (high confidence) is that botulism spores are 
prevalent throughout Australia, and especially in north Australia (Sackett et al. 2006).  The 
movement of cattle across the country in the past 50 years may have ensured both C and D types are 
equally prevalent. 
Distribution contracting Distribution stable Distribution increasing 
    X      
 
Prevalence 
From reports commencing in the mid-1960s when botulism was recognised and vaccination was 
unavailable or not used, it is suggested (moderate confidence) that within the northern forest of 
north Australia, lethal dose challenge may occur on average in 0.3% of cattle yearly, and in 3% every 
5yrs, with full protection usually afforded by vaccination; in the absence of published data, assumed 
rates in northern downs are 0.15% and 1.5%, in sub-tropical north Australia are 0.03% and 0.3% and 
in southern Australia are 0.01% and 0.1%, respectively.  
Prevalence decreasing Prevalence increasing 
    X      
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Economics 
Assumptions: Botulism – southern 
Table 4-29 Assumptions: botulism – southern (cattle) 
Variable Value adopted Confidence 
Regional 
Extent 
All cattle have the potential to be exposed to botulism *** 
% herds 
infected 
All cattle in a low-challenge environment in which an average 
of 0.03% of cattle are challenged annually 
* 
Mortalities 100% of unvaccinated challenged cattle ** 
Weight loss No temporary weight loss ** 
Fertility No impact *** 
Market 
avoidance 
No impact *** 
Movement 
restrictions 
Nil *** 
Treatment No treatment available *** 
Prevention Almost no routine vaccination used *** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of botulism in cattle in southern Australia at $6.0M (Table 4-30). 
Table 4-30 Economic cost of botulism – southern (cattle) 
 Treatment Prevention Production Total 
 H M L H M L H M L H M L 
Per Cattle $0 $0 $0 $0 $0 $0 $0 $0 $0.29 $0 $0 $0.29 
Per Herd $0 $0 $0 $0 $0 $0 $0 $0 $110 $0 $0 $110 
Total $0M $0M $6.0M $6.0M 
 
There is no expected net gain from changing current practice for southern herds. 
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Assumptions: Botulism – northern 
Table 4-31 Assumptions: botulism – northern (cattle) 
Variable Value adopted Confidence 
Regional 
Extent 
All cattle have the potential to be exposed to botulism *** 
% herds 
infected 
52% of cattle in a moderate-high challenge probability region 
where 0.2% of stock challenged annually 
48% of cattle in a low-challenge probability region where 
0.1% of stock challenged annually 
* 
Mortalities 100% of unvaccinated challenged cattle ** 
Weight loss No temporary weight loss ** 
Fertility No impact *** 
Market 
avoidance 
No impact *** 
Movement 
restrictions 
Nil *** 
Treatment No treatment available *** 
Prevention 
Within the high-, medium- and low-challenge regions, 80%, 
50% and 10% of cattle are vaccinated annually 
* 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of botulism in cattle in northern Australia at $22.0M (Table 4-32). 
 
Table 4-32 Economic cost of botulism – northern (cattle) 
 Treatment Prevention Production Total 
 H M L H M L H M L H M L 
Per Cattle $0 $0 $0 $1.61 $1.01 $0.18 $0.32 $0.79 $0.71 $1.93 $1.80 $0.89 
Per Herd $0 $0 $0 $1,282 $801 $140 $253 $629 $566 $1,534 $1,430 $706 
Total $0M $12.5M $9.5M $22.0M 
 
The net gain from moving all northern herds experiencing botulism to the lowest level of disease is 
estimated at $8.0M. 
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Total cost of disease 
The total cost of botulism in cattle across Australia at the current prevalence of disease is estimated 
at $28.0M per annum. The net gain from moving only northern herds experiencing botulism to the 
lowest level of disease is estimated at $8.0M. The impact of botulism would be much higher if 
widespread use of efficacious vaccine was not already being practised. 
 
4.10 Grass tetany (hypomagnesaemia) 
The disease 
Grass tetany is seen in beef herds grazing improved pastures on solodic and solodised soils in the 
higher rainfall regions of south-eastern Australia (disease is essentially absent outside of this region). 
These soils are dense clays with high salt contents and strongly adsorbed sodium and magnesium 
ions. Magnesium is essential for proper functioning of muscle and nerve tissue and is involved in 
complex relationships with other ions – especially calcium and potassium - in moderating cell 
function. Absorption of magnesium by grazing cattle may be insufficient if there is insufficient 
magnesium, calcium and/or phosphorous or if there are high levels of inhibitory substances such as 
potassium and nitrogen in the soil or pasture. These conditions are most common on improved 
grass-dominant pasture or cereal crops that have received potash fertilisers. Magnesium demand is 
greatest in lactating cows and therefore grass tetany is most commonly seen in late winter and 
autumn in freshly lactating (winter-spring calving) cows. 
Unknown aetiology Known aetiology 
        X  
 
Prevention 
Grass tetany may be effectively managed by moving to spring calving. The supplementation of cattle 
with magnesium (Causmag®, magnesium block, magnesium rumen boluses), controlling potassium 
intake (fertiliser programs), managing fibre intake (hay feeding) and minimising stress in grazing 
stock are ways that grass tetany risk and occurrence can be managed. 
Low efficacy/ unproven preventives available Effective preventives available 
       X   
 
Treatment 
Most clinical cases are found dead before treatment. Intravenous calcium and magnesium 
supplementation can save clinical cases. Prevention is more important than treatment. 
Low efficacy/ unproven treatments available Effective treatments available 
     X     
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Distribution 
Approximately 60% of southern beef cattle are in high rainfall regions predominated by solodic and 
solodised soils. Up to 40% of herds can experience disease with up to 5% clinical incidence in mature 
cows in severe outbreaks. 
Distribution contracting Distribution stable Distribution increasing 
    X      
 
Prevalence 
The within-herd incidence of disease is typically very low. Outbreaks can occur when a risk factor – 
such as high potash pasture, bad weather – occur in at risk cattle. Most cattle producers are aware of 
grass tetany and understand most requirements for managing disease in their herds. The feeding of 
hay and supplementation of cows with Causmag® are the main preventives. System-level controls 
such as modified fertilizer programs, pasture renovation, timing of calving and stocking density 
adjustments were not considered. 
Prevalence decreasing Prevalence increasing 
    X      
 
Economics 
Assumptions: Grass tetany – southern 
Table 4-33 Assumptions: grass tetany – southern (cattle) 
Variable Value adopted Confidence 
Regional 
Extent 
60% of southern cattle are on properties in higher rainfall regions (> 
600 mm per annum) with 10% in the pastoral zone (no requirement 
for control in most years) 
*** 
% herds 
infected 
5% of properties experience high levels of disease: 2.5% incidence in 
younger cows and 5.0% incidence in older cows. 
15% of properties experience moderate levels: 1.0% incidence in 
younger cows and 2.0% incidence in older cows. 
40% of properties experience moderate levels: 0.0% incidence in 
younger cows and 0.5% incidence in older cows. 
40% of properties do not have grass tetany 
** 
Mortalities 
50% mortality in younger cows and 80% mortality in older clinical 
cases are assumed 
** 
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Variable Value adopted Confidence 
Weight loss 
No weight loss or fertility impacts are assumed. Calves of affected 
dams are assumed to survive. 
*** 
Fertility Nil *** 
Market 
avoidance 
Nil *** 
Movement 
restrictions 
Nil *** 
Treatment 
Treatment is applied in only 50% of cases as most cases die or are 
found dead. Intravenous calcium and magnesium is applied. Some 
require veterinary attention. An average cost of $100 per case is 
assumed. 
** 
Prevention 
Effective control relies on use of hay and Causmag®. A total cost of 
$10 per adult cow is assumed for control  
- 100% of highly affected properties use Causmag® and hay 
- 66% of moderately affected properties use Causmag® and 
hay 
- 33% of lowly affected properties use Causmag® and hay 
** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of grass tetany in cattle in southern Australia at $24.3M (Table 4-34).  
 
Table 4-34 Economic cost of grass tetany – southern (cattle) 
 Treatment Prevention Production Total 
 H M L H M L H M L H M L 
Per Cattle $0.67 $0.27 $0.10 $3.33 $2.20 $1.10 $7.29 $2.91 $1.25 $11.29 $5.38 $2.45 
Per Herd $126 $51 $19 $630 $416 $208 $1,377 $551 $236 $2,133 $1,017 $463 
Total $1.2M $9.7M $13.4M $24.3M 
 
The net gain from moving all southern herds to the lowest level of disease is estimated at $9.1M. 
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4.11 Calf scours (southern) 
The disease 
Calf scours due to cryptosporidia, rotavirus, coronavirus, salmonella and/or E.coli is an emerging 
problem of the southern beef cattle industry. Surveys3 suggest that 80% of southern producers have 
at least one case of white scours each year. The majority (70%) of producers experiencing outbreaks 
have fewer than 5% of calves affected but 20% can have up to 15% of calves affected and 10% with 
up to 30% of calves affected. The case fatality rate can be 10%. Whilst the major pathogens are 
generally known, the frequency of outbreaks and the size of outbreaks may be trending upwards. 
Intensification and concurrent disease are risk factors for outbreaks. 
Unknown aetiology Known aetiology 
      X    
 
Prevention 
Vaccination has a role in some outbreaks. Mixed pathogen involvement is common. Vaccination of 
the pregnant cow is required for some pathogens (e.g. E. coli K99).  
Low efficacy/ unproven preventives available Effective preventives available 
     X  X   
 
Treatment 
Treatment is symptomatic – replacement of lost fluids and parenteral antibiotic support. 
Dehydration, malnutrition (whilst withheld from milk) and secondary infection are the main causes 
of mortality. Electrolytes and antibiotics are effective in most cases but application is labour 
intensive. 
Low efficacy/ unproven treatments available Effective treatments available 
      X    
 
  
                                                          
3 Incidence and prevalence surveys were not random – a selection or self-reporting bias is likely to be 
present 
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Distribution 
Distribution appears to be expanding (along with severity and size of outbreaks). Surveys indicate 
that intensification of production is associated with increased disease. 
Distribution contracting Distribution stable Distribution increasing 
       X   
 
Prevalence 
The size of outbreaks is increasing on affected farms. Reports of up to 50% of calves affected have 
been received. Multiple pathogen involvement may be contributing. Furthermore, multiple 
pathogens and associated disease (trace element deficiency, parasites) may result in larger 
outbreaks on affected farms. 
Prevalence decreasing Prevalence increasing 
      X    
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Economics 
Assumptions: Calf scours (southern) 
Table 4-35 Assumptions: calf scours – southern (cattle) 
Variable Value adopted Confidence 
Regional 
Extent 
80% of southern beef herds have at least one case of calf scours per 
year.  
*** 
% herds 
infected 
5% of southern herds experience large-scale outbreaks: up to 30% 
of calves affected 
15% of southern herds experience moderate outbreaks: up to 15% 
of calves affected 
60% of southern herds experience minor outbreaks: up to 5% of 
calves affected 
20% of southern herds experience no disease 
** 
Mortalities 10% mortality rate is assumed ** 
Weight loss 
No weight loss or other production effects are assumed; all 
production losses are due to calf deaths. 
** 
Fertility Nil *** 
Market 
avoidance 
Nil *** 
Movement 
restrictions 
Nil *** 
Treatment 
Treatment is by electrolytes, antibiotics and support. A cost of $25 
per case has been assumed. However only 5% of cases are found 
alive and treated. 
** 
Prevention 
Prevention is by vaccination. A dose is estimated to cost $1.00 
(vaccine plus labour) and 50%, 70% and 90% of highly, moderately 
and lowly affected herds are assumed to vaccinate. 
** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of calf scours in cattle in Australia at $23M per year (Table 4-36).  
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Table 4-36 Economic cost of calf scours – southern (cattle) 
 Treatment Prevention Production Total 
 H M L H M L H M L H M L 
Per Cattle $516 $258 $86 $221 $74 $37 $1,158 $579 $193 $1,895 $911 $316 
Per Herd $2.76 $1.38 $0.46 $1.18 $0.39 $0.20 $6.19 $3.10 $1.03 $10.13 $4.87 $1.69 
Total $6.4M $2.4M $14.3M $23.0M 
 
The net gain from moving all southern herds experiencing disease to the lowest level of calf scours 
disease is estimated at $9.2M per annum. 
 
4.12 Vibriosis 
The disease 
Campylobacteriosis (vibriosis) is caused by a bacterium that is sexually transmitted between cattle. It 
has primarily been associated with embryo loss (Clark 1971), which usually occurs prior to the typical 
time for foetal ageing in commercial beef herds; abortions are also regularly caused by vibriosis.  
However, in a large north Australian study, high prevalence of vaginal mucus samples positive for 
antibodies to C.fetus sp.veneralis had no association with percent pregnant within 4 months of 
calving, but was associated with 7% higher foetal and calf loss than in herds where >30% of cows had 
vaginal mucus antibodies than where antibody prevalence was low to moderate (McGowan et al. 
2014).  The epidemiology of the disease is not fully understood as sensitive and specific tests for 
both the bacterium and evidence of infection are unavailable (Lew et al. 2006). 
Unknown aetiology Known aetiology 
   X       
 
Prevention 
One vaccine is available, and is primarily used in bulls at approximately $12.50/year including labour 
to administer.  The efficacy of the vaccine is not clear, though research published at the time it was 
developed suggested it was high (Clark 1971).  Schatz (2011) showed an 11% increase in early-mating 
conceptions in vaccinated compared to unvaccinated heifers. O’Rourke et al. (1992) reported that 
19% of north Australian beef producers in 1990 vaccinated. Bortolussi et al. (2005a, 2005b) reported 
that 29-71% of bulls were being vaccinated against vibriosis in northern Australia in 1996-97, with 3% 
of properties vaccinating in northern WA.  McGowan et al. (2014) reported that 68% of north 
Australian beef business vaccinated bulls against vibriosis.  An average of ~0.5M doses of vaccine was 
sold in 2012-13 (Zoetis, pers comm).  Biosecurity management is very difficult as diagnosis is difficult, 
primarily because the bacterium is a strict anaerobe, and cohabits the reproductive tract with a large 
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number of other bacteria.  Infection seems to be ephemeral in some studies (Lew et al. 2006), which 
may create false perception during diagnosis.  PCR tests (e.g. McMillen et al. 2006) generally have 
insufficient specificity. 
Low efficacy/ unproven preventives available Effective preventives available 
   X    X   
 
Treatment 
The bacterium can be cleared with antibiotic therapies, but this is rarely done because of the 
difficulty of diagnosis. 
Low efficacy/ unproven treatments available Effective treatments available 
      X    
 
Distribution 
The bacterium is relatively ubiquitous. 
Distribution contracting Distribution stable Distribution increasing 
    X      
 
Prevalence 
McGowan et al. (2014) reported that 4-14% of north Australian herds had a high prevalence of 
vaginal mucus antibody in breeding cows. In over 4,000 samples assayed, 9.4% were positive with 
little evidence of year or age differences. There was some evidence for lower prevalence of 
antibody-positive animals in regions where bull vaccination was more prevalent. While vibriosis has 
historically been considered to have low prevalence in the south, anecdotal evidence suggests it may 
not be as low as perceived. As no published data are available for prevalence in southern herds, the 
same prevalence as in northern Australia is presumed. 
Prevalence decreasing Prevalence increasing 
    X      
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Economics 
Assumptions: Vibriosis – southern 
Table 4-37 Assumptions: vibriosis – southern (cattle) 
Variable Value adopted Confidence 
Regional Extent 10%, 10%, 10% and 70% of herds with a high, medium, low and nil 
prevalence rate 
* 
% herds 
infected 
An average of 40%, 20%, and 10% of cows are infected annually in 
high, medium and low incidence herds, respectively 
* 
Mortalities No mortalities caused *** 
Weight loss No temporary weight loss *** 
Fertility 5% fewer of infected cows fail to calf ** 
Market 
avoidance 
No market impact *** 
Movement 
restrictions 
Nil *** 
Treatment Treatment rarely used *** 
Prevention 
Vaccination of bull in 40% of herds, and heifers only vaccinated in 
1% of high-prevalence herds 
** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of vibriosis in cattle in southern Australia at $8.3M (Table 4-38). 
Table 4-38 Economic cost of vibriosis – southern (cattle) 
 Treatment Prevention Production Total 
 H M L H M L H M L H M L 
Per Cattle $0 $0 $0 $0.16 $0.13 $0.13 $4.34 $2.17 $1.09 $4.51 $2.31 $2.31 
Per Herd $0 $0 $0 $30 $25 $25 $817 $408 $204 $847 $433 $229 
Total  $0M $0.4M $7.8M $8.3M 
 
The net gain from moving all southern herds experiencing vibriosis to the lowest level of disease is 
estimated at $4.5M. 
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Assumptions: Vibriosis – northern 
Table 4-39 Assumptions: vibriosis – northern (cattle) 
Variable Value adopted Confidence 
Regional 
Extent 
10%, 40%, 10% and 40% of herds with a high, medium, low 
and nil prevalence rate 
** 
% herds 
infected 
An average of 40%, 20%, and 10% of cows are infected 
annually in high, medium, low and nil incidence herds, 
respectively 
* 
Mortalities No mortalities caused *** 
Weight loss No temporary weight loss *** 
Fertility 5% fewer of infected cows fail to calf ** 
Market 
avoidance 
No market impact *** 
Movement 
restrictions 
Nil *** 
Treatment Treatment rarely used *** 
Prevention 
Vaccination of bulls in 60% of herds, and 15% of heifers 
vaccinated in high-prevalence herds 
** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of vibriosis in cattle in northern Australia at $12.7M (Table 4-40). 
 
Table 4-40 Economic cost of vibriosis – northern (cattle) 
 Treatment Prevention Production Total 
 H M L H M L H M L H M L 
Per Cattle $0 $0 $0 $0.41 $0.11 $0.11 $2.20 $1.10 $0.55 $2.61 $1.21 $0.66 
Per Herd $0 $0 $0 $323 $90 $90 $1,746 $873 $437 $2,069 $963 $527 
Total $0M $1.5M $11.2M $12.7M 
 
The net gain from moving all northern herds experiencing vibriosis to the lowest level of disease is 
estimated at $6.5M. 
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Total cost of disease 
The total cost of vibriosis in cattle across Australia at the current prevalence of disease is estimated 
at $21.0M per annum. The net gain from moving all herds to the lowest level of disease is estimated 
at $11.0M. It is acknowledged that these estimates are based on unsubstantiated opinion for 
southern Australia where prevalence has not been systematically investigated. 
 
4.13 Theileria 
The disease 
Theileria is a tick-borne infection of cattle produced (in Australia) by the Theileria orientalis group of 
haemoprotozoan parasites. T. orientalis (buffeli) has been present in Australia since the early 1900s 
and was traditionally associated with asymptomatic infections.  Since 2006 an increasing number of 
clinical infections due to pathogenic strains of the parasite – especially Ikeda, and Chitose – have 
been reported along the eastern seaboard and recently in Western Australia. The majority of clinical 
disease has been reported in the southern industry (however a ‘hot spot’ in the far north of 
Queensland has been identified).  The range of disease is believed by many to follow the distribution 
of the bush tick (Haemaphysalis longicornis). The emerging disease has been named bovine anaemia 
caused by Theileria orientalis to separate the disease syndrome from infection with the endemic and 
typically non-pathogenic Buffeli serotype and called Benign Bovine Theileriosis. 
There is a spectrum of disease ranging from non-pathogenic infection (mainly Buffeli serotype) 
through to severe anaemia, abortion, recumbency and death.  Clinically affected animals lose weight. 
Mortalities of 10% in young stock (<2YO) and up to 3% of adults can occur in severe outbreaks. This 
is typically associated with recent introduction of pathogenic strains into naïve herds. A recent New 
Zealand study found clinical anaemia to be the major driver of clinical signs and production loss (not 
parasitaemia per se). Anaemia was strongly associated with reduced milk production and reduced 
reproductive performance in dairy cattle. Significant recovery times after severe anaemia can occur. 
Weight loss can be dramatic and abortion and reproductive failure are common sequelae. 
The disease agents are known but the reasons behind the emergence of pathogenicity (mutation or 
introduction) is not clear. The local intermediate host(s) range and distribution have not been 
confirmed, but are the subject of ongoing research. 
Unknown aetiology Known aetiology 
     X     
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Prevention 
There are no effective preventive methods. Whilst tick control can assist control, only a small 
number of ticks are required to spread the parasite. There is currently no vaccine. A vaccine will 
likely be essential to prevent disease due to the persistence in intermediate hosts (ticks) especially 
along the length of the eastern and northern seaboards. 
Low efficacy/ unproven preventives available Effective preventives available 
  X     X   
 
Treatment 
There are no registered effective treatments for the parasite. Buparvaquone has been shown to be 
effective at controlling the infection but there is no registered product available in Australia. 
Symptomatic treatment of the anaemia (nursing) can reduce mortalities. Treatment is time 
consuming and expensive. Recovery is slow as the animal needs to replace red cells lost due to the 
anaemia. 
Low efficacy/ unproven treatments available Effective treatments available 
  X        
 
Distribution 
Small scale typing studies found the prevalence of infected herds to be high in Queensland (85%) and 
Victoria (80%) with slightly lower prevalence in NSW (45%). Ikeda was more prevalent in NSW and 
Victorian isolates than in Queensland. Mixed infection (Ikeda and Chitose) were common. The 
distribution of disease-causing strains is increasing along the eastern seaboard. 
Distribution contracting Distribution stable Distribution increasing 
       X   
 
Prevalence 
Approximately 55% of sampled Queensland cattle were seropositive. The NSW cow-level sample 
seroprevalence was approximately 25% and in Victoria it was 34%. However not all positive animals 
showed disease signs. Large outbreaks are increasingly common in previously naïve herds. 
Prevalence decreasing Prevalence increasing 
       X   
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Economics 
Assumptions: Theileria (southern) 
Table 4-41 Assumptions: theileria – southern (cattle) 
Variable Value adopted Confidence 
Regional 
Extent 
50% of southern cattle population in exposed region (excludes the 
arid inland regions). 
** 
% herds 
infected 
1% of herds newly infected and previously naive highly affected: 
25% of herd (all ages) infected 
10% of herds moderately affected: 15% of young stock, 5% of older 
stock infected 
34% of herds lowly affected: 10% of young stock and 1% of older 
infected 
** 
Mortalities 10% in young stock, 5% in older. ** 
Weight loss 
Significant weight loss in affected (20 kg in young stock, 10 kg in 
older stock). 
** 
Fertility 
Clinical cases have reduced fertility (45% pregnancy rate versus 90% 
pregnancy rate). Clinical course of disease is 3 months therefore 
average reduction in pregnancies for clinical cases is 11%.   
* 
Market 
avoidance 
Nil ** 
Movement 
restrictions 
Nil ** 
Treatment Not available *** 
Prevention Not available *** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of theileria infection in cattle in southern Australia at $18.0M per year 
(Table 4.42). 
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Table 4-42 Economic cost of theileria – southern (cattle) 
 Treatment Prevention Production Total 
 H M L H M L H M L H M L 
Per 
Cattle 
$0.33 $0.05 $0 $0 $0 $0 $18.64 $6.02 $2.81 $18.97 $6.07 $2.81 
Per 
Herd 
$615 $9 $0.02 $0 $0 $0 $3,486 $1,126 $526 $3,547 $1,135 $526 
Total  $0.1M $0M $17.9M $18.0M 
 
The net gain from moving all southern herds experiencing theileria to the lowest level of disease is 
estimated at $5.0M. 
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Assumptions: Theileria (northern) 
Table 4-43 Assumptions: theileria – northern (cattle) 
Variable Value adopted Confidence 
Regional 
Extent 
50% of northern cattle population in exposed region (coastal)  ** 
% herds 
infected 
Disease incidence is half that of southern industry 
0.5% of herds newly infected and previously naïve, highly affected: 
12.5% of herd (all ages) infected 
5% of herds moderately affected:  5% of young stock, 2% of older 
stock infected 
17% of herds lowly affected: 0.5% of young stock and 0% of older 
infected 
** 
Mortalities 10% in young stock, 5% in older. ** 
Weight loss 
Significant weight loss in affected (20kg in young stock, 10kg in older 
stock) 
** 
Fertility 
Clinical cases have reduced fertility (45% pregnancy rate versus 90% 
pregnancy rate), Clinical course of disease 3 months therefore 
average reduction in pregnancies for clinical cases is 11%   
* 
Market 
avoidance 
Nil ** 
Movement 
restrictions 
Nil ** 
Treatment Not available *** 
Prevention Not available *** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of theileria in cattle in northern Australia at $1.6M (Table 4-44). 
 
  
B.AHE.0010 Final Report: Priority list of endemic diseases for the red meat industries 
Page 81 of 282 
Table 4-44 Economic cost of theileria – northern (cattle) 
 Treatment Prevention Production Total 
 H M L H M L H M L H M L 
Per Cattle $0.45 $0.20 $0.02 $0 $0 $0 $2.78 $1.12 $0.12 $3.23 $1.31 $0.15 
Per Herd $337 $146 $18 $0 $0 $0 $2,075 $833 $92 $2,412 $980 $110 
Total  $0.2M $0M $1.3M $1.6M 
 
The net gain from moving all northern herds experiencing theileria to the lowest level of disease is 
estimated at $1.1M. 
Total cost of disease 
The total cost of theileria in cattle across Australia at the current prevalence of disease is estimated 
at $19.6M per annum. The net gain from moving all herds experiencing theileria to the lowest level 
of disease for their regions is estimated at $6.1M. 
 
4.14 Pinkeye 
The disease 
Infectious bovine keratoconjunctivitis (Pinkeye) is an infection of the eye caused by the bacterium 
Moraxella bovis and it occurs in all cattle producing regions of Australia. Disease is more common in 
naïve animals and in general outbreaks are more common in young stock in spring and summer in 
the southern industry but may occur in any age group. Affected cattle may lose weight and there are 
significant welfare concerns with clinical disease – especially if both eyes are affected concurrently. 
The risk factors for disease are well understood. M. bovis must adhere to the cornea to produce 
disease. Adherence is facilitated by damage to the cornea such as may follow dusty conditions, fly 
irritation, direct sunlight and/or physical scratching of the corneal surface (e.g. hay). Bos taurus are 
more susceptible than Bos indicus. Increased herd size and grouping of young stock into larger 
numbers may predispose to outbreaks. 
Unknown aetiology Known aetiology 
      X    
 
Prevention 
Vaccination is available. Piligard has three strains only; not all outbreaks are due to the strains in the 
vaccine. Managing dust, flies and eye trauma reduces the risk of outbreaks. A recent Australian sero-
survey found (only) 64% of isolates were homologous with vaccine strains. Other infectious agents 
B.AHE.0010 Final Report: Priority list of endemic diseases for the red meat industries 
Page 82 of 282 
may also produce ocular disease. Many ‘unnecessary’ treatments are also used e.g. Vit ADE in the 
belief they have an effect. 
Low efficacy/ unproven preventives available Effective preventives available 
       X   
 
Treatment 
Topical antibiotics may be used to treat disease. These need to be applied daily to ensure corneal 
levels remain at therapeutic levels. Veterinarians may inject a depot of antibiotics into the cornea 
that can last several days. Eye patches and isolation further reduce spread. Treatment is time 
consuming – repeat yarding needed. There are also significant animal welfare aspects that must be 
considered. 
Low efficacy/ unproven treatments available Effective treatments available 
       X   
 
 
Distribution 
Disease is more common in the southern beef industry due primarily to the predominance of B. 
indicus cattle in northern Australia. 
Distribution contracting Distribution stable Distribution increasing 
    X      
 
Prevalence 
Slatter et al. (1982) found a high prevalence of farms experiencing disease in southern Australia 
(80%) and reported a within-herd incidence range of 1% (Tasmania) to 8% (NSW). Unfortunately the 
age cohort specific incidences were not reported. GHD has therefore assumed 80% of southern 
herds have at least one case per year and 80% of northern herds avoid pinkeye resulting in an annual 
incidence estimate of around 2.5% of cattle in southern Australia and 0.6% in northern Australia. 
Whilst the underlying prevalence research is now thirty years old there is no evidence that disease 
has changed over the ensuing period. The high quality of the original survey work provides a robust 
estimate of pinkeye in the southern herd. The prevalence of pink eye has been assumed to be stable 
in the southern industry. Larger herds may however be prone to bigger outbreaks due to aggregation 
effects. 
Outbreak prevalence decreasing Outbreak prevalence increasing 
     X     
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Economics 
Assumptions: Pinkeye – southern  
Table 4-45 Assumptions: pinkeye – southern (cattle) 
Variable Value adopted Confidence 
Regional 
Extent 
80% of southern cattle properties experience at least once case per 
year. 80-90% of herds are Bos taurus. 
** 
% herds 
infected 
5% of herds highly infected and previously naive (50% of calves and 
1% of adults affected) 
10% of herds moderately affected (20% of calves and 0.5% of older 
stock infected) 
70% of herds lowly affected (5% of calves and 0% of older stock 
infected) 
** 
Mortalities 1% in young stock * 
Weight loss 
10 kilograms in young stock (5 kg permanent, 5 kg temporary) 
5 kg in older stock (temporary) 
** 
Fertility No impact *** 
Market 
avoidance 
10% of clinical disease in young stock develop severe corneal 
scarring precluding them from sale into some markets (e.g. 
feedlots) 
*** 
Movement 
restrictions 
Nil *** 
Treatment 
Treatment applied to 75%, 50% and 25% of clinical cases in highly, 
moderately and lowly affected herds. Treatment costs assumed at 
$10.00 head to $12.50 head across the course of disease (multiple 
yarding and handling, antibiotic treatments, patches etc.) 
** 
Prevention 
Vaccination deployed in 50% of highly affected, 25% of moderately 
affected and 15% of lowly affected herds. 
* 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of pinkeye in cattle in southern Australia at $10.9M as shown in Table 
4-46 below.  
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Table 4-46 Economic cost of pinkeye – southern (cattle) 
 Treatment Prevention Production Total 
 H M L H M L H M L H M L 
Per Cattle $1.74 $0.47 $0.06 $1.37 $0.68 $0.41 $3.37 $1.35 $0.27 $6.47 $2.50 $0.73 
Per Herd $323 $88 $11 $258 $129 $77 $637 $255 $50 $1,224 $472 $138 
Total $1.8M $4.2M $4.9M $10.9M 
 
The net gain from moving all southern herds experiencing pinkeye to the lowest level of disease is 
estimated at $4.8M.  
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Assumptions: Pinkeye – northern 
Table 4-47 Assumptions: pinkeye – northern (cattle) 
Variable Value adopted Confidence 
Regional 
Extent 
85% of northern cattle herds are Bos indicus or crossbreed. 
Pinkeye is rarely seen in Bos Indicus breeds). Disease incidence is 
less than for southern industry 
** 
% herds 
infected 
1% of herds highly infected and previously naive (12.5% of all age 
groups affected) 
3% of herds moderately affected (5% of young stock and 2% of 
older stock infected) 
18% of herds lowly affected (0.5% of young stock and 0% of older 
stock infected) 
* 
Mortalities 1% of clinically-affected young stock ** 
Weight loss 
10 kilograms in young stock (5 kg permanent, 5 kg temporary) 
5 kg in older stock (temporary) 
* 
Fertility No impact *** 
Market 
avoidance 
10% of clinical disease in young stock develop severe corneal 
scarring precluding them from sale into some markets (e.g. 
feedlots) 
*** 
Movement 
restrictions 
Nil *** 
Treatment 
Treatment applied to 25%, 10% and 5% of clinical cases in highly, 
moderately and lowly affected herds 
* 
Prevention 
Vaccination deployed in 25% of highly affected, 10% of moderately 
affected and 1% of lowly affected herds. 
* 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of pinkeye in cattle in northern Australia at $2.4M (Table 4.48). 
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Table 4-48 Economic cost of pinkeye – northern (cattle) 
 Treatment Prevention Production Total 
 H M L H M L H M L H M L 
Per Cattle $0.93 $0.19 $0.01 $0.68 $0.27 $0.03 $3.15 $1.26 $0.28 $4.77 $1.72 $0.32 
Per Herd $731 $147 $9 $537 $215 $21 $2,469 $987 $220 $3,736 $1,349 $250 
Total $0.3M $0.3M $1.8M $2.4M 
 
The net gain from moving all northern herds experiencing pinkeye to the lowest level of disease is 
estimated at $1.4M. 
Total cost of disease 
The total cost of pinkeye in cattle across Australia at the current prevalence of disease is estimated 
at $13.3M per annum. The net gain from moving all herds experiencing pinkeye to the lowest level of 
disease is estimated at $6.2M. 
 
4.15 Clostridial diseases (southern) 
The disease 
The common clostridial diseases of southern beef cattle are tetanus (C. tetani), botulism (C. 
botulinum), blackleg (C. chauvoei), malignant oedema (C. septicum), black disease (C. novyi) and 
entertoxaemia (C. perfringens type D). Clostridia bacteria are widespread and can survive in the 
environment for long periods. The low prevalence of phosphorous deficiency in southern Australia 
limits bone chewing – the main risk factor for botulism in the northern industry – provides for 
reduced impact of clostridial diseases in the southern compared to the northern industry (note that 
botulism is separately discussed in section 4.9). Unhygienic calf castration can precipitate tetanus 
outbreaks. Disease is invariably fatal however highly effective and cheap vaccines exist against the 
major variants. 
Unknown aetiology Known aetiology 
        X  
 
  
B.AHE.0010 Final Report: Priority list of endemic diseases for the red meat industries 
Page 87 of 282 
Prevention 
Effective combination vaccines are available and are widely used. This prevents the majority of 
disease.  Black disease is often associated with liver fluke infestations – but fluke areas are generally 
well known and preventive measures (fluke and black disease) are typically applied. 
Low efficacy/ unproven preventives available Effective preventives available 
       X   
 
Treatment 
Treatment is generally ineffective – most cases are found dead. Tetanus can produce less fulminating 
disease depending on the dose of toxin absorbed. 
Low efficacy/ unproven treatments available Effective treatments available 
 X         
 
Distribution 
Distribution is found in all cattle farming regions of the south and is an inherent risk of all cattle 
enterprises in these regions. 
Distribution contracting Distribution stable Distribution increasing 
    X      
 
Prevalence 
The disease is ever-present. 
Prevalence decreasing Prevalence increasing 
    X      
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Economics 
Assumptions: Clostridial disease (southern) 
Table 4-49 Assumptions: clostridial disease – southern (cattle) 
Variable Value adopted Confidence 
Regional 
Extent 
All beef herds are at risk of clostridial disease. However, the majority 
(85%) of producers use effective vaccination programs and do not 
see the disease.  
*** 
% herds 
infected 
1% of southern herds experience large-scale outbreaks (generally 
arising from failure to vaccinate or incorrect vaccine 
administration/storage) 
- Up to 10% of young stock and 2.5% of rising two-year-olds 
affected. No adult losses 
4% of southern herds experience moderate outbreak (again due to 
inadequate vaccination) 
- Up to 2% of young stock and 0.5% of rising two-year-olds. 
No adult losses 
10% of southern herds experience minor outbreak (again due to 
inadequate vaccination – generally of individual animals) 
- Up to 0.5% of young stock affected. No rising two-year-olds 
or adult losses 
85% of southern herds experience no disease 
** 
Mortalities 100% mortality rate assumed *** 
Weight loss 
No weight loss or other production effects are assumed; all 
production losses are due to deaths. 
*** 
Fertility No impact *** 
Market 
avoidance 
Nil *** 
Movement 
restrictions 
Nil *** 
Treatment 
Treatment is by antibiotics and support. A cost of $50 per case has 
been assumed. However only 5% of cases are found alive and 
treated. 
** 
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Variable Value adopted Confidence 
Prevention 
Prevention is by vaccination. A dose is estimated to cost $1.00 
(vaccine plus labour) and 50%, 70% and 90% of highly, moderately 
and lowly affected herds are assumed to vaccinate. 
*** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of $6.7M in cattle in southern Australia (Table 4-50).  
 
Table 4-50 Economic cost of clostridial disease – southern (cattle) 
 Treatment Prevention Production Total 
 H M L H M L H M L H M L 
Per Cattle $0.08 
$0.0
2 
$0.0
0 
$0.7
8 
$1.0
9 
$1.4
0 
$21.4
6 
$4.3
6 
$0.7
2 
$22.3
1 
$5.47 
$2.1
2 
Per Herd $15 $3 $1 $146 $204 $262 
$4,01
2 
$816 $135 
$4,17
3 
$1,02
3 
$397 
Total $0.0M $2.0M $4.7M $6.7M 
 
The net gain from moving all southern herds to the lowest level of clostridial disease is $3.4M. It 
should be noted that the estimated cost of a complete vaccination program across the southern 
industry is $15.9M per annum ($291 per herd per year). Whilst this is greater than the expected gain 
from better control of clostridial diseases the cost of prevention per herd is markedly less than the 
expected losses from a severe outbreak ($291 pa compared to $4,173 pa).  
 
4.16 Tick fever 
The disease 
Bock (1999) reviewed tick fever in north Australia.  Tick fever is the combined diseases caused by 
three protozoan parasites (Babesia bovis, Babesia bigemina, Anaplasma marginale) that inhabit host 
red blood cells and are transmitted between cattle by various life stages of the cattle tick, 
Rhipicephalus microplus. Haemolysis is a common feature of each disease. The severity of disease 
caused is greatest with Anaplasma and higher from B. bovis than B. bigemina, with some variation in 
virulence of organisms.  Increasing Bos indicus content generally confers greater resistance to clinical 
disease.  Cattle aged up to at least nine months are not usually susceptible to tick fever.  
Transmission of disease is affected by parasitaemia rates in ticks and the survival and attachment 
rates of ticks which are highest in warm moist conditions.  In a field transmission study, 20% of 
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infected crossbred steers experienced severe clinical disease, with 2% mortality, which is consistent 
with reported field outbreaks in northern Australia during 1990-98.  There is no published data to 
support significant permanent weight loss or reduced calf output due to tick fever. 
Unknown aetiology Known aetiology 
        X  
 
Prevention 
A trivalent vaccine available from DAFF in Queensland is considered to achieve 85-95% immunity 
(Bock 1999).  Managing tick populations to achieve infection in juvenile cattle is a key strategy, which 
must take account of parasites being present in as few as 0.04% of ticks (Bock 1999).  O’Rourke et al. 
(1992) reported that approximately 20% of cattle within the infected region are vaccinated.  Based 
on on-going sales, it is estimated that about one-third of weaners are vaccinated annually. This is 
consistent with a report that 22% of 16 surveyed north Australian businesses vaccinate against this 
disease (Levantis and Hooper 2009). Tick control also prevents infection. The widespread adoption of 
effective vaccination is critical to the prevention of disease and losses would increase markedly if a 
vaccine was not available. 
Low efficacy/ unproven preventives available Effective preventives available 
       X X  
 
Treatment 
Treatment is rarely instituted under field conditions.  Oxytetracycline is reported effective against 
Anaplasma.  Imidocarb is effective against Babesia. 
Low efficacy/ unproven treatments available Effective treatments available 
      X    
 
Distribution 
Dry and cool climate areas combined with tick-free zones restricts the vector, thus the disease to 
eastern and northern areas of Queensland, Northern Territory and Western Australia.  
Approximately 45% of Queensland’s cattle are within the tick-free zone.  There is a low prevalence of 
ticks in Queensland’s endemic tick zones beyond 200 km from the coast following droughts in the 
1990’s, 2000’s and current, where approximately 40% of cattle are reared.  There has been limited 
resurgence of ticks during wetter years where dry seasonal conditions have eliminated them. 
Distribution contracting Distribution stable Distribution increasing 
    X      
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Prevalence 
Tick fever and the mortality it causes can be dramatic.  Bock (1999) reported that 4-23% of over 
7,000 cattle surveyed in NW Queensland in the dry years of 1996-97 had tick fever immunity.  
However, in a sub-coastal herd in central Queensland, immunity in yearlings was 63% to B bovis and 
95% to Anaplasma.  Bock (1990) reported that in the period 1990-98, only 25 cases of tick fever were 
confirmed across north Australia with an average of approximately 50 mortalities per year.  Tick 
fever outbreaks are limited in high-prevalence areas as most juvenile cattle gain immunity, and it is 
in tick marginal regions where infected ticks are not continually present and may be transported in 
on cattle that cattle are at most risk. There can be a large seasonal effect on the local amount of 
disease if seasons favour an increase in tick populations and disease transmission. 
Prevalence decreasing Prevalence increasing 
    X      
 
Economics 
Assumptions: Tick fever – southern 
As tick fever is restricted to northern Australia, the annual cost of tick fever in southern Australia is 
nil. 
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Assumptions: Tick fever - northern 
Table 4-51 Assumptions: tick fever – northern (cattle) 
Variable Value adopted Confidence 
Regional 
Extent 
25%, 40% and 35% of herds with a medium, low and nil 
incidence 
* 
% herds 
infected 
An average of 1% of cattle are naïve and have a severe 
clinical infection annually and once every 5 years in medium 
and low incidence herds, respectively 
* 
Mortalities 10% of clinically-affected cattle die ** 
Weight loss No temporary weight loss * 
Fertility No measurable fertility impacts ** 
Market 
avoidance 
Low market impact, though some live export market 
protocols require no recent tick fever outbreaks 
*** 
Movement 
restrictions 
Nil *** 
Treatment Treatment rarely used *** 
Prevention 
33% of juvenile cattle within the infected region are 
vaccinated, plus 25% of bulls in their lifetime 
** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of tick fever in cattle in northern Australia at $4.3M (Table 4-52).  The 
relatively low impact reflects the high impact of dedicated resources to its control and widespread 
use of an efficacious vaccine. 
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Table 4-52 Economic cost of tick fever – northern (cattle) 
 Treatment Prevention Production Total 
 H M L H M L H M L H M L 
Per Herd $0 $0 $0 $0 $227 $227 $0 $126 $96 $0 $353 $323 
Per Cattle $0 $0 $0 $0 $0.29 $0.29 $0 $0.16 $0.12 $0 $0.45 $0.41 
Total $0M $2.9M $1.4M $4.3M 
 
There is no apparent net gain from moving all northern herds experiencing tick fever to the lowest 
level of disease. 
Total cost of disease 
The total cost of tick fever in cattle across Australia at the current prevalence of disease is estimated 
at $4.3M per annum. There is no apparent net gain from moving all herds experiencing tick fever to 
the lowest level of disease. 
 
4.17 Bovine Johne’s disease 
The disease 
Bovine Johne’s disease (BJD) is due to infection with Mycobacterium avium subsp. Paratuberculosis 
(MAP). BJD is endemic within the dairy industry of Victoria, Tasmania, South Australia and New 
South Wales with the highest prevalence of infected dairy herds in the south east of the country. 
Disease has occasionally been identified in a few beef cattle herds at a low within-herd prevalence in 
Victoria – generally a result of spill-over contact with dairy animals (cattle strains of MAP). There is 
however an increasing rate of isolation of sheep strain (S strain) from beef cattle (again at very low 
within-herd prevalence) in the sheep-beef regions (north east and western districts) of Victoria. 
Disease was historically absent from Western Australia, Queensland and the Northern Territory 
however the recent confirmation of a novel bison strain in cattle originating from a large Queensland 
Brahman stud has resulted in trace forward contacts into each of these jurisdictions. 
Johne’s disease is a chronic incurable disease however the majority of infected beef cattle do not live 
long enough to express clinical disease. Diagnostic tests have inadequate sensitivity to detect 
infected individuals and therefore test-and-cull programs to eradicate disease from infected herds 
are ineffective. Vaccines to date provide incomplete protection and cross-react with tuberculosis 
tests (that may be used in other countries). Vaccination may assist to control disease but may not 
guarantee eradication of disease from infected herds. Many countries ban the importation of cattle 
from herds confirmed to have diseased and/or BJD vaccinated cattle.  
The direct economic impact of clinical BJD in beef cattle herds is small. A recent study estimated that 
eradication (by destocking) was not feasible until the annual clinical incidence exceeded 5%. The 
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(potential) loss of trade due to regulatory restriction presents the greatest source of loss. Beef stud 
herds may be limited in ability to sell bulls and live exporters may have cattle excluded from markets 
due to the presence of disease. Not all infected farms will experience approximately ‘average’ 
economic impacts; some infected farms will experience business-threatening loss of incomes if 
confirmed (or suspected) to have disease. 
The disease is well known. The rate and extent of S-strain spillover into southern cattle from infected 
sheep is unknown as is the likelihood of MAP establishing in the north of Australia following the 
recent introduction of the bison strain. 
Unknown aetiology Known aetiology 
      X    
 
Prevention 
There are no effective preventive methods besides strict quarantine and selective introductions. The 
poor sensitivity of diagnostic tests makes introduction of test-negative animals a risk. The 
persistence of MAP in the environment (and especially water) can negate animal movement 
controls. A vaccine can assist control but not eradicate disease from most infected herds. 
Low efficacy/ unproven preventives available Effective preventives available 
 X      X   
 
Treatment 
There are no registered effective treatments. 
Low efficacy/ unproven treatments available Effective treatments available 
X          
 
Distribution 
There appears to be an increasing spread from sheep and dairy cattle to the beef herd in the south. 
The level of establishment of BJD in the northern industry following introduction and dissemination 
of the bison strain is unknown. 
Distribution contracting Distribution stable Distribution increasing 
      X    
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Prevalence 
The within-herd prevalence of clinical disease and infection with MAP is low. New Zealand modelling 
studies suggest the within-herd prevalence of S-strain in beef herds may stabilise at less than 1% 
infected. 
Prevalence decreasing Prevalence increasing 
    X      
 
Economics 
Assumptions: Johne’s disease – southern 
Table 4-53 Assumptions: Johne’s disease – southern (cattle) 
Variable Value adopted Confidence 
Regional 
Extent 
The organism can potentially inhabit a range of environments but is 
less persistent in dry regions 
** 
% herds 
infected 
5% of southern cattle properties may be infected at low prevalence: 
2% of adult cattle develop clinical disease per year. 
** 
Mortalities 100% mortalities in clinical cases *** 
Weight loss 
No weight loss, fertility or other production effects are costed as all 
production losses are captured in mortality (100%). 
*** 
Fertility 
50% of clinical cases fail to provide a calf in the year of their 
death/culling 
*** 
Market 
avoidance 
Nil – the issue of live export market restrictions is not discussed in 
this report  
N/A 
Movement 
restrictions 
Quarantine of studs and infected/suspect herds 
*** 
Treatment No treatment  ** 
Prevention Strict quarantine and selective introductions *** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of Johne’s disease in cattle in southern Australia at $2.5M as shown in 
Table 4-54. 
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Table 4-54 Economic cost of bovine Johne’s disease – southern  
 Treatment Prevention Production Total 
 H M L H M L H M L H M L 
Per Cattle $0 $0 $0 $0 $0 $0 $0 $0 $4.87 $0 $0 $4.87 
Per Herd $0 $0 $0 $0 $0 $0 $0 $0 $921 $0 $0 $921 
Total $0M $0M $2.5M $2.5M 
 
Assumptions: Johne’s disease – northern 
Table 4-55 Assumptions: Johne’s disease – northern (cattle) 
Variable Value adopted Confidence 
Regional 
Extent 
The organism can potentially inhabit a range of environments but 
is less persistent in dry regions 
** 
% herds 
infected 
1% of northern cattle herds may be infected (exposed): 1% of adult 
cattle develop clinical disease per year. 
** 
Mortalities 100% mortalities in clinical cases *** 
Weight loss 
No weight loss, fertility or other production effects are assumed; 
all production losses are due to deaths. 
*** 
Fertility 
50% of clinical cases fail to provide a calf in the year of their 
death/culling 
*** 
Market 
avoidance 
Nil – the issue of live export market restrictions is not discussed in 
this report  
N/A 
Movement 
restrictions 
Quarantine of studs and infected/suspect herds 
*** 
Treatment No treatment  ** 
Prevention Strict quarantine and selective introductions *** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of Johne’s disease in cattle in northern Australia at $0.3M (Table 4-
56). 
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Table 4-56 Economic cost of bovine Johne’s disease – northern  
 Treatment Prevention Production Total 
 H M L H M L H M L H M L 
Per Cattle $0 $0 $0 $0 $0 $0 $0 $0 $2.22 $0 $0 $2.22 
Per Herd $0 $0 $0 $0 $0 $0 $0 $0 $1,669 $0 $0 $1,669 
Total $0M $0M $0.3M $0.3M 
 
Total cost of disease 
The total cost of Johne’s disease in cattle across Australia at the current prevalence of disease is 
estimated at $2.8M per annum. Currently it is not possible to eradicate Johne’s disease. If it were, 
the net gain for the beef industry is estimated to be up to $4.5M per annum. 
 
5 Results – Sheep diseases 
5.1 Neonatal mortalities 
The Syndrome 
Neonatal mortality is a complex syndrome resulting in the death of new born lambs up to about a 
week of age. The causes of mortality are numerous with starvation-mismothering, exposure, 
dystocia and primary predation (foxes, wild dogs, pigs and crows) the most common causes. Other 
causes include neonatal infection and a group of other minor causes make up the remainder.  The 
syndrome is a complex interaction of nutrition, environmental factors, sheep genotype and 
management.    
Typical neonatal lamb mortalities range from 10-35% (Hinch 2014).  Industry recommendations are 
that losses should not exceed 10% for singles and 20% for twins (www.Lifetimewool.com). Typical 
industry neonatal losses are 10% from singles and 30% from twins (MLA 2008). 
Note that dystocia mortalities are also considered separately (along with ewe mortalities) and are a 
subset of neonatal lamb mortalities. The causes of neonatal lamb mortalities are well known though 
complicated by many underlying risk factors. 
Unknown aetiology Known aetiology 
       X   
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Prevention 
It is unrealistic to prevent all neonatal mortalities, though substantial industry improvements can be 
made. Prevention requires a multifactorial systems approach including management of the breeding 
flock, optimising nutrition (Lifetime ewe management), genetic improvement, flock health and farm 
planning to improve pastures and shelter.  Typical feeding costs are about $1.50 per ewe, though is 
dependent on season and pastures. Long term improvements through genetic improvement are 
important though the cost is not considered as is the cost of land improvement including shelter, 
subdivision and breed selection. Supervision of the lambing flock is considered. Management is the 
key to prevention and must be managed in the context of optimising flock nutrition, other diseases 
and syndromes. 
 
Low efficacy/ unproven preventives available Effective preventives available 
      X    
 
Treatment 
Treatment of neonatal mortalities largely relates to supervision of lambing ewes. Intensive 
supervision must be balanced with interruption of lambing ewes where problems are of low risk. 
Low efficacy/ unproven treatments available Effective treatments available 
      X    
 
Distribution 
The distribution is stable. 
Distribution contracting Distribution stable Distribution increasing 
    X      
 
Prevalence 
In this study the prevalence of neonatal mortalities was assumed to be 23% for Merinos and 17% for 
prime lamb flocks. Prevalence is generally constant – but influenced by season. The trend towards 
more meat sheep breeds may contribute to reducing the number of neonatal mortalities. 
Prevalence decreasing Prevalence increasing 
     X     
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Economics 
Assumptions: Neonatal mortalities 
Table 5-1 Assumptions: neonatal mortalities in sheep 
Variable Value adopted Confidence 
Regional 
Extent 
All regions  *** 
% flocks 
affected 
Average neonatal lamb losses due to all causes based on ewe 
flock include: 
- Merino X Merino: 23% 
- Dual purpose: 22% 
- Specialist prime lamb (first cross ewes X terminal sire): 
17% 
(Geenty et al. 2014, DEPI Sentinel Flock 2012, Holst et al. 2002.) 
*** 
Mortalities See above. Nil ewe mortalities *** 
Weight loss 
Ewes that fail to rear lambs are 6% heavier in summer (Lee et 
al. 1995) have a subsequent fertility benefit of 4.5%. No other 
production losses are attributed to neonatal mortality including 
impact on flock stocking rate or age structure.   
*** 
Fleece weight 
Ewes that lose lambs should produce about 6% more wool due 
to no lactation (Lee et al. 1995). 
*** 
Wool 
Ewes that do not rear lambs will produce slightly broader fleece 
and 2 N/kTex lower staple strength (Scrivener CJ et al. 1997) 
** 
Fertility 4.5% more lambs produced in following year ** 
Market 
avoidance 
Nil *** 
Movement 
restrictions 
Nil *** 
Treatment There is no treatment considered *** 
Prevention 
Supervision of flocks to reduce ewe losses primarily due to 
dystocia is adopted widely. On average, 80% of specialist prime 
lamb flocks and dual purpose flocks supervise lambing with 
50% of Merino flocks supervising lambing at a cost of 
$0.05/ewe day for 6 weeks.  The most important aspects of 
** 
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Variable Value adopted Confidence 
prevention relate to genetic improvement and nutritional 
management, paddock selection and long term investment in 
shelter which should be undertaken to optimise flock 
reproductive performance. The average cost of nutrition alone 
is assumed to be $1.50/ewe. Note that investment in shelter is 
not included. 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of neonatal mortalities in sheep in Australia at $540.4M (Table 5-2). If 
neonatal mortality rates reduce by 5%, an additional $132M income would be produced before 
considering any extra costs to achieve the reduction. Whilst it is unrealistic to eliminate all losses 
associated with neonatal lamb mortalities, there are many opportunities to reduce some losses. If 
neonatal mortality rates are reduced to industry recommendations that losses should not exceed 
10% for singles and 20% for twins (www.Lifetimewool.com), an additional $147M income would be 
produced before considering any extra costs to achieve the reduction. Consideration needs to be 
given to each strategy to weigh up the cost of reducing losses, the extra income gained, the extra 
costs of additional lambs and the impacts on flock structure, stocking rate and enterprise mix. 
 
Table 5-2 Economic cost of neonatal mortalities in sheep 
  Treatment Prevention Production Losses Total 
  H M L H M L H M L H M L 
Per Sheep $0 $0 $0 $4.69 $0 $0 $23.35 $0 $0 $28.04 $0 $0 
Per Flock $0 $0 $0 $7,235 $0 $0 $36,223 $0 $0 $43,458 $0 $0 
Total $0M $98.8M $441.6M $540.4M 
 
Note that the costs of dystocia and mastitis are also included in Table 5-2 although they are 
separately discussed in sections 5.3 and 5.8 respectively. The relative contribution of these 
diseases/conditions to neonatal lamb mortality is shown in Table 5-3.  Campylobacter abortions 
(section 5.22) are considered separately, although some neonatal deaths are likely to be due to 
campylobacter abortions. 
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Table 5-3 Relative cost of neonatal mortalities 
Disease/syndrome Direct losses of 
neonatal lamb 
mortalities  
% of total neonatal 
losses 
Neonatal lamb mortalities $474M*  
Dystocia $149M 31.4% 
Mastitis $43M 9.1% 
* Note that production losses of $441.6M in Table 5-2 is less than the $474M in Table 5-3  
 because it includes offsetting costs associated with increased wool production in the ewe as a result 
of lamb loss.  
 
5.2 Internal parasites 
The disease 
Gastrointestinal parasites and lungworm occur in all sheep rearing areas of Australia. The amount 
and distribution of rainfall determines what parasites are predominant and their financial impact, 
both from lost production and the costs of treatment and control. Infections are more problematic in 
high rainfall areas (an annual rainfall of >450 mm). The effects of parasitism are more severe in 
young animals and late pregnant and lactating ewes, especially maiden and older ewes.  
Previous estimates of the total costs and losses from gastrointestinal parasitism in the Australian 
sheep flock have been made including Beck et al. (1985), (McLeod, 1995) and (Sackett et al, 2006).  
All three studies ranked gastro-intestinal parasites as the most costly animal health condition in 
Australia, up to twice the estimated cost of blowfly strike.  All studies found that most of the costs 
associated with internal parasites were attributable to lost production rather than to treatment 
costs. 
The overwhelming conclusion, supported by more recent on-farm demonstration studies (IPMs 
2007), is that internal parasites are a major constraint on production in Australian sheep flocks. 
Production losses in the animal occur primarily as a result of reduced food intake, but also accrue 
from poor nutrient utilisation and redistribution of protein for tissue repair (Symons and Steel 1978; 
Sykes and Coop 2001). Less obviously, there may be substantial indirect costs associated with 
internal parasites. For example, the stocking rate, flock structure and grazing management on farms 
in high rainfall areas of Australia are often influenced by the producer’s attitude to internal parasites 
(Lean et al. 1997). 
The sheep most susceptible to the effects of internal parasite infections are young sheep.  
Uncontrolled clinical infections in young sheep can lead to a mortality approaching 100%, but such 
severe losses are rare because producers have adopted some form of control program.  In contrast, 
sub-clinical infections are common and may reduce liveweight gains by about 20% and wool growth 
by up to 30% in both young and adult sheep (Barger 1982).  
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There have been changes in the distribution and population of sheep in Australia since the work by 
Sackett et al. (2006). In addition, the relative value of sheep meat and wool production has also 
changed, along with the cost and range of treatments. For example, two new anthelmintic groups 
have been introduced since 2010, one as a single product (monepantel, marketed as Zolvix™), and 
another, derquantel, in combination with abamectin (Startect™). 
Anthelmintic resistance is potentially a serious constraint to sheep production in the high rainfall 
areas, although there is some evidence that farms in the high winter rainfall zone are able to manage 
with worm programs based around strategic timing of drench treatments integrated with other 
control options, such as testing for drench resistance, monitoring worm egg counts, grazing 
management and the selection of sheep with enhanced immunity to internal parasites (WormBoss 
2014, Larsen et al. 2006). Anthelmintic resistance is potentially more serious in uniform and summer 
dominant rainfall areas where Barbers Pole Worm (Haemonchus) is consistently present, as 
populations can increase rapidly and cause significant mortalities in both ewes and lambs. Effective 
long-term control strategies seek to minimise the impact of parasites but also reduce the rate of 
development of anthelmintic resistance, typically by reducing the number of treatments and 
integrating these with other control options, such as grazing management and selection for sheep 
with enhanced immunity to internal parasites (Besier and Love 2003, Larsen 2014).  
Nevertheless, some production loss is inevitable even when relatively immune sheep are exposed to 
infection, with from 3-5% lower bodyweights and 10% less wool production in both Merinos and 
prime lamb breeds (Kahn et al. 2007, Barger and Southcott, 1975, Meat & Livestock Australia Project 
BAHE0045 progress reports 2013-14). Decreased growth rates also occur in rapidly growing prime 
lambs, although these effects are often small if the amount and quality of pasture is good. For 
example, prime lambs kept free of internal parasites by continuous suppressive treatment with 
ivermectin capsules gained 1.6 kg more than untreated lambs (Carmichael et al. 2005). Similar but 
less consistent differences were observed in a more recent project comparing untreated lambs with 
a cohort treated with long-acting moxidectin injections in four regions of eastern Australia (Meat & 
Livestock Australia Project BAHE0045 progress reports 2013-14).  
In winter and uniform rainfall areas, substantially increased costs accrue from the accumulation of 
‘dag’ on breech wool. In adult sheep this is predominantly due to ‘hypersensitivity scouring’, an 
immune response by certain sheep following challenge with worm larvae (Larsen et al. 1994). In 
addition to direct costs associated with crutching, dag is also a major risk factor for breech strike in 
these areas (Tyrell et al. 2014). 
Unknown aetiology Known aetiology 
         X 
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Prevention 
Effective long-term control strategies seek to minimise the impact of parasites but also reduce the 
rate of development of anthelmintic resistance.  Prevention is based on a combination of strategic 
treatment, monitoring to determine the timing and need for additional treatments, monitoring the 
effectiveness of drenches and integrating these with other control options, such as grazing 
management and selection for sheep with enhanced immunity to internal parasites to reduce the 
reliance on anthelmintics. 
Low efficacy/ unproven preventives available Effective preventives available 
      X    
 
Treatment 
Treatment in the face of high worm burdens is considered part of prevention programs. The main 
limitation on the efficacy of anthelmintics is the widespread nature of drench resistance and the 
limited extent of resistance testing by sheep producers. 
Low efficacy/ unproven treatments available Effective treatments available 
       X   
 
Distribution 
Distribution is stable although, with intensification of production systems, worm problems may 
increase if effective control programs are not implemented. The occurrence of severe outbreaks may 
increase in some areas, and the distribution of certain parasites, such as Haemonchus, may be slowly 
expanding due to climate change. 
Distribution contracting Distribution stable Distribution increasing 
    X      
 
Prevalence 
Prevalence is variable between years depending on climatic conditions. Prevalence may increase 
without continued monitoring of drench resistance as a result of potential use of products with 
suboptimal efficacy. 
Prevalence decreasing Prevalence increasing 
    X      
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Economics 
Assumptions: Internal parasites 
Table 5-4 Assumptions: internal parasites in sheep 
Variable Value adopted Confidence 
Regional 
Extent 
Distribution Australia wide, though problems are more serious 
in higher rainfall regions particularly above 450mm rainfall.   
*** 
% Flocks 
affected  
All flocks affected though with differing levels. Different risk 
zones are considered: High rainfall high risk (41%), Wheat 
sheep zone medium risk (47%) and Pastoral zone low risk 
(12%).   
*** 
Mortalities 
Merinos 
High rainfall:        Weaners:  3.5%      Adults: 1.7% 
Summer rainfall:  Weaners:  6.4%      Adults: 3.2% 
Wheat sheep:      Weaners:  1.4%      Adults: 0.4% 
Pastoral:              Weaners:  0.2%      Adults: 0.05% 
Prime lambs:  30%  of Merino enterprises 
** 
Weight loss  
Temporary kg BW loss 
High rainfall:        Weaners: 0.8kg     Adults: 1.7kg 
Summer rainfall:  Weaners: 0.8         Adults: 1.7 
Wheat sheep:      Weaners: 0.3         Adults: 1.0 
Pastoral:              Weaners: 0.1         Adults:  0 
Permanent kg BW loss 
High rainfall:        Weaners: 0.8kg     Adults:  1.7kg 
Summer rainfall:  Weaners: 0.8         Adults:  1.7 
Wheat sheep:      Weaners: 0.3         Adults:  1.0 
Pastoral:              Weaners:  0.1        Adults:   0 
Prime lambs:       80% of Merino enterprises 
(Kahn et al. 2007, Barger and Southcott, 1975, Meat & 
Livestock Australia Project BAHE0045 progress reports 2013-
14, Carmichael et al. 2005) 
** 
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Variable Value adopted Confidence 
Fertility 
decline 
1.5% per kg bodyweight loss ** 
Fleece weight 
loss % 
Merinos 
High rainfall:   Weaners: 6.1%  Adults: 
6.1% 
Summer rainfall: Weaners: 6%  Adults: 6% 
Wheat sheep:  Weaners: 2.7%  Adults: 
2.7% 
Pastoral:  Weaners: 0.5%  Adults: 
0% 
Prime lambs:  2/3rd of Merino enterprises 
(Kahn et al. 2007, Barger and Southcott 1975, Meat & 
Livestock Australia Project BAHE0045 progress reports 2013-
14) 
** 
Staple 
strength 
discount 
N/kTex 
Merinos 
High rainfall:  Weaners: 8.5  Adults:  8 
Summer rainfall: Weaners: 8  Adults:  7 
Wheat sheep:  Weaners: 3.5  Adults:  0 
Pastoral:  Weaners:  0  Adults:  0 
Prime lambs: nil 
(Sackett et al. 2006) 
** 
Market 
avoidance 
Nil  *** 
Movement 
restrictions 
Nil *** 
Treatment Considered as part of prevention program  *** 
Prevention  
Drench frequency (per year) 
 Weaners Maiden 
ewes 
Adult 
ewes 
Wethers 
High rainfall: 3 2.2 2.7 1.8 
** 
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Variable Value adopted Confidence 
Summer rainfall: 5 4 5.6 4.0 
Wheat sheep: 2.5 1.8 1.5 1.3 
Pastoral 0.8 0.3 0.2 0 
Note ~ 3% capsule & 10% long acting use in HRZ 
Cost of drench including labour & adjusted for long acting: 
$0.45/dose adults, $0.38/weaner 
 
Monitoring frequency WEC (per year) 
 Weaners Ewes Wethers 
High rainfall: 0.6 0.8 0.5 
Summer rainfall: 0.6 1 1 
Wheat sheep: 0.3 0.7 0.4 
Pastoral 0.1 0 0 
Cost per sheep per monitor: $0.12/sheep 
Drench resistance testing: FECRT cost: $600 1% 
flocks/annum 
(Reeve et al. 2014) 
Dags 
Proportion with dags due to worms 
 Weaners Adults Reduction in 
fleece value 
High rainfall: 38% 35% $0.34 
Summer rainfall: 9% 5% $0.09 
Wheat sheep: 14% 14% $0.15 
Pastoral 0% 0% $0.00 
(Larsen et al. 1994) 
Part crutching cost (of $1.40) allocated to dag management in 
wheat/sheep (10%) and high rainfall zone (25%) 
** 
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Based on the adopted prevalence and impacts of internal parasites on the classes of animals 
affected, GHD has calculated the annual cost of internal parasites in sheep in Australia at $436M 
(Table 5-5).  
 
Table 5-5 Economic cost of internal parasites in sheep 
  Treatment Prevention Production Losses Total 
  H M L H M L H M L H M L 
Per Sheep $0 $0 $0 $5.63 $3.26 $0.71 $22.66 $9.08 $0.58 $28.29 $12.34 $1.29 
Per Flock $0 $0 $0 $9,317 $5,399 $1,183 $37,566 $15,037 $963 $46,883 $20,436 $2,146 
Total  $0M $93.77M $341.89M $435.92M 
 
If the severity of internal parasites is reduced by 50% before extra costs are considered then the gain 
to the industry would be $164M. 
 
5.3 Dystocia 
The disease 
The causes of dystocia in sheep are complex but mostly commonly associated with foeto-pelvic 
disproportion.  Risk factors include breed, nutrition, age of dam, metabolic problems such as 
hypocalcaemia, pasture toxicity (such as clover disease) and gender of lamb.  The economic cost of 
dystocia is associated with increased neonatal mortality, ewe mortality and extra supervision 
associated with lambing. Apart from the direct loss of lambs due to dystocia, up to 80% of lambs that 
die within a few days of birth due to starvation-mismothering-exposure are associated with brain 
injury and difficult birth (Hinch et al 2014), though not all these losses associated with starvation-
mismothering-exposure were considered as part of the dystocia complex. Dystocia is a risk in all 
climatic zones.   
Unknown aetiology Known aetiology 
      X    
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Prevention 
Prevention of dystocia is largely related to management including nutrition of ewes (avoiding too fat 
or too light (BCS 3-3.5 target). Avoiding metabolic disease is important and avoiding ewe exposure to 
toxic pastures will reduce the risk of dystocia.  Long term improvement with genetic improvement 
and breed selection will help reduce dystocia. 
Low efficacy/ unproven preventives available Effective preventives available 
      X    
 
Treatment 
Treatment of dystocia largely relates to supervision of lambing ewes. Intensive supervision must be 
balanced with interruption of lambing ewes where problems are of low risk. 
Low efficacy/ unproven treatments available Effective treatments available 
       X   
 
Distribution 
Distribution is considered to be stable. 
Distribution contracting Distribution stable Distribution increasing 
    X      
 
Prevalence 
Prevalence is generally constant – but influenced by season. With the trend towards more meat 
sheep breeds, dystocia will increase but overall lamb losses should decrease. 
Prevalence decreasing Prevalence increasing 
     X     
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Economics 
Assumptions: Dystocia 
Table 5-6 Assumptions: dystocia in sheep 
Variable Value adopted Confidence 
Regional 
Extent 
All regions  *** 
% flocks 
affected 
Neonatal lamb losses due to dystocia based on ewe flock include: 
- Merino X Merino: 5.3% 
- Dual purpose:      8.4% 
- Specialist prime lamb (first cross ewes by terminal): 5.0% 
(Geenty et al. 2014, Sentinel Flock DEPI 2012, Holst et al. 
2002) 
** 
Mortalities 
Mortality rates in ewes due to dystocia are assumed to be: 
- Merino X Merino: 0.26% 
- Dual purpose:      0.49% 
- Specialist prime lamb (first cross ewes by terminal): 
0.29% 
- Typical dystocia rates assisted birth: 3.6% 
 (Sentinel Flock DEPI 2012, McGrath et al. 2013) 
** 
Weight loss 
Ewes that fail to rear lambs are 6% heavier in summer (Lee et 
al.1995) resulting in a subsequent fertility benefit of 4.5%. No 
other production losses are attributed to dystocia including 
impact on flock stocking rate or age structure.   
*** 
Fleece 
Ewes that lose lambs should produce about 6% more wool due to 
no lactation (Lee et al. 1995). 
*** 
Wool 
Ewes that do not rear lambs will produce slightly broader fleece 
but their fleece has lower staple strength (2 N/kTex) resulting in 
a 1% discount in fleece value. (Scrivener CJ et al. 1997) 
** 
Fertility 4.5% more lambs produced in following year ** 
Market 
avoidance 
Nil *** 
Movement 
restrictions 
Nil *** 
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Variable Value adopted Confidence 
Treatment There is no treatment apart from assisting ewes with dystocia. *** 
Prevention 
Supervision of flocks to reduce ewe losses with dystocia is 
adopted widely. On average 80% of specialist prime lamb flocks 
and dual purpose flocks supervise lambing with 50% of Merino 
flocks supervising lambing at a cost of $0.05/ewe day for 6 
weeks.  Further prevention relates to genetic improvement and 
nutritional management which should be undertaken to optimise 
flock reproductive performance. The cost of nutrition was not 
considered as part of this syndrome apart from a small cost of 
allocation of ewes to paddocks for lambing ($0.30/ewe). 
** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of dystocia in Australia at $219M (Table 5-7). Reducing dystocia rates 
by 50% will produce a gain to the industry of $77M before considering extra costs to achieve the 
benefit.  Note that dystocia is a sub-set of neonatal lamb mortalities with additional loss from the 
mortality of ewes included (see section 5.1). 
 
Table 5-7 Economic cost of dystocia in sheep 
  Treatment Prevention Production Losses Total 
  H M L H M L H M L H M L 
Per Sheep $0 $0 $0 $3.09 $0 $0 $8.14 $0 $0. $11.23 $0 $0 
Per Flock $0 $0 $0 $4,883 $0 $0 $12,814 $0 $0 $17,697 $0 $0 
Total  $0M $64.89M $154.27M $219.16M 
 
  
B.AHE.0010 Final Report: Priority list of endemic diseases for the red meat industries 
Page 111 of 282 
5.4 Weaner illthrift and mortality 
The disease 
Weaner illthrift describes the syndrome of young sheep failing to thrive when other stock classes on 
the farm are in satisfactory health.  It is manifested by poor growth and wool production, increased 
susceptibility to disease, and excessive mortality in young sheep in the first year after weaning.  It 
has multiple, concurrent causes, many of which are related to nutrition and husbandry.  Increased 
post-weaning mortality is a component of the weaner illthrift syndrome and an important 
contributor to adverse production and animal welfare effects of the condition. Note that a number 
of disease syndromes contribute to weaner illthrift and mortality including internal parasites, liver 
fluke, footrot, perennial ryegrass toxicosis, pneumonia, mastitis and flystrike. 
Unknown aetiology Known aetiology 
       X   
 
Prevention 
Recent studies have concentrated on factors that reduce weaner mortality, with nutrition having a 
significant effect.  Improving weaner bodyweight, and growth rates in particular, profoundly reduces 
post-weaning mortality.  It is likely that strategies to improve survival would reduce illthrift in 
general, as would prevention of specific components of the illthrift syndrome, such as strategic 
worm control and blowfly strike prevention and treatment.  
A national survey of weaner management (Campbell et al. 2014) identified that ‘excessive’ (> 4%) 
mortality was less likely on farms that subdivided weaner mobs based on body weight or condition 
score, presumably because this allows lightweight, high mortality risk weaners to receive differential 
management or improves their access to feed.  The same study showed that offering high-protein 
supplementary feeds, such as lupins, improved survival.   
The key barrier to these various strategies, effectively reducing weaner illthrift, appears to still be 
communicating the key information to farmers and encouraging them to monitor risk factors such as 
body weight and growth rate, and adjust nutritional management and husbandry accordingly. 
 
Low efficacy/ unproven preventives available Effective preventives available 
      X    
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Treatment 
Treatment for specific factors contributing to weaner illthrift, including gastrointestinal parasitism 
and blowfly strike, exist and are discussed elsewhere in this review. 
Low efficacy/ unproven treatments available Effective treatments available 
       X   
 
Distribution 
Distribution of weaner mortalities is widespread across climatic zones though more severe in the 
pastoral zone and in Merinos compared with Merino-cross weaners. 
Distribution contracting Distribution stable Distribution increasing 
    X      
 
Prevalence 
Based on a single year’s survey in 2008 (Campbell et al. 2014), weaner mortality appears to be 
highest in the pastoral zone (average annual post-weaning mortality 7.7%) compared to the wheat-
sheep (4.4%) and the high rainfall (4.6%) zones.  Average weaner mortality was greater in 
Queensland (6.1%), Western Australia (5.8%) and Tasmania (5.2%) compared to NSW or Victoria 
(both 4.4%) or South Australia (3.5%).  Greater mortality was reported in Merino enterprises (5.2%) 
than crossbred flocks (4.6%).  Similar results were observed in 2009 and 2010 Wool Desk surveys (K. 
Curtis, unpublished). 
These figures were self-reported by farmers during a telephone survey and are likely to be biased, 
with actual weaner mortality probably higher than those reported.  For example, average weaner 
mortality has been reported at 11% in Victoria (Mackinnon Project, unpublished, reported in 
Campbell et al. (2009)), 7% Central Tablelands, NSW (Hatcher et al. 2010), 15% Yass, NSW (Hatcher 
et al. 2008) and 6–9% in South Australia (Hocking-Edwards et al. 2008). 
It is also difficult to estimate the prevalence of illthrift, above that of actual weaner mortality.  Since 
post-weaning mortality represents an extreme form of weaner illthrift, it could be reasonable to 
estimate that the additional prevalence of illthrifty weaners in a flock is 1–2 times the actual weaner 
mortality. 
Prevalence decreasing Prevalence increasing 
    X      
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Economics 
Assumptions: Weaner illthrift and mortality 
Table 5-8 Assumptions: weaner illthrift and mortality in sheep 
Variable Value adopted Confidence 
Regional 
Extent 
Regional differences are based on climatic zones with 
highest risk pastoral zone (12% of the sheep flock), 
moderate risk high rainfall zone (41% of the sheep flock) 
and lowest risk in the wheat sheep zone with (47% of the 
sheep flock) 
*** 
% Flocks 
affected  
Weaners affected with illthrift 
High rainfall zone: Merino 9.8%; Dual purpose 7.4% 
Wheat sheep zone: Merino 9.7%; Dual purpose 6.4% 
Pastoral zone Merino: 17.0%, Dual purpose 12.0% 
Prime lamb flocks not affected 
*** 
Mortalities 50% mortality in affected weaners (only ewe weaners for 
dual purpose as wether weaners sold) 
** 
Weight loss 
Temporary weight loss of 5 kg in affected weaners 
(Merino); 3 kg for crossbred lambs in dual purpose flocks 
** 
Fertility 
3.75% Merino, 3% dual purpose for maidens ewes 
previously affected by illthrift  
* 
Fleece weight 13% reduction in Merinos, 7% reduction in dual purpose ** 
Wool price 
7% reduction in price for Merino weaner wool due to lower 
staple strength 
** 
Market 
avoidance 
Nil *** 
Movement 
restrictions 
Nil *** 
Treatment Considered in specific diseases ** 
Prevention 
50% flocks in high rainfall and wheat sheep zones adopt 
grain feeding at a cost including labour of $4.03/animal (2.5 
kg/month for 5 months) 
* 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of weaner illthrift and mortality in sheep in Australia at $188M (Table 
5-9).  
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Table 5-9 Economic cost of weaner illthrift and mortality in sheep 
  Treatment Prevention Production Losses Total 
  H M L H M L H M L H M L 
Per Sheep $0 $0 $0 $0 $1.53 $1.53 $8.71 $5.14 $4.77 $8.71 $6.67 $6.30 
Per Flock $0 $0 $0 $0 $2,529 $2,529 $14,422 $8,498 $7,904 $14,422 $11,027 $10,433 
Total $0M $36.15M $151.40M $187.55M 
 
Note that this syndrome includes a number of different diseases including gastrointestinal 
parasitism. Hence, when considering the financial cost of weaner mortality and illthrift, it should not 
be considered in addition to other diseases such as gastrointestinal parasitism. 
The net gain from moving all flocks to below an industry standard of 4% mortality rate is estimated 
at $40.34M. 
 
5.5 Flystrike 
The disease 
Flystrike is an important disease of sheep with two main presentations: breech strike and body 
strike.  Other strikes include pizzle strike, poll strike and wound strike.  Breech, body and pizzle strike 
are considered as part of the evaluation undertaken.  L. cuprina is by far the most important fly 
species accounting for at least 90% of all strikes. There are a number of important risk factors 
including: 
 Susceptible sheep: for breech strike, urine and faecal staining caused by scouring mostly 
associated with internal parasites, enteritis and pasture.  Less wrinkle and more breech bare area 
reduce the risk as will mulesing.  For body strike, sheep that develop fleece rot and 
dermatophilosis especially in wet conditions are most at risk.  Pizzle strike is associated with urine 
staining of the belly wool. In the long term selection for sheep genetic parameters will reduce 
sheep susceptibility. 
 Suitable weather conditions associated with moisture and warmth with prolonged wet conditions 
with susceptible sheep resulting in fly strike waves. 
 Sheep and farm management: a number of important management factors have a major impact 
into the risk of flystrike including time of shearing, crutching, chemical prevention, mulesing, tail 
docking procedures, control of scouring, paddock selection for susceptible sheep, control of fly 
numbers, and genetic selection of sheep.  
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The economic cost associated with flystrike is due to mortalities, production losses associated with 
loss of wool growth and value, weight loss including reproduction penalty, treatment and prevention 
costs. 
Unknown aetiology Known aetiology 
        X  
 
Prevention 
An integrated approach to flystrike control can be very effective including reducing sheep 
susceptibility by chemical control, genetic selection and management and reducing fly populations 
during at-risk periods (Larsen et al. 2012a, Larsen et al. 2012b, Lucas et al. 2013). 
Low efficacy/ unproven preventives available Effective preventives available 
       X   
 
Treatment 
Treatment of individual struck sheep is effective, especially if implemented early.  A number of 
effective and safe chemicals are available to kill fly larvae in association with clipping flystrike 
affected wool with their use reasonably well adopted.  Treatment of severe flystrike cases with 
antibiotics and anti-inflammatory therapeutics will improve survival rates.  The main limitation to 
effective treatment is the labour requirement for supervision and early intervention. 
Low efficacy/ unproven treatments available Effective treatments available 
       X   
 
Distribution 
Distribution is stable though varies widely with seasonal conditions. 
Distribution contracting Distribution stable Distribution increasing 
    X      
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Prevalence 
Prevalence is generally constant – but influenced greatly by season.  The risk of flystrike will 
potentially increase if effective preventive treatments are not adopted to counteract the decline in 
mulesing. Managing flystrike will become more difficult with L. cuprina developing chemical 
resistance. 
Prevalence decreasing Prevalence increasing 
    X      
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Economics 
Assumptions: Flystrike 
Table 5-10 Assumptions: flystrike in sheep 
Variable Value adopted Confidence 
Regional 
Extent 
High rainfall; wheat-sheep; and pastoral zones are considered as high, 
medium and low risk respectively. 
*** 
% flocks 
infected 
Average flystrike prevalence per property (Reeve et al. 2014, Sackett 
et al. 2006) 
 High 
rainfall 
Wheat 
sheep 
Pastoral 
Ewes    
body 2.1% 1.5% 2.3% 
breech 2.4% 2.3% 2.1% 
Weaners    
body 3.4% 2.9% 3.9% 
breech 2.8% 2.5% 2.4% 
pizzle 0.5% 0.9% 0.2% 
Wethers    
body 1.5% 1.6% 2.8% 
breech 0.9% 1.3% 2.1% 
pizzle 0.6% 0.8% 1.6% 
Note: It is assumed 40-60% of producers jet at strategic times, 30-40% 
at high risk times and 20% when fly strike detected.  35% of producers 
only treat individual struck sheep. 30% cross over between breech and 
body strike 
** 
Mortalities  
10% for adults; 20% for hoggets - averaged across body, breach and 
pizzle strikes  (Lucas et al. 2013, Sackett et al. 2006) 
** 
Weight 
loss 
12% for body, breach and pizzle strike (Lucas et al. 2013) *** 
Fleece Clean fleece weight reduction of 8% *** 
Wool 
Fibre diameter penalty of 1.5 micron/kg cfw loss; staple strength 
reduction 18 N/KTex for 100% of affected sheep (Lucas et al. 2013, 
Sackett et al. 2006, Colditz et al. 2005). Wool price discount (%) as per 
below (Nolan 2012). 
Staple strength 
N/kTex 
Superfine Fine Mediu
m 
28-38 5% 2% 1% 
21-28 9% 5% 4% 
*** 
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Variable Value adopted Confidence 
14-21 16% 9% 8% 
<14 18% 11% 10% 
 
Fertility 1.5% per kg body weight for 50% of body weight loss  ** 
Market 
avoidance 
Nil *** 
Movement 
restrictions 
Nil *** 
Treatment 
Clip wool and apply chemical to affected sheep ($5.05/sheep mostly 
labour - 10 minutes/sheep @ $30/hour), 1% treated with antibiotics 
@$5.00/sheep. 80% of affected pastoral sheep treated; 90% of wheat-
sheep and high rainfall affected sheep are treated.  
** 
Prevention 
Between 40-60% of producers jet at strategic times, 30-40% at high 
risk times and 20% when fly strike detected.  35% of producers only 
treat individual struck sheep. 30% cross over between breech and 
body strike. (Reeve et al. 2014) 
Chemical group  
(from Flyboss 2014) 
Cost 
$/sheep 
crutch & body 
Cost 
$/sheep 
body 
Cost 
$/sheep 
crutch 
Clik 
Cyromazine jet 
$1.43 
$0.30 
$0.95 $0.43 
Cyromazine spray $0.59   
Spinosad 
ML 
$0.53 
$0.47 
  
 
Labour costs 
Shortwool backliner: $0.20 
Long wool hand 
jetting: 
$0.50 
Long wool backliner: $0.30 
Jetting race: $0.10 
** 
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Variable Value adopted Confidence 
Mulesing: $0.90 (excluding lamb marking cost, 
include Clik) (48% producers mulesing 
70% for Merinos 20% for self-replacing 
meat sheep) 
Trisolvin: $0.75 (60% use) 
Crutch: assume 50% of crutch cost allocated to 
flystrike at $1.40/animal = $0.70 
 
 
Based on the adopted prevalence and impacts of flystrike on the classes of animals affected, GHD 
has calculated the annual cost of flystrike in sheep in Australia at $173M (Table 5-11). This figure will 
vary widely in individual years depending on climatic conditions.  
 
Table 5-11 Economic cost of flystrike in sheep 
  Treatment Prevention Production Losses Total 
  H M L H M L H M L H M L 
Per 
Sheep 
$0.49 $0.44 $0.44 $2.38 $2.18 $1.87 $5.06 $4.69 $5.01 $7.93 $7.31 $7.31 
Per 
Flock 
$821 $731 $727 $3,956 $3,628 $3,103 $8,387 $7,780 $8,310 $13,165 $12,139 $12,140 
Total  $11.34M $57.30M $104.53M $173.17M 
 
Reducing the prevalence of flystrike by 50% before considering extra costs will reduce the cost of 
flystrike to the industry by $43.5M. 
 
5.6 Perennial rye grass toxicosis 
The disease 
Perennial ryegrass (PRG) pastures infected with the wild-type (WT) endophyte Neotyphodium lolii 
produces several classes of alkaloids which, when ingested by livestock, cause perennial ryegrass 
toxicosis (PRGT). The effects of PRGT are widespread and potentially severe, with serious outbreaks 
causing considerable production losses, animal welfare problems and further indirect costs and 
subclinical losses resulting in considerable economic losses.  Fungal endophytes in ryegrass act in a 
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symbiotic relationship providing resistance to insect pests and thus confer agronomic advantages 
which enhance the persistence and productivity of ryegrass (Leury et al. 2013).  
The two main alkaloids that cause toxicosis of livestock include Lolitrem B and Ergovaline.  Lolitrem 
B, a neurotoxin that affects muscle activity, has widespread impact on the respiratory, cardiovascular 
and digestive systems. It causes tremors and has profound effects on smooth muscle, altering gut 
motility and severely disrupting digestion. Ergot alkaloids interact with dopamine receptors leading 
to peripheral vaso-constriction, disruption of thermoregulation and endocrine dysfunction. 
Reduction of blood circulation to glands, skin and extremities raises blood pressure, temperature 
and respiration rate causing heat stress, reduced food intake and serum prolactin, and potentially 
impaired reproductive efficiency (Reed 2005). 
It is estimated that six million hectares are sown to PRG predominantly in Victoria, Tasmania 
southern South Australia and Western Australia and parts of the high rainfall regions of New South 
Wales, with old populations having a frequency of N. lolii infection of 80-90% (Reed et al. 2004). 
The concentration of toxic alkaloids peaks in summer autumn.  Clinical signs vary between years 
depending on environmental conditions (and consequent pasture growth) and composition of 
pastures.  Symptoms are usually more severe in years when late spring rain results in carryover feed 
in summer, followed by summer rain that triggers some growth, which is then followed by dry and 
hot conditions in summer and autumn that stress pasture. Severe outbreaks tend to occur 
approximately every five years, although in high risk regions some outbreaks occur every year with 
additional ongoing subclinical effects occurring well after staggers has diminished. 
Economic losses are caused by mortalities (misadventure, drowning, chronic recumbency and 
hyperthermia, as well as secondary consequences due to flystrike and parasitism), production losses 
associated with lower weight gain, poor reproductive performance, increased dags and reduced 
fleece values. In outbreak years, substantial labour resources are diverted to husbandry to manage 
the welfare of affected sheep.  Many indirect impacts of PRGT are associated with interference and 
delay of normal farm husbandry procedures such as worm control and fly control resulting in lower 
production and higher death rates.  From a social perspective, the overwhelming impact of a severe 
PRGT event causes substantial stress on managers of affected sheep flocks (and cattle herds).   
There are several important strategies to minimise the impact of outbreaks and ongoing production 
losses. In the first instance, supervision of recumbent stock and removal of at risk mobs from toxic to 
safe pastures will minimise losses.  If no safe pastures are available, either supplementing to dilute 
toxic pastures or, if severe, removal from pasture and feedlotting may be necessary.  Novel alkaloid 
detoxifying agents such as Elitox® or Mycofix® supplemented in a lick appear to have beneficial 
effects at reducing the impact of PRGT. 
In the long term, replacement of PRG pastures infested with wild-type endophytes with safe 
pastures is the best solution as long as successful establishment is achieved and new pastures are 
persistent and more productive (Leury et al. 2014).  Safe pastures include alternative pasture species 
(such as phalaris, fescues and cocksfoot), PRG with novel endophytes (such as AR37 or Endo 5) that 
are less toxic to stock and still protect against insect attack.  Many persistent cultivars and species of 
pastures are available that are more productive than PRG infected with wild type endophyte. Some 
endophyte-free cultivars of PRG are commercially available but poor persistence is an issue. The 
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main limitation to adoption of whole scale replacement of toxic pasture is the cost, risk of failure, 
concern about persistence of new pasture, concern that new pasture will be re-invaded with wild 
type PRG and timeframe to achieve an adequate return on investment. 
The cause of PRGT is well known though some of the physiological effects and production impacts of 
toxic alkaloids are not clear. In addition, the importance of alkaloids apart from Lolitrem B and 
Ergovaline are not as clear. 
Unknown aetiology Known aetiology 
        X  
 
Prevention 
Prevention relies on removal of stock from toxic to safe pastures, diluting the effects of toxic 
pastures and by supplementary feeding or feedlotting during severe outbreaks.  Alkaloid detoxifying 
agents are commercially available however the full benefits of compounds available are not well 
documented.  In the long term permanent replacement of toxic pastures with safe pasture is 
economically viable as long as replacement pastures are persistent and more productive. 
Low efficacy/ unproven preventives available Effective preventives available 
       X   
 
Treatment 
No therapeutic compound is available to treat PRGT.  The only option to treat clinically affected stock 
is to remove them from toxic pasture and provide supportive husbandry (food and water) whilst they 
recover.   
Low efficacy/ unproven treatments available Effective treatments available 
 X         
 
Distribution 
The distribution of PRGT is limited to high rainfall regions (>600 mm) where PRG with wild-type 
endophyte is grown.  PRG with wild-type endophyte is grown on at least six million hectares in 
southern Australia, particularly in Victoria and Tasmania but also NSW, southern South Australia and 
southern Western Australia. Increased fertiliser application encourages PRG hence potentially 
increasing the severity of outbreaks over time.  Producers that have previously experienced severe 
outbreaks of PRGT are actively replacing toxic PRG pasture, though the extent of this is relatively 
small. 
Distribution contracting Distribution stable Distribution increasing 
    X      
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Prevalence 
The prevalence of PRGT varies from season to season.  In high risk regions severe outbreaks occur in 
about 20% of years and moderate impact in 40% of years.  In moderate risk regions, outbreaks occur 
about 30% of the time and in low risk regions outbreaks occur about 10% of the time (Sackett et al. 
2005). Weaners are more at risk than adult sheep and Merinos appear more susceptible than 
crossbred sheep and meat breeds. Prevalence is generally stable, though varies between years 
depending on climatic conditions. 
Prevalence decreasing Prevalence increasing 
    X      
 
Economics 
Assumptions: PRGT 
Table 5-12 Assumptions: PRGT in sheep 
Variable Value adopted Confidence 
Regional 
Extent 
About 11.2% of Australia’s sheep flock is exposed to a high 
risk of PRGT, about 3.5% to a medium risk and 9.2% to a low 
risk of PRGT. The remainder of the sheep population is not 
exposed to PRGT. PRGT is highest risk in higher rainfall 
regions of Victoria and Tasmania. 
*** 
% Flocks 
affected  
High risk flocks are exposed to a severe impact in 20% of 
years, a moderate impact in 40%, a low impact in 20% and no 
risk in 20% of years.  Moderate risk flocks are exposed to a 
moderate impact in 30% years and low impact 10% of years. 
Low risk flocks are exposed to a low impact in 10% of years. 
** 
Mortalities 
No accurate published data is available but based on 
experience and surveys, the following estimates are used: 
 Weaners Adults 
High impact 12% 7% 
Moderate impact 3% 2% 
Low impact 1% 0% 
 
 
** 
Weight loss  
Weight loss data is highly variable between trials and regions 
though a best estimate of the temporary weight loss attributed 
to PRGT is: 
 Weaners Adults 
High impact 2 kg 2 kg 
Moderate impact 1 kg 1 kg 
** 
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Variable Value adopted Confidence 
Low impact 0 0 
 
Fertility 
The impact of PRGT on reproductive performance is highly 
variable. Based on experience and trials the following 
estimates have been used (the impact is likely to be due to 
the direct effects of PRGT and the secondary impacts on 
lower bodyweight): High impact - 12% reduction; moderate 
impact - 6%; low impact - 2%. 
* 
Fleece 
weight % 
Little data is available on the effects on wool growth, however 
in some longer term trials in NZ reduced wool growth has 
been experienced as is the case in Australia in outbreak 
years.  Fleece weight reductions are assumed to be: 10% for 
high impact, 4% for moderate and 0.5% for low impact 
scenarios. 
** 
Wool price 
discounts 
Staple strength reduced by 5 N/kTex in high risk situations. 
* 
Market 
avoidance 
No information is available, although timing of sales is often 
restricted due to inability to transport staggering stock. 5% of 
stock sales are assumed to be delayed by 2 months. 
** 
Movement 
restrictions 
Nil 
** 
Treatment 
 Labour1 Supplementary 
Feed (amount & 
cost)2 
Extra drenching3 
  Weaners Adults Weaner Adults 
High 
Impact 
$2400 10 kg 
$2.50 
5 kg 
$1.25 
1 0.5 
Moderate 
Impact 
$1200 5 kg 
$1.25 
2 kg 
$0.50 
0.5 0 
Low 
Impact 
$400 3 kg 
$0.75 
0 0 0 
1. The total extra cost of labour to manage a high impact, 
moderate and low cost scenario ($/flock). 
2. Supplementary feeding required over an outbreak at a 
cost of $250/t ($/head) 
3. Likely extra drenching undertaken due to poor timing 
of drenches and producer response to extra dags. Cost of 
drenching $0.45/dose adults, $0.38/weaner.    
** 
B.AHE.0010 Final Report: Priority list of endemic diseases for the red meat industries 
Page 124 of 282 
Variable Value adopted Confidence 
Prevention  
No cost considered although pasture renovation costs may be 
substantial. 
** 
Other costs 
and 
production 
losses 
Additional costs associated with PRGT 
Increased dags 
PRGT increases dag in sheep.  The cost associated with this 
is reduced wool value due to faecal soiling and extra crutching 
costs 
 Weaners Adults 
High impact $0.54 $0.54 
Moderate impact $0.43 $0.43 
Low impact 0 0 
 
Other production losses associated with PRGT 
Reduced milk production: 13% lower in sheep in high risk flocks 
resulting in 2.4 kg/lamb decrease in weight; 6.5% lower in 
moderate impact scenarios 1.2 kg/lamb decrease in weight. 
 
Lower bodyweights: Adult sheep with consistently lower 
bodyweight when grazing toxic pastures even when clinical 
staggers is not apparent. This has several potential effects 
including:  
 Lower bodyweight of adult sheep so lower sale value 
(~2 kg high, ~ 1kg moderate) and lower reproduction 
(3%) 
 Lifetime wool impact of ewes consistently in lower body 
condition estimated to produce progeny that have 
fleeces that have 0.1 kg clean less wool but the fleece 
is 0.3 micron higher fibre diameter. 
** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of PRGT in sheep in Australia at $105M (Table 5-13). This disease was 
not considered in the Sackett et al report, though a separate project undertaken by Sackett and 
Frances (2006) calculated to cost of PRGT at $63M using similar methodology and assumptions to 
the Sackett report. 
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Table 5-13 Economic cost of PRGT in sheep 
  Treatment Prevention Production Losses Total 
  H M L H M L H M L H M L 
Per Sheep $0 $0 $0 $1.91 $0.63 $0.07 $31.03 $11.55 $2.32 $32.94 $12.18 $2.39 
Per Flock $0 $0 $0 $3,161 $1,049 $123 $51,369 $19,120 $3,840 $54,530 $20,169 $3,964 
Total $0M $5.95M $99.05M $104.99M 
 
If the area of land affected with PRGT is reduced by 50% before extra costs are considered then the 
cost to industry would reduce by $52.5M. 
 
5.7 Lice 
The disease 
Lice infestation caused by Bovicola ovis is an important disease of the Australian sheep flock causing 
significant economic loss through reduction in fleece values, lower bodyweight and the cost of 
control and prevention.  The most recent survey (Reeve et al. 2014) indicates that as of 2011, 23.3% 
of producers Australia-wide reported seeing live lice in their flocks with 27.1% of producers reporting 
some sheep rubbing and 54.1% reporting no evidence of lice.  It appears that the prevalence of lice 
has increased from 10% in 2006 and the number of flocks reporting no evidence of lice has reduced 
from 62.6% in 2006 to 54.1% in 2011. 
There are several important reasons for the likely increase in prevalence of lice in the Australian 
sheep flock (James 2011).  Firstly, the emergence of chemical resistance to the IGR group of 
chemicals that was first detected in the early 2000’s (until recently the IGR group was important for 
the control and eradication of lice).  It should be noted that the recent introduction of highly 
effective chemicals onto the market is likely to restrict the development of chemical resistance and 
result in reduced use of inferior chemicals. Secondly, the withdrawal of the effective chemical 
diazinon (due to OH&S issues) from the market in 2009 and its replacement with less effective 
products may have contributed to the increase in prevalence reported at the time.  Currently, there 
are effective chemicals available to control and eradicate lice, so the prevalence is more likely to be 
stable. 
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Ongoing poor application technique and poor biosecurity are continuing issues.  The emergence of 
exotic breeds, especially in pastoral areas is likely to increase the prevalence of lice due to the 
perception that treatment is not necessary and these breeds appear to be less restricted by 
conventional fencing.  The increased use of meat breeds resulting in increased trading of breeding 
stock will potentially increase transmission and spread of lice. 
Unknown aetiology Known aetiology 
         X 
 
Prevention 
There are effective strategies to prevent lice including on farm biosecurity measures such as 
quarantining introduced sheep, ensuring secure boundary fencing and proper use of available 
products. Ongoing development of chemical resistance will result in reduced efficacy of products if 
reliance on chemicals continues. 
Low efficacy/ unproven preventives available Effective preventives available 
       X   
 
Treatment 
There are effective chemicals to control lice however effectiveness is reduced due to poor 
application technique. Ongoing development of chemical resistance will result in reduced efficacy of 
products if reliance on chemicals continues. 
Low efficacy/ unproven treatments available Effective treatments available 
      X    
 
Distribution 
Distribution is stable to possibly increasing in pastoral areas as the population of non-woolled breeds 
increases where less lice control is used. 
Distribution contracting Distribution stable Distribution increasing 
     X     
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Prevalence 
Prevalence is generally stable but may possibly increase as chemical resistance emerges. The 
introduction of new chemical groups may stabilise prevalence until resistance develops to new 
chemical groups. Recent evidence indicates that lice prevalence is increasing slightly. 
Prevalence decreasing Prevalence increasing 
     X     
 
Economics 
Assumptions: Lice 
Table 5-14 Assumptions: lice in sheep 
Variable Value adopted Confidence 
Regional 
Extent 
All sheep regions  *** 
% flocks 
infected 
Prevalence 43% (pastoral zone) and 29% (wheat/sheep and high 
rainfall zones) (Reeve 2014). 
*** 
Mortalities Nil *** 
Weight loss No reduction in bodyweight ** 
Fleece weight 
Reduction in clean fleece weight of between 2% – 18% (Wilkinson et 
al. 1982, Wilkinson 1988) 
*** 
Wool price 
Wool price discount average 2% in pastoral zone and 1% in wheat 
sheep and high rainfall zones).  Discount on cotting range from 0.1 
for soft cotts to 17% for severe cotting, depending on micron (Nolan 
2012).  No fibre diameter discount (Wilkinson et al. 1982, Wilkinson 
1988). 
** 
Fertility Nil *** 
Market 
avoidance 
Nil *** 
Movement 
restrictions 
Notifiable disease in some states restricts selling opportunities until 
infestation controlled, although no price discount on sale sheep 
considered. 
** 
Treatment 
Range of different treatment methods varying from off-shears back 
lining, short wool dip and long wool back lining. Average treatment 
cost of $1.42/adult (LiceBoss 2014) with 28%, 10% and 8% treated 
*** 
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Variable Value adopted Confidence 
to control lice in long wool for pastoral, wheat/sheep and high 
rainfall zone respectively.  
Prevention 
Similar to treatment but effectiveness of lice prevention is restricted 
due to poor on farm biosecurity and poor application of chemicals 
to eradicate lice. Average prevention cost of $0.85/adult (LiceBoss 
2014) with 68%, 66% and 52% treated for control and eradication 
after shearing in pastoral, wheat/sheep and high rainfall zone 
respectively. 
*** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of lice in sheep in Australia at $81M (Table 5-15). The reduction in the 
cost of lice is consistent with reduced sheep numbers in Australia. 
 
Table 5-15 Economic cost of lice in sheep 
 Treatment Prevention Production Total 
 H M L H M L H M L H M L 
Per Sheep $0.50 $0.12 $0.10 $1.92 $1.87 $1.51 $2.00 $0.87 $0.87 $4.42 $2.86 $2.48 
Per Flock $827 $199 $159 $3,182 $3,098 $2,510 $3,333 $1,445 $1,445 $7,342 $4,743 $4,115 
Total $3.77M $41.19M $25.54M $81.08M 
 
The net gain of moving all flocks to the lowest level of lice disease in sheep is estimated at $10.13M. 
 
5.8 Mastitis 
The disease 
Sheep mastitis is present in the Australian sheep flock in a number of forms.  This includes severe 
forms leading to peracute gangrenous mastitis, predominantly caused by Mannheimia sp. and 
Staphylococcus aureus. A number of other bacteria lead to more chronic forms of clinical mastitis 
leading to changes in milk quality, quantity and udder appearance.  Sub-clinical mastitis caused 
predominantly by Staphylococci and Streptococci is also relatively common in some breeds leading 
to potential reductions in lamb growth rate due to a reduction in milk quality and quantity during 
infection.   Mastitis can lead to death of ewes and/or death of their lambs or may only result in a 
reduction in performance due to reductions in ewe bodyweight, lamb weaning rate or lamb and ewe 
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survival rates. The cause of clinical mastitis is well established but more work is needed to elucidate 
importance of sub-clinical mastitis. 
Unknown aetiology Known aetiology 
      X    
 
Prevention 
There are no current preventive strategies available for sheep producers although some vaccine 
development work was undertaken in the 1990’s and some autogenous vaccines have demonstrated 
efficacy.  No products are commercially available. 
Low efficacy/ unproven preventives available Effective preventives available 
X          
 
Treatment 
Treatment of clinical cases of mastitis is limited to injectable antibiotics with potential use of extra-
label intramammary antibiotics.  The primary problem with this treatment is in treating animals prior 
to significant health impacts on the ewe or on their progeny.  It is common in peracute cases for both 
the ewe and lamb to die within a few days of infection leaving minimal time for diagnosis and 
treatment by the farmer and/or veterinarian. 
 
Low efficacy/ unproven treatments available Effective treatments available 
     X     
 
Distribution 
Mastitis of sheep is spread widely across all sheep raising areas.  Due to a lack of survey data there is 
no good reference point to know if incidence is changing.  A further difficulty is that mastitis rates 
vary considerably from year to year due to environmental factors, hence measurement is required 
over several years to monitor any real long term trends. 
Distribution contracting Distribution stable Distribution increasing 
    X      
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Prevalence 
The prevalence of mastitis is likely to be increasing as more ewes are bred for prime lamb 
productions systems.  These ewes tend to have higher milk production than Merinos and higher 
rates of twinning, hence are more likely to develop mastitis.   
Prevalence decreasing Prevalence increasing 
      X    
 
Economics 
Assumptions: Mastitis 
Table 5-16 Assumptions: mastitis in sheep 
Variable Value adopted Confidence 
Regional 
Extent 
Generally restricted to high rainfall and sheep/wheat zones 
** 
% Flocks 
affected  
Clinical mastitis in British Breeds - 5% (such as pure Poll 
Dorsets hence serious problem in seed stock enterprises) 
Clinical mastitis in prime lamb maternals - 2.5% 
Clinical mastitis in Merino - 1% 
Sub-clinical mastitis in British Breeds - 30% 
Sub-clinical mastitis in prime lamb maternals - 15% 
Sub-clinical mastitis in Merino - 7% 
(Omaleki et al. 2011, Barber et al. 2011) 
* 
Mortalities 40% of clinical cases die.  Ratio of twin to single dams in this 
is generally 2:1 with most (80%) lambs dying (Omaleki et al. 
2011) 
** 
Weight loss  Significant weight loss in clinically affected ewes (if they 
survive) estimated at 5kg temporary. Many clinically affected 
ewes that survive will be culled.  Lambs that survive from 
clinically affected ewes are assumed to be 15% lighter.  
Sub-clinical mastitis - reduced weaning weight of lambs by 
9%.  This may have more importance in survivability for 
Merino lambs due to lower weaning weights (De Olives et al. 
2013). 
** 
Fertility Ewes with clinical mastitis produce 4% less lambs in * 
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Variable Value adopted Confidence 
following year 
Fleece weight 
% 
Estimate 5% less for clinical cases that survive. 
* 
Wool price 
discounts 
Large reduction in tensile strength in clinical cases, though 
not documented (estimate at 15 N/kTex).  Presumably some 
reduction in subclinical but minimal though not documented.   
** 
Market 
avoidance 
Nil  
*** 
Movement 
restrictions 
Nil 
*** 
Treatment Available, but limited due to low detection rates. Assume 
10% clinical cases treated with antibiotics - $10/case.  
* 
Prevention  Nil available ** 
Other costs  
 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of mastitis in sheep in Australia at $52M (Table 5-17). This estimate is 
highly uncertain due to lack of data on prevalence both in terms of prevalence in breeds other than 
British Breeds and the uncertain impact of subclinical mastitis.  Part of the cost of mastitis is a subset 
of neonatal mortalities.  
 
Table 5-17 Economic cost of mastitis in sheep 
  Treatment Prevention Production Losses Total 
  H M L H M L H M L H M L 
Per Sheep $0.01 $0 $0 $0 $0 $0 $2.82 $0 $0 $2.83 $0 $0 
Per Flock $19 $0 $0 $0 $0 $0 $4,589 $0 $0 $4,608 $0 $0 
Total $0.23M $0M $51.97M $52.20M 
 
The net gain from moving all flocks to the lowest level of mastitis disease is estimated at $52.20M. 
This would completely offset the current estimated economic cost of mastitis. 
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5.9 Footrot 
The disease 
Footrot is a complex disease caused by the bacteria Dichelobacter nodosus.  Footrot causes a large 
spectrum of clinical disease ranging from benign footrot, which is widespread and usually causes 
mild disease, to virulent footrot which can cause severe disease and substantial economic loss if left 
uncontrolled. Intermediate footrot is sometimes described and refers to strains between benign and 
virulent.  The clinical expression of the disease is dependent on several important factors including 
the strain or strains of D nodosus present, the local environment (specifically moisture availability, 
temperature and pasture conditions), the resistance of sheep to footrot and whether control is 
restricting the clinical expression of the disease. All these factors must be considered when making a 
diagnosis of the specific strain of footrot present. In most states virulent footrot is a notifiable 
disease.  Diagnosis is usually based on clinical expression although, depending on individual state 
regulations, additional laboratory tests may be used to classify the strain. However, there are serious 
limitations on the ability of laboratory tests to classify the strains (Allworth 2014).  
Production losses associated with footrot depend on the strain of footrot, breed of sheep, local 
environment and control measures adopted. The impact of footrot is less severe in years of short 
growing seasons and low rainfall compared with years of high rainfall and extended growing seasons 
when more sheep become infected with more severe lesions that affect sheep for a longer period of 
time.  The clinical expression of some intermediate-type strains is benign under lower rainfall 
conditions and more virulent in high rainfall regions.  The analysis in this report is based on the 
clinical appearance. 
Virulent footrot is very costly if not adequately controlled when endemic, with the cost of 
eradication exceeding $10/sheep (Allworth 1990).  Indirect costs can exceed the direct costs of the 
disease with management distracted by the need to reduce stocking rates or delay other critical 
management events resulting in increased animal health problems such as worms or flystrike. In 
contrast, benign footrot has a relatively minor impact on production and control measures are not as 
expensive. 
Unknown aetiology Known aetiology 
        X  
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Prevention 
Biosecurity measures to ensure footrot is not introduced include limiting the purchase of new sheep, 
inspection and quarantine of new sheep, and ensuring boundary fences prevent the introduction of 
stray sheep.  Control of footrot when present depends on the strain of footrot present, the local 
environment and management skills, but is largely based on the use of footbathing (usually with zinc 
sulphate) during spread periods to limit the severity of existing lesions and slow the development of 
new lesions. Vaccines previously registered are no longer available although a new targeted 
mono/bivalent vaccine (Dhungyel et al. 2008) appears very effective at controlling and possibly 
eradicating footrot in some situations.  Eradication of footrot is achieved by inspection and culling of 
infected sheep during non-spread periods or total destocking. 
Low efficacy/ unproven preventives available Effective preventives available 
       X   
 
Treatment 
Treatment of footrot is most commonly based on footbathing using zinc sulphate, particularly during 
wet periods when the disease is progressing. The efficacy of footbathing is limited by the intensive 
labour required, particularly with virulent strains where regular footbathing is required. There is also 
the difficulty of footbathing during lambing if this coincides with spread periods.  During dry periods, 
parenteral antibiotics are commonly used to salvage severely affected sheep and may also be part of 
a footrot eradication program to cure infected sheep thus reducing the number of sheep that require 
culling. 
Low efficacy/ unproven treatments available Effective treatments available 
       X   
 
Distribution 
After a period where state based footrot eradication programs successfully reduced the level of 
virulent footrot, the distribution of footrot is relatively stable.  Benign footrot is widespread across 
all high rainfall regions of Australia and virulent footrot is widespread in Tasmania and to a lesser 
degree in the high rainfall regions of Victoria.  Intermediate strains are widespread in Victoria and to 
a lesser degree in southern NSW where conditions are less conducive to their expression due to 
shorter growing seasons.  In Tasmania, the widespread distribution of virulent footrot probably 
overwhelms the level of intermediate strains. 
Distribution contracting Distribution stable Distribution increasing 
    X      
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Prevalence 
The prevalence of footrot depends on the strain of footrot present on farm, local environmental and 
climatic conditions, and control measures adopted.  The prevalence of footrot lesions in sheep on a 
farm can range from very low (<5%) in drought years to over 80% in wet years with extended 
growing seasons. 
Prevalence decreasing Prevalence increasing 
    X      
 
Economics 
Assumptions: Footrot 
Note that economic costs are calculated separately for benign footrot and for virulent/intermediate 
footrot 
Table 5-18 Assumptions: footrot in sheep 
Variable Value adopted Confidence 
Regional 
Extent 
Distribution of virulent footrot predominantly in high rainfall 
regions of Victoria and Tasmania.  Benign footrot widely 
distributed across high rainfall zone of Australia. 
** 
% Flocks 
affected  
Based on state reports and surveys: 
State Benign >450mm^ Virulent (intermediate) 
NSW 40% 0.4%* (5% intermediate in 
HRZ) 
Tasmania 40% 25% (15%) 
Victoria 50% 4% (10%) 
SA 20% 0.6%* mostly intermediate 
(3% in south-east SA) 
WA 30% 0.6%* mostly intermediate 
^  Benign footrot of limited consequence in low rainfall zone 
* Based mostly on state reports at national footrot workshop 
(Anon 2012) -  reported figures doubled  
* 
Mortalities No published data. Estimate 1% higher in flocks with virulent 
footrot (mostly due to flystrike, weaner illthrift and delayed 
management). Note: Marshall et al. (1991) indicated 4.5% 
higher mortality in mobs with uncontrolled virulent strain vs. 
mobs with footrot controlled. 
** 
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Variable Value adopted Confidence 
Weight loss  Average across Merino flocks and climatic zones and years 
considering control programs implemented: 
Benign: Temporary BW loss 0.5% 
Intermediate: Temporary kg BW loss 1.25%; Permanent 
1.25%  
Virulent: Temporary kg BW loss 2.5%; Permanent 2.5%  
Meat breeds: 50% of impact of Merinos  
(Marshall et al. 1991, Stewart et al. 1984, Symons 1978, 
Cummins 1991, Glynn 1993) 
** 
Fertility 1.5% per kg bodyweight loss  ** 
Fleece weight 
% 
Average across flocks and climatic zones and years 
considering control programs implemented: 
Benign footrot: 0.5% 
Intermediate Footrot: 2% 
Virulent footrot: 3% 
(Marshall et al. 1991, Stewart et al. 1984, Symons 1978, 
Cummins 1991, Glynn 1993, Abbott  2000) 
** 
Wool price 
discounts 
None considered, though wool produced is finer in affected 
sheep due to weight loss 
** 
Market 
avoidance 
 Nil 
*** 
Movement 
restrictions 
Footrot is a notifiable disease in most states that restrict 
sales: assume $5/sheep discount due to sale restriction on 
properties with virulent footrot (except Tasmania).   
** 
Treatment Considered as part of prevention program  *** 
Prevention  Footbathing for control ($0.15/sheep incl labour) 
  Benign footrot: 50% footbath 1 time per year 
  Intermediate footrot: Footbath 3 times per year 
  Virulent footrot: Footbath 5 times per year 
 
Salvage antibiotics: ($1.00/sheep plus $1.00 labour) 
  Intermediate footrot: 5% of affected flocks treat 5% sheep 
  Virulent footrot: 10% affected flocks treat 10% sheep 
 
Eradication: 
** 
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Variable Value adopted Confidence 
120 flocks annually. Annual cost of inspections and 20% 
salvage treatment with antibiotics (3 inspections @ $1.50 per 
inspection antibiotics $1.00/animal, additional labour 
$1.03/animal assisting with inspections) 
Biosecurity shared maintenance of fencing (shared with 
OJD, Lice and footrot) $0.20/animal 100% properties 
3.8% of all properties footbath introduced sheep average 75 
sheep. 
(Reeve et al. 2014) 
Other costs 2% additional sheep treated for flystrike (intermediate and 
virulent footrot (Allworth 1990) 
Supplementary feed cost considered with weight loss 
Additional labour costs associated with husbandry 
$0.25/sheep ($240/1000 sheep) 
Other indirect costs such as impact of delayed management, 
such as drenching or lower stocking rate not considered 
though may be substantial on individual farms 
** 
 
Based on the adopted prevalence and impacts of virulent footrot on the classes of animals affected, 
GHD has calculated the annual cost of virulent footrot in sheep in Australia at $32.28M (Table 5-19). 
In addition, the cost of benign footrot is calculated to be $12.1M in sheep in Australia (Table 5-20).  
 
Table 5-19 Economic cost of virulent footrot in sheep 
  Treatment Prevention Production Losses Total 
  H M L H M L H M L H M L 
Per 
Sheep 
$0.06 $0.01 $0 $5.02 $1.49 $0 $21.76 $6.03 $0.63 $26.84 $7.53 $0.63 
Per 
flock 
$91 $23 $0 $8,286 $2,457 $0 $35,866 $9,952 $1,037 $44,243 $12,432 $1,037 
Total  $0.04M $3.47M $28.76M $32.28M 
 
The net gain from moving all flocks experiencing virulent footrot to the lowest level of disease is 
estimated at $17.21M. 
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Table 5-20 Economic cost of benign footrot in sheep 
  Treatment Prevention Production Losses Total 
  H M L H M L H M L H M L 
Per Sheep $0 $0 $0 $0.37 $0 $0 $1.29 $0 $0 $1.66 $0 $0 
Per flock $0 $0 $0 $605 $0 $0 $2,144 $0 $0 $2,749 $0 $0 
Total $0M $2.65M $9.45M $12.10M 
The net gain from moving all flocks experiencing benign footrot to the lowest level of disease is 
estimated at $12.10M. This would completely offset the current estimated economic cost of benign 
footrot. 
If the prevalence of virulent and intermediate footrot is reduced by 50% before extra costs are 
considered then the cost to industry would reduce by $8.6M. 
 
5.10 Arthritis 
The Disease 
Arthritis is a common problem of lambs and occasionally older sheep.  There are several major 
syndromes including Erysipelas arthritis, Chlamydophila (Chlamydia) polyarthritis and purulent 
arthritis caused by a range of pyogenic bacteria, and many bacteria causing sporadic arthritis 
(Farquharson 2007, Paton et al. 2003, and Watt 2010).  Erysipelas and Chlamydophila polyarthritis 
are the most common causes, though many laboratory submissions fail to diagnose the underlying 
cause. In one study, Fusobacterium necrophorum was the most important cause of post-mulesing 
arthritis in western NSW (Curran 2012, Watt 2010). There are a variety of risk factors depending to 
some extent on the timing of infection including marking, mulesing, shearing and any procedure that 
damages the skin. Poor hygiene and wet muddy conditions are also important risk factors. Poor 
nutrition with resulting poor colostrum production of ewes is likely to lead to higher levels of 
neonatal arthritis in lambs.   
The epidemiology of Chlamydophila polyarthritis is not well known.  Prevalence rates vary but range 
between 0.63%-3.07% (Farquharson 2007) to 2.4% (Paton et al. 2003). Paton et al. (2003) reported 
there was a high correlation between mulesing and shearing and a higher incidence of arthritis which 
is more likely to occur in merino lambs.  In contrast, Farquharson (2007) reported Chlamydophila 
polyarthritis was more common in rapidly growing lambs, favouring meat breeds though was still 
reported in merino lambs that were growing at lower rates. Economic losses result from on farm 
mortality, lower production of surviving lambs, treatment and prevention costs and post farm gate 
condemnation of carcases. 
Unknown aetiology Known aetiology 
     X     
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Prevention 
An effective vaccine is available to prevent Erysipelas arthritis though adoption is not high due to 
uncertainty of cost effectiveness. General hygiene at marking, mulesing or dipping and other 
management procedures are undertaken.  Avoiding shearing and mulesing of terminal meat lambs 
will reduce prevalence as well (Paton et al. 2003). 
Low efficacy/ unproven preventives available Effective preventives available 
    X   X   
 
Treatment 
Early treatment of arthritis with parenteral antibiotics is moderately effective in early cases.  In 
reality many cases are not treated until well advanced when mobs are mustered for other reasons. 
Low efficacy/ unproven treatments available Effective treatments available 
    X      
 
Distribution 
Distribution is considered to be stable. 
Distribution contracting Distribution stable Distribution increasing 
    X      
 
Prevalence 
Good on farm data to determine the prevalence of arthritis is limited.  On farm data which is 
available almost certainly under-estimates the true prevalence because many lambs die without the 
aetiology confirmed.  Abattoir surveillance provides good information about the prevalence of 
arthritis in slaughter sheep without information of aetiology.   
Prevalence decreasing Prevalence increasing 
    X      
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Economics 
Assumptions: Arthritis 
Table 5-21 Assumptions: Arthritis in sheep 
Variable Value adopted Confidence 
Regional 
Extent 
Widespread across all regions and climatic zones *** 
% flocks 
infected 
Average prevalence of lambs/weaners 2%; adults 1% (Farquharson 
2007, Paton et al. 2003) 
** 
Mortalities 50% of lambs affected  * 
Weight loss 
3kg, 4kg and 4.5kg for affected Merino, dual purpose and prime 
lambs (Farquharson 2007) 
* 
Fleece Nil * 
Wool Nil * 
Fertility Nil * 
Market 
avoidance 
0.018% carcases condemned, 0.07% carcases trimmed. Average 
3kg/affected carcase (Farquharson 2007)  
* 
Movement 
restrictions 
Nil *** 
Treatment 
12% of affected lambs treated with antibiotics at a cost of 
$8.00/lamb (Farquharson 2007) 
* 
Prevention 
16% of 2 yo ewes vaccinated twice and 8% of adult ewes vaccinated 
once with Eyrvac at a cost of $0.87/dose including labour 
*** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of Arthritis in sheep in Australia at $39M (Table 5-22).  
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Table 5-22 Economic cost of Arthritis in sheep 
  Treatment Prevention Production Losses Total 
  H M L H M L H M L H M L 
Per Sheep $0.03 $0 $0 $0.20 $0 $0 $1.31 $0 $0 $1.54 $0 $0 
Per Flock $48 $0 $0 $338 $0 $0 $2,164 $0 $0 $2,550 $0 $0 
Total $0.66M $4.98M $33.80M $39.44M 
 
The net gain from moving all flocks experiencing arthritis to the lowest level of disease is estimated 
at $39.44M. This would completely offset the current estimated economic cost of arthritis. 
 
5.11 Ovine Johne’s disease 
The Disease 
Ovine Johne’s disease (OJD) caused by the sheep strain of Mycobacterium avium subsp. 
Paratuberculosis is a chronic wasting disease of sheep that causes high death rates in adult sheep of 
well over 10% in uncontrolled situations, lost production and restrictions on trade (Bush et al. 2008, 
Abbott et al. 2004). Historically, the disease spread from a focus in the central tablelands of NSW in 
the early 1980’s to become widespread from the mid 1990’s in most southern medium to high 
rainfall regions of eastern and western Australia.  A period of attempted eradication in some regions 
failed, but with the advent of vaccination and a better understanding on management of the disease, 
OJD appears to be better under control with vaccination reducing mortalities to low levels. 
Vaccination, risk-based trading and on farm and regional biosecurity measures are now the main 
strategies to control OJD.  Not all properties in high risk regions vaccinate for OJD and over time 
many presumably will develop clinical disease with varying mortality rates before embarking on 
vaccination, whilst those that have more recently started vaccination will benefit from reduced 
clinical disease. 
Abattoir surveillance data (Animal Health Australia 2014a) shows the percentage of lines infected 
with OJD peaked in 2010-11 and now appears to be reducing from 4.8% in 2010-11 to 1.5% in 2014. 
This data is skewed as not all major abattoirs participate in surveillance.  
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Apart from the obvious impact of mortalities many producers cull advanced cases of OJD (no 
commercial value).  Early clinical cases have a reduction in fleece weight and lower body weight with 
potential reproduction consequences (Abbot et al. 2004). Trading limitations have reduced but still 
have some consequence in states such as South Australia.  The main prevention cost now is 
associated with flock vaccination and biosecurity measures.  Some regulatory costs are associated 
with flocks in the SheepMAP (Animal Health Australia 2014a).  In addition, other losses are due to 
carcase trimming (due to vaccination lesions) and condemnation of offal (Hernandez-Jover et al. 
2013). 
Unknown aetiology Known aetiology 
         X 
 
Prevention 
The main strategy to prevent OJD is to vaccinate lambs from infected sheep flocks with Gudair™ 
vaccine at less than 16 weeks of age (Windsor 2014).  If vaccination programs are well adopted, 
shedding of bacteria substantially reduces and clinical disease reduces to very low levels. Limitations 
to the effectiveness of vaccination programs include poor vaccination techniques, partial flock 
vaccination and introducing unvaccinated sheep. Other strategies to manage OJD are to adopt 
property and regional biosecurity strategies to minimise the risk of introduction of OJD into flocks.  
Low efficacy/ unproven preventives available Effective preventives available 
       X   
 
Treatment 
No treatment is available to treat clinical OJD cases. OJD in clinically affected sheep is uniformly fatal. 
Low efficacy/ unproven treatments available Effective treatments available 
X          
 
Distribution 
Distribution of OJD appears to be stable with current control measures in place, though current 
surveillance regimes in some areas are somewhat limited. 
Distribution contracting Distribution stable Distribution increasing 
    X      
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Prevalence 
Prevalence appears to be stable but reducing within flock due to widespread use of vaccine in 
infected flocks and biosecurity measures. 
Prevalence decreasing Prevalence increasing 
   X       
 
Economics 
Assumptions: OJD 
Table 5-23 Assumptions: OJD in sheep 
Variable Value adopted Confidence 
Regional 
Extent 
Generally restricted to high rainfall and sheep/wheat zones *** 
% flocks 
infected 
Prevalence regions were broken down in the regions previously 
used until 2012 with prevalence based on current abattoir 
monitoring data assuming ~50% sensitivity (70% multibacillary 
30% sensitivity paucibacillary) (Bradley et al 2005, GHD 2014). 
Assumptions for Merinos as follows: 
- High prevalence: 29% of sheep population, 50% 
prevalence, 1% mortality in infected flocks 
- Medium prevalence: 29% of sheep population, 10% 
prevalence, 0.5% mortality in infected flocks 
- Low prevalence: 42% of sheep population, 0.2% 
prevalence, 0.2% mortality in infected flocks 
Prime lamb mortality rate 50% of Merinos 
** 
Mortalities See above ** 
Weight loss 
Production losses 4% body weight loss 8 months prior to death, 
11% 6 months prior to death (Abbott et al. 2004).  
*** 
Fleece weight 
Reduction in clean fleece weight of between 2% – 18%. Assumed 
6% fleece weight loss in year prior to death (Abbott et al. 2004). 
*** 
Wool quality No impact * 
Fertility Body weight loss leads to reduced reproduction rate 1.5%/1 kg BW *** 
Market 
avoidance 
0.5%, 0.25%, 0.1% suffer $10 loss of sale value in high, medium, 
low prevalence areas respectively. OJD trimming costs 1% in 
** 
B.AHE.0010 Final Report: Priority list of endemic diseases for the red meat industries 
Page 143 of 282 
Variable Value adopted Confidence 
vaccinated lines 0.74kg CW trim (Hernandez-Jover et al. 2013). 
Approx $60K offal condemned 
Movement 
restrictions 
No consideration of cost of livestock trading restrictions due to 
regulation though could potentially be substantial and devastating 
for studs in some states 
** 
Treatment There is no treatment available  *** 
Prevention 
Vaccination costs $2.50/animal including labour. 5.6 million doses 
annually 
*** 
Regional 
control 
426 flocks in SheepMAP annual costs $600/flock. $0.20 per animal 
biosecurity (fencing) cost (shared with lice and footrot). 
** 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of OJD in sheep in Australia at $35M (Table 5-24).  
 
Table 5-24 Economic cost of OJD in sheep 
 Treatment Prevention Production Total 
 H M L H M L H M L H M L 
Per Sheep $0 $0 $0 $1.16 $0.46 $0.04 $1.38 $0.68 $0.60 $2.54 $1.14 $0.64 
Per Flock $0 $0 $0 $1,937 $769 $62 $2,295 $1,126 $999 $4,232 $1,895 $1,060 
Total $0M $14.06M $20.62M $34.94M 
 
The net gain from moving all flocks experiencing OJD to the lowest level of disease, with current 
levels of vaccination, is estimated at $19.01M. 
 
5.12 Clostridial disease 
The disease 
The most common clostridial disease of sheep is enterotoxaemia (C. perfringens type D) with 
occasional tetanus (C. tetani) and less commonly recognised malignant oedema (C. septicum), 
blackleg (C. chauvoei), and black disease (C. novyi). Clostridia bacteria are widespread and can 
survive in the environment for long periods. Enterotoxaemia (or pulpy kidney) is commonly 
encountered with young sheep grazing lush pasture or in feedlot situations.  Sheep on a diet high in 
carbohydrates which are not completely broken down will pass into the small intestine where 
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bacteria rapidly multiply producing toxins precipitating disease (Farquharson 1994). Poor hygiene at 
lamb marking will very occasionally cause tetanus outbreaks. Disease is invariably fatal however 
highly effective and cheap vaccines exist against the major clostridial diseases.   
Enterotoxaemia is often blamed for sudden deaths, however, in many situations sudden death 
resulting in rapid carcass autolysis may be caused by many diseases so the prevalence of clostridial 
diseases may be over-estimated. 
Unknown aetiology Known aetiology 
       X   
 
Prevention 
Effective combination vaccines are available and are widely used as various trade names (e.g. “5 in 
1”, “3 in 1” or “6 in 1”) or in combination with drenches. This prevents the majority of disease. In 
high risk situations, more frequent vaccination for enterotoxaemia may be necessary.  Black disease 
is often associated with liver fluke infestations – but fluke areas are generally well known and 
preventive measures (against fluke and black disease) are typically applied. 
Low efficacy/ unproven preventives available Effective preventives available 
       X   
 
Treatment 
Treatment is generally not effective in the broad-acre livestock industries.   
Low efficacy/ unproven treatments available Effective treatments available 
X          
 
Distribution 
The distribution of clostridial diseases is widespread and is stable. 
Distribution contracting Distribution stable Distribution increasing 
    X      
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Prevalence 
Clostridial diseases risk is ever present though often higher risk in situations of lush pasture or 
intensive feeding.   
Prevalence decreasing Prevalence increasing 
      X    
 
Economics 
Assumptions: Clostridial diseases 
Table 5-25 Assumptions: clostridial diseases in sheep 
Variable Value adopted Confidence 
Regional 
Extent 
All sheep flocks are at risk of clostridial disease. About 75-
80% use effective vaccination in ewes and 50% in lambs ** 
% Flocks 
affected  
- 1% of flocks experience large-scale outbreaks (generally 
arising from failure to vaccinate or incorrect vaccine 
administration/storage). 2% of young stock and 0.25% of 
adults affected. 
- 19% of flocks experience moderate outbreak (again due 
to inadequate vaccination). Up to 0.5% of young stock 
and 0.1% of adults affected.  
- 80% of flocks experience no disease 
* 
Mortalities 100% of clinical cases *** 
Weight loss  Nil *** 
Fertility Nil *** 
Fleece 
weight % 
Nil 
*** 
Wool price 
discounts 
Nil 
*** 
Market 
avoidance 
Nil  
*** 
Movement 
restrictions 
Nil 
*** 
Treatment Nil  *** 
Prevention  Prevention is by vaccination. A dose is estimated to cost 
$0.30 (vaccine plus labour). Few estimates are available 
** 
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Variable Value adopted Confidence 
regarding vaccine use. Based on a recent survey of 1600 
producers (Thompson 2011), 44% of producers vaccinated 
once at marking, 54% twice to lambs, 77% vaccinated ewes 
annually, 21% wethers annually and 55% rams annually.  
This is probably a reasonable estimate of industry practice. 
Other costs  
 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of clostridial diseases in sheep in Australia at $32M (Table 5-26). This 
estimate is highly uncertain due to lack of data about prevalence of disease and to a certain extent 
the vaccination programs adopted.  
 
Table 5-26 Economic cost of clostridial diseases in sheep 
  Treatment Prevention Production Losses Total 
  H M L H M L H M L H M L 
Per Sheep $0 $0 $0 $0 $0.28 $1.39 $3.49 $0.97 $0 $3.49 $1.25 $1.39 
Per Flock $0 $0 $0 $0 $459 $2,270 $5,689 $1,578 $0 $5,689 $2,037 $2,270 
Total  $0M $26.91M $4.77M $31.69M 
 
The net gain from moving all flocks to the lowest level of clostridial diseases is negligible as the cost 
of vaccination is higher than the losses recorded in low risk flocks as vaccination is effective at 
controlling the disease.   
 
5.13 Liver fluke 
The disease 
Liver fluke (Fasciola hepatica) is an important disease of sheep in the regions where it occurs.  Liver 
fluke can infect many species in addition to sheep and cattle (including wildlife).  Fluke is usually 
distributed to regions above 600 mm rainfall, although outside this area fluke can occur, particularly 
in irrigation and swampy areas.  Adult fluke live in the bile ducts of the liver, pass eggs out in the 
faeces and intermediate stages infect snails (most commonly, Austropeplea tomentosa, but 
potentially, Austropeplea viridis and Pseudosuccinea columella that have a much wider range) (Boray 
et al. 1985) where they multiply and eventually sheep become reinfected from grazing pasture 
infested with metacercariae.  Acute fluke infection can occur where large numbers of larvae are 
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ingested causing severe damage and death.  More commonly chronic fluke causes production losses, 
anaemia and bottle jaw.  Rarely, black disease is caused by Clostridium novyi in association with 
larval fluke migrating through the liver (prevented by 5 in 1 vaccination). 
Production losses associated with liver fluke include mortalities, weight loss, reduction in wool 
growth, and in association with lower body weight, lower reproductive performance.  Post farm gate 
offal condemnation in abattoirs is very common.  Control is based on strategic and tactical drenching 
with flukicides, fencing off swampy at risk areas, improving drainage (especially in irrigation areas) 
and grazing management to avoid high risk animals grazing high risk paddocks. 
Unknown aetiology Known aetiology 
         X 
 
Prevention 
Long-term control relies on the strategic use of flukicides that kill immature and adult fluke 
populations in sheep to prevent production losses and reduce pasture contamination.  Specific 
timing of drenching depends on the level of challenge and regional climate conditions.  Monitoring of 
fluke burdens is useful to fine-tune strategic drenching programs.  Additional control can be achieved 
by fencing off swampy areas or grazing with adult cattle that are less susceptible to fluke.  The 
development of resistance to Triclabendazole, the most commonly used and effective flukicide, will 
make fluke control more difficult if not managed. 
 
Low efficacy/ unproven preventives available Effective preventives available 
      X    
 
Treatment 
Treatment in the face of high fluke burdens is considered part of prevention programs. The main 
limitation on the efficacy of anthelmintics is the widespread nature of drench resistance and the 
limited extent of resistance testing amongst sheep producers. 
Low efficacy/ unproven treatments available Effective treatments available 
       X   
 
Distribution 
The introduction of new snail species (Austropeplea viridis and Pseudosuccinea columella) that can 
survive a wider range of climatic zones and environments may increase the distribution of fluke in 
future, including in Western Australia where currently no fluke are present. The distribution of liver 
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fluke may be enhanced by climate change, with warmer winters for survival on pasture balanced 
with higher mortality with hot temperatures. 
Distribution contracting Distribution stable Distribution increasing 
     X     
 
Prevalence 
Prevalence is generally stable, though the prevalence increases in wet years.  Resistance to 
Triclabendazole will potentially reduce the efficacy of control programs and increase the severity of 
fluke. 
Prevalence decreasing Prevalence increasing 
    X      
 
Economics 
Assumptions: Liver fluke 
Table 5-27 Assumptions: liver fluke in sheep 
Variable Value adopted Confidence 
Regional 
Extent 
Distribution predominantly in NSW, Victoria, Southern QLD 
and Tasmania, rare in South Australia, exotic to Western 
Australia.  More common above 600 mm rainfall and irrigated 
pasture outside the high rainfall regions.  13.6% sheep flocks 
considered high risk, 2.1% moderate risk and 84.3% low to 
nil risk. 
*** 
% Flocks 
affected  
Based on abattoir surveillance (Animal Health Australia 2014a): 
State % lines positive % livers with 
fluke 
% sheep with 
fluke in positive 
lines 
NSW 34% 26% 9.25% 
QLD 13% 25% 2.56% 
Tasmania 15% 20% 3.38% 
Victoria 10% 8% 0.97% 
SA 0.4% 12% 0.06% 
A survey of NSW and Victoria (Hort 1998) indicated 33% of properties had 
positive FEC tests. 
** 
Mortalities No published data. Estimate 0.25% in affected flocks.  * 
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Variable Value adopted Confidence 
Weight loss  In affected sheep:  
Temporary weight loss: 5.5% in high risk flocks, 3% mod risk 
Permanent weight loss: 5.5% high risk, 3% mod risk 
 
* 
Fertility 1.5% per kg bodyweight ** 
Fleece weight 
% 
In affected sheep, wool production penalty 14% in high risk 
flocks, 7% mod risk 
 
* 
Wool price 
discounts 
Due to reduction in staple strength of 8 N/kTex 
* 
Market 
avoidance 
0.01302% adult offal (Liver) condemned (GHD 2009) 
0.00326% lamb offal (Liver) condemned 
Average value $0.81/liver 
** 
Movement 
restrictions 
Nil 
*** 
Treatment Considered as part of prevention program  ** 
Prevention  Cost of drench: $0.40/dose including labour 
Drench frequency: 1.45 drenches per year (Hort 1998) 
Monitoring costs: $0.12/sheep, 0.25 times per year 
** 
 
Total cost of disease 
Based on the adopted prevalence and impacts of internal parasites on the classes of animals 
affected, GHD has calculated the annual cost of liver fluke in sheep in Australia at $25M (Table 5-28).  
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Table 5-28 Economic cost of liver fluke in sheep 
  Treatment Prevention Production Losses Total 
  H M L H M L H M L H M L 
Per Sheep $0 $0 $0 $0.39 $0.08 $0 $7.11 $0.97 $0 $7.51 $1.05 $0 
Per Flock $0 $0 $0 $651 $136 $0 $11,794 $1,609 $6 $12,445 $1,745 $6 
Total $0M $1.30M $23.48M $24.78M 
 
If the severity of Liver fluke is reduced by 50% before extra costs are considered, the cost to industry 
would reduce by $9.78M. 
 
5.14 Pneumonia 
The disease 
Pneumonia is usually considered a sporadic disease of sheep affecting both adult sheep and lambs. 
There are a variety of causes including Mannheimia haemolytica which is most commonly isolated 
(Watt et al. 2013) but other causes include Arcanobacter pyogenes with primary agents including 
Mycoplasma sp and viruses such as Parainfluenza 3 virus (St George 1972).  Numerous other bacteria 
have been implicated though none on a widespread basis.  Lungworm (Dictyocaulis filaria, Meullerus 
capillaris and Protostrongylus rufescens) was historically commonly reported, however with the use 
of broad-spectrum anthelmintics it is now relatively uncommon as a cause of pneumonia.   
Whilst on farm data is very limited or not available regarding the prevalence of pneumonia, based on 
abattoir monitoring the disease(s) associated with pneumonia are widespread in Australia.  About 
4.6% of all carcases inspected showed evidence of damage due to pneumonia with a higher 
proportion of adults showing evidence of pneumonia compared with lambs. For example in NSW, 
42% of lamb consignments and 64% of sheep consignments show some evidence of pneumonia.  
About 3.3% of all lambs and 5.7% of all sheep showed evidence of pneumonia (Watt et al. 2013).  
Across Australia, 0.016% of adult carcases and 0.0013% of lamb carcases are condemned due to 
pneumonia (DAFF 2014, Animal Health Australia 2014a). Therefore, the causes of pneumonia are 
reasonably well known but apart from stress and change of weather, predisposing causes are not 
always clear. 
Unknown aetiology Known aetiology 
      X    
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Prevention 
No control measures are used to prevent pneumonia.  Lung worm is largely managed with the use of 
anthelmintics for worm control and any cost is incidental to this. Vaccines are available for cattle and 
internationally for sheep though none are available in Australia. 
Low efficacy/ unproven preventives available Effective preventives available 
 X         
 
Treatment 
Treatment is based on antibiotic therapy (usually long acting oxytetracyclines). Generally treatment 
is not common and only implemented with large outbreaks as most “low level” outbreaks are not 
recognised. Treatment is moderately effective but limited as outbreaks in sheep flocks are usually 
advanced before treatment is implemented and low level outbreaks are often not detected. 
Low efficacy/ unproven treatments available Effective treatments available 
      X    
 
Distribution 
Distribution seems to be widespread across sheep growing regions. 
Distribution contracting Distribution stable Distribution increasing 
    X      
 
Prevalence 
Prevalence is generally constant. 
Prevalence decreasing Prevalence increasing 
    X      
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Economics 
Assumptions: Pneumonia 
Table 5-29 Assumptions: Pneumonia in sheep 
Variable Value adopted Confidence 
Regional 
Extent 
Prevalence is assumed to be constant across regions. * 
% flocks 
infected 
Based on abattoir surveillance, about 3.3% of lambs and 5.7% of 
adults show evidence of pneumonia (Watt et al. 2013 DAFF 2014, 
Animal Health Australia 2014a) 
* 
Mortalities 10% of weaners and 5% of adults with clinical pneumonia * 
Weight loss 
Production loss data is limited. In New Zealand, Alley (2002) found 
that lambs with pneumonic lesions had on average 1.5 kg lower 
carcase weight (3.3 kg liveweight) than control lambs. The penalty 
for lambs with minor lesions is small but lambs with more than 20% 
of their lungs affected had severe weight penalties. No penalty has 
been considered for weight loss in adults. 
* 
Fleece weight Nil  * 
Wool quality Nil  * 
Fertility Nil  * 
Market 
avoidance 
Carcase and offal condemnation: 
a. Condemnation: 0.016% of adults, 0.0013% lambs (DAFF 
2014)  
b. Carcase trim and offal condemnation 0.49% of adults, 
0.039% lambs average 1.1 kg cw/carcase (GHD 2009, Hernandez-
Jover M 2013) 
c. Offal value $0.61/offal condemnation (GHD 2009) 
*** 
Movement 
restrictions 
Nil * 
Treatment 
Treatment is implemented by antibiotic therapy $10.00 per dose. 
Only lambs treated, assumed 1% of clinical cases treated 
* 
Prevention Prevention is not available ** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of pneumonia in sheep in Australia at $20M (Table 5-30).   
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Table 5-30 Economic cost of pneumonia in sheep 
  Treatment Prevention Production Losses Total 
  H M L H M L H M L H M L 
Per Sheep $0.05 $0 $0 $0 $0 $0 $1.12 $0 $0 $1.17 $0 $0 
Per Flock $82 $0 $0 $0 $0 $0 $1,860 $0 $0 $1,942 $0 $0 
Total $0.67M $0M $19.71M $20.38M 
 
Reducing prevalence by 50% without extra costs considered would reduce the cost to industry by 
$10M. Note that no value on potential production losses has been included for adult sheep as they 
are unknown. 
 
5.15 Caseous lymphadenitis 
The Disease 
Caseous lymphadenitis (CLA), commonly called cheesy gland, is caused by Corynebacterium 
psuedotuberculosis. Infected sheep develop abscesses in lymph nodes and a variety of organs 
including the lungs and liver.  Initially, abscesses develop after which time wool production may be 
affected (Paton et al. 1988).  CLA is widespread affecting sheep in all climatic zones. Infection is 
thought to most commonly occur at the first or second shearing.  Infection via shearing cuts when 
sheep are in close contact is exacerbated with dipping post shearing even after several months 
where the bacteria may pass through intact skin (Paton et al. 1988,  Paton et al. 1994, Paton et al. 
2003). 
The prevalence of cheesy gland in the sheep flock is estimated to average 29% in unvaccinated flocks 
whereas the prevalence in fully vaccinated flocks that receive an annual booster is 3%. Flocks that 
are only vaccinated as lambs had a similar prevalence to unvaccinated flocks.  In one study, 95% of 
223 flocks had CLA (Paton et al. 2003).  The economic effects of CLA are due to lower wool 
production that occurs in the year of infection (presumably due to the sheep mounting an immune 
response) and the cost of vaccination. Post farm gate costs include condemnation of between 0.5-1% 
of adult carcases and additional carcase downgrading and trimming costs. 
Unknown aetiology Known aetiology 
         X 
 
Prevention 
Vaccination with CLA vaccine is the most effective strategy to prevent CLA. Hygiene at shearing, 
shearing young sheep first and avoiding handling freshly shorn sheep is also recommended. The 
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effectiveness of CLA vaccine is limited due to inappropriate usage and the perception that the 
vaccine is not cost effective. 
Low efficacy/ unproven preventives available Effective preventives available 
      X    
 
Treatment 
There is no known treatment for CLA. 
Low efficacy/ unproven treatments available Effective treatments available 
X          
 
Distribution 
Distribution remains stable to possibly decreasing as fewer mature wethers are present in sheep 
enterprises. 
Distribution contracting Distribution stable Distribution increasing 
    X      
 
Prevalence 
Prevalence is generally stable to possibly decreasing due to the increase in vaccination use and the 
use of wet dips (which is a risk factor for CLA) for the control of lice decreases. 
Prevalence decreasing Prevalence increasing 
    X      
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Economics 
Assumptions: CLA 
Table 5-31 Assumptions: CLA in sheep 
Variable Value adopted Confidence 
Regional 
Extent 
22% flocks high risk with no vaccination, 58% moderate risk with 
partial vaccination and 20% low risk with full vaccination program 
** 
% flocks 
infected 
Prevalence segregated based on vaccine program adopted (Paton et  
al. 2003):  
22% of sheep flocks: no vaccination, prevalence of 29% in adults. 
58% of sheep flocks: non-effective vaccination program, prevalence 
of 28% in adults 
20% of sheep flocks: effective vaccination program, prevalence of 
3% in adults  
** 
Mortalities Nil  *** 
Weight loss Nil  *** 
Fleece weight 
5% reduction in clean fleece weight in year of infection with 
resulting reduction in fibre diameter (Paton et  al. 1988) 
*** 
Wool quality Slight reduction in FD ** 
Fertility Nil  *** 
Market 
avoidance 
0.3% of adult carcases sold condemned, 3%  of offal sets 
condemned and 3% carcases trimmed (0.6kg) (Paton et al. 2008, 
GHD 2009, Pointon 2008) 
** 
Movement 
restrictions 
Nil *** 
Treatment Nil *** 
Prevention 
Prevention is by vaccination with CLA vaccine. Marginal cost of 
$0.12/dose (cost above clostridial vaccine component) with 50% of 
labour cost $0.12/dose 
** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of CLA in sheep in Australia at $17.83M as shown in Table 5-32.  
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Table 5-32 Economic cost of CLA in sheep 
  Treatment Prevention Production Total 
  H M L H M L H M L H M L 
Per Sheep 
$0 $0 $0 $0 $0.27 $0.85 $0.38 $0.37 $0.04 
$0.3
7 
$0.64 $0.88 
Per Flock $0 $0 $0 $0 $454 $1,409 $637 $618 $66 $637 $1,073 $1,474 
Total $0M $9.43M $8.40M $17.83M 
 
The cost of prevention is similar to the total production losses partly because the majority of 
producers do not implement an adequate control program to prevent the disease, so still bear the 
cost but are affected by similar production losses as flocks with no control. 
There is no apparent net gain from moving all affected flocks experiencing CLA to the lowest level of 
disease. 
 
5.16 Pregnancy toxaemia 
The disease 
Pregnancy toxaemia is a common metabolic disease of sheep. Pregnancy toxaemia usually occurs 
towards the end of the final trimester of pregnancy in ewes carrying multiple pregnancies with very 
fat or very thin ewes most at risk, particularly older ewes. Twin bearing ewes require 180% of the 
energy required by single bearing ewes. The condition results from the inability of ewes to consume 
enough dry matter and energy such that the demand of ewes outstrips the supply.  The negative 
energy balance mobilises fatty acids from body reserves and the liver is unable to produce enough 
glucose such that the liver is overwhelmed with fatty acids and the production of ketones with 
resulting outcome being ketosis or pregnancy toxaemia.  Other risk factors include: change in diet; 
sudden feed restriction caused by yarding; and concurrent diseases, especially foot abscess and 
hypocalcaemia. 
Early intervention and treatment is moderately effective, but late treatment is only about 50% 
effective. Untreated ewes generally die.  Prevention usually relates to adequate supply of pasture or, 
if not available, supplementary feed. Separation of twin bearing and triplet bearing ewes from single 
bearing ewes with differential feeding will reduce the risk.  Controlling concurrent diseases such as 
hypocalcaemia and foot abscess will reduce the risk of pregnancy toxaemia. 
Pregnancy toxaemia is present in all climatic zones though good prevalence data is not available.  In 
the Victorian sentinel flock project (DEPI 2012), 13% of ewe deaths over a three year period were 
caused by metabolic problems of which 80% were attributed to pregnancy toxaemia.  Metabolic 
disease was more commonly diagnosed as the cause of death in ewes in prime lamb flocks (15.5%) 
compared to dual purpose (8.7%) and Merino (3.7%) flocks.  Surveys in South Australia, Victoria and 
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New South Wales all identified pregnancy toxaemia as an important cause of death in late pregnant 
ewes (Anon 2013, McGrath 2013, Harris et al. 1988, Trengove 2014). 
Unknown aetiology Known aetiology 
        X  
 
Prevention 
Prevention usually relates to adequate supply of pasture or if not available supplementary feed. 
Separation of twins and triplets from single bearing ewes with differential feeding will reduce the 
risk.  Controlling concurrent diseases such as hypocalcaemia and foot abscess will reduce the risk of 
pregnancy toxaemia. 
Low efficacy/ unproven preventives available Effective preventives available 
      X    
 
Treatment 
A variety of treatments is available though none are effective if adopted late in the course of the 
disease. 
Low efficacy/ unproven treatments available Effective treatments available 
   X       
 
Distribution 
Distribution is considered to be stable. 
Distribution contracting Distribution stable Distribution increasing 
    X      
 
Prevalence 
Prevalence is generally constant but influenced by season. A trend to meat breeds with high 
fecundity is likely to lead to an increase in pregnancy toxaemia if nutrition is not well managed. 
Prevalence decreasing Prevalence increasing 
     X     
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Economics 
Assumptions: Pregnancy toxaemia 
Table 5-33 Assumptions: pregnancy toxaemia in sheep 
Variable Value adopted Confidence 
Regional 
Extent 
The distribution of pregnancy toxaemia is widespread in all regions 
and sporadic in nature, with higher risk years being drought years 
and wet years associated with foot abscess. 
** 
% flocks 
infected 
Pregnancy toxaemia is distributed across all climatic zones and 
regions with 0.5% of prime lamb flocks affected, 0.4% of dual 
purpose flocks and 0.25% of Merino flocks with all cases in mature 
(>2 yo) ewes. 
* 
Mortalities A 50% mortality rate has been assumed for pregnancy toxaemia. ** 
Weight loss Temporary weight loss of 2 kg.   * 
Fleece weight No reduction in fleece weight considered  ** 
Wool quality 
Wool price discounts range from 1% - 18% depending on wool 
micron categories (Nolan 2012). Surviving ewes have a reduction 
in staple strength of 15 N/kTex. 
 
Fertility 25% of surviving ewes fail to rear lambs * 
Market 
avoidance 
Nil *** 
Movement 
restrictions 
Nil *** 
Treatment 
The most common treatment is supplied by providing oral or 
parenteral dextrose or glucose fluids and electrolytes. Providing 
additional supplementary feed will also help reduce the re-
occurrence and prevent new cases. About 25% of cases are 
assumed to be treated with intensive therapy costing $15/ewe. 
* 
Prevention 
Prevention is by providing adequate pasture or supplementary 
feed and preventing concurrent disease. The value of 
supplementary feed is partially considered as it is supplied to ewes 
as normal farm management (assumed 1 kg/ewe extra for 4 weeks 
to 20% of mature ewes). 
* 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of pregnancy toxaemia in sheep in Australia at $16M (Table 5-34). The 
Sackett report does not include a cost for pregnancy toxaemia.  
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Table 5-34 Economic cost of pregnancy toxaemia in sheep 
  Treatment Prevention Production Losses Total 
  H M L H M L H M L H M L 
Per Sheep $0.02 $0 $0 $0.32 $0 $0 $0.39 $0.00 $0.00 $0.73 $0 $0 
Per Flock $41 $0 $0 $525 $0 $0 $645 $0 $0 $1,211 $0 $0 
Total $0.52M $7.11M $8.19M $15.82M 
 
Due to the sporadic nature of the disease and likely extra costs, there is no apparent net gain from 
moving all flocks experiencing pregnancy toxaemia to the lowest level of disease. 
 
5.17 Hypocalcaemia 
The disease 
Hypocalcaemia is a sporadic disease that occasionally causes substantial losses.  Ewes which 
normally mobilize skeletal calcium reserves to meet the foetal demands during late pregnancy are 
particularly susceptible to hypocalcaemia when intake or absorption of calcium decreases. The 
young lamb will maintain its plasma calcium concentration at the expense of bone structure when 
dietary calcium intake is inadequate during growth. Young lambs are unable to absorb sufficient 
calcium from pasture. Milk intakes that result in growth rates greater than 150 g/day during the first 
six weeks are necessary to prevent osteoporosis by the time lambs are weaned at 12 weeks (Caple 
1989). 
Hypocalcaemia has several underlying causes and syndromes (Caple 1989, Watt 2012): 
 Hypocalcaemia is regularly encountered in sheep (especially ewes and weaners) that have 
been supplemented for a long period of time (usually greater than 2-3 months) with cereal 
grain which is low in calcium or when grazing dual purpose cereal crops such as oats during 
winter.   
 Perhaps the most common syndrome is observed in late pregnant ewes grazing lush grass-
dominant pasture, short feed or cereal crops.  Older ewes carrying multiple lambs are most 
at risk and outbreaks are more severe in ewes that have been fed grain for extended periods 
such as during droughts.  Handling ewes in late pregnancy exacerbates the risk. 
Hypocalcaemia in lactating ewes appears more common in northern regions (Watt B pers 
com). 
 Hypocalcaemia caused by short term interruption of food supply such as with severe 
weather or when held off feed, such as if held for shearing or transport, with late pregnant 
ewes most at risk.  Conditions such as foot abscess can lead to anorexia with secondary 
hypocalcaemia. 
 Hypocalcaemia is common in weaner sheep when associated with underlying osteoporosis.  
Osteoporosis in young sheep has many causes but is commonly associated with malnutrition, 
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poor milk supply, calcium, copper or vitamin D deficiency and gastro intestinal parasitism 
(Caple et al. 1988). 
 Whilst hypocalcaemia is widespread there are few detailed reports and surveys indicating 
the prevalence of hypocalcaemia in ewes and lambs.  
 Occasionally hypocalcaemia is induced in sheep grazing pastures such as soursob (oxalis sp) 
or sorrel high in oxalates that bind calcium thereby inducing hypocalcaemia. 
Early treatment is important, particularly in pregnant ewes as delayed therapy will lead to 
complications such as pregnancy toxaemia.  
Unknown aetiology Known aetiology 
       X   
 
Prevention 
Prevention is based on ensuring young sheep do not suffer malnutrition and receive adequate milk 
supply from ewes and prevent any underlying nutritional deficiencies that increase the risk of 
hypocalcaemia and osteoporosis.  Dietary management is the most important factor to reduce the 
risk of hypocalcaemia in ewes and lambs.  The highest risk groups are older twin and triplet bearing 
ewes and weaners up to 15 months of age in southern states that are poorly grown. 
Dietary management of ewes and weaners is the most important strategy to control hypocalcaemia. 
Providing adequate nutrition to ewes to ensure lambs have growth rates above 150 g/day is 
important to prevent hypocalcaemia. Limestone supplements are often recommended to ewes fed 
grain for extended periods and licks to ewes and weaners grazing cereal crops though wheat appears 
most at risk of deficiency of magnesium. Other prevention strategies include avoiding removal of 
heavily pregnant ewes from pasture for extended periods. 
Low efficacy/ unproven preventives available Effective preventives available 
      X    
 
Treatment 
Treatment requires administering a calcium injection as soon as possible.  Recovery after treatment 
is good if not complicated with pregnancy toxaemia. 
Low efficacy/ unproven treatments available Effective treatments available 
        X  
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Distribution 
Distribution varies between years and is more common in regions affected with drought (Larsen et 
al. 1986). Distribution has been increasing with a trend to high fertility breeds in merinos and meat 
sheep and wider adoption of grazing cereals. 
Distribution contracting Distribution stable Distribution increasing 
     X     
 
Prevalence 
Prevalence is stable but varies between seasons and is highest risk after droughts.   
Prevalence decreasing Prevalence increasing 
    X      
 
Economics 
Assumptions: Hypocalcaemia 
Table 5-35 Assumptions: hypocalcaemia in sheep 
Variable Value adopted Confidence 
Regional 
Extent 
Highest risk in high rainfall zone, moderate in wheat sheep and 
lowest risk in pastoral zone. 
** 
% flocks 
infected 
a. Ewes HRZ Merinos 0.3% (0.1% for 9 in 10 years, 2% 1 in 10 
years), meat breeds 0.4%, all weaners 0.4% 
b. Ewes Wheat-sheep 0.24% (0.14% for 9 in 10 years, 2% 1 in 
10 years), meat breeds 0.3%, all weaners 0.2% 
c. Ewes Pastoral 0.2%, weaners 0.2% 
(Sentinel Flock Project DEPI 2012, McGrath et al. 2013, Larsen et 
al. 1986) 
* 
Mortalities 
A 40% mortality rate has been assumed for hypocalcaemia 
(untreated cases). Note that pregnancy toxaemia is considered 
separately with the underlying cause likely to be hypocalcaemia 
in many cases. 
* 
Weight loss 
No weight loss, fertility or other production effects are assumed; 
all production losses are due to deaths 
** 
Fleece Nil *** 
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Variable Value adopted Confidence 
Wool Nil *** 
Fertility Nil * 
Market 
avoidance 
Nil *** 
Movement 
restrictions 
Nil *** 
Treatment 
Treatment by administering injectable calcium. The cost of 
calcium injections and labour is $10.00/ewe. 60% of ewes with 
clinical hypocalcaemia treated. 
* 
Prevention 
Prevention is by provision of adequate dietary nutrients (no cost 
allocated). About 30% of producers supply lime at 1.5% of diet in 
drought years (1 in 10 years @$0.60) and 5% of producers 
provide a supplement in an average year ($0.30). A survey of 
producers (McGrath et al. 2013) in the wheat-sheep zone of 
southern NSW grazing dual purpose crops found 40% of 
producers graze cereals.  Across Australia this is estimate to be 
20% overall. An estimated 55% of producers supplemented with 
calcium and roughage. Cost of lick supplement 2c/day for 28 days 
= $0.56/ewe and weaner.  In addition roughage costs were 
estimated to be $0.42/ewe and weaner. Preventive strategies 
such as Unimix™ or Vitamin D are adopted in such a low level 
they are not considered. 
* 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of hypocalcaemia in sheep in Australia at $11.16M.  
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Table 5-36 Economics of hypocalcaemia in sheep 
  Treatment Prevention Production Losses Total 
  H M L H M L H M L H M L 
Per Sheep $0.06 $0.04 $0.03 $0.09 $0.41 $0.00 $0.32 $0.22 $0.19 $0.47 $0.67 $0.22 
Per Flock $99 $68 $58 $145 $676 $0 $533 $366 $312 $777 $1,109 $369 
Total $1.08M $4.36M $5.72M $11.16M 
 
Due to the sporadic nature of the disease the net gain from moving all flocks experiencing 
hypocalcaemia to the lowest level of disease is difficult to calculate. 
 
5.18 Foot abscess 
The disease 
Foot abscess is primarily caused by Fusobacterium necrophorum although other bacterium such as 
Arcanobacterium pyogenes is considered to have a role (Roberts et al. 1968, West 1981, Egerton et 
al. 1989).  The disease also includes heel abscess.  The infection starts at the basal layers of the skin 
spreading to subcutaneous tissue and can extend to the distal interphalangeal joint causing 
suppurative arthritis swelling and severe pain with abscesses bursting leaving a draining sinus. 
Heavily pregnant older ewes and rams are most at risk in lush wet conditions with dry sheep much 
less at risk. Toe abscess can occur in all classes of sheep though typically in heavy sheep in wet 
conditions.  Wet conditions and mechanical trauma with breaking of overgrown horn and shelly toe 
can result in invasion of bacteria into the sensitive lamina and subsequent infection resulting in 
severe pain.  
Foot abscess outbreaks vary from year to year with lush wet seasons resulting in large outbreaks of 
over 10% of sheep affected. The economic impact of foot abscess can be significant.  Affected sheep 
if pregnant are at risk of secondary pregnancy toxaemia and death.  Affected sheep will usually 
develop a severe break in the wool resulting in lower fleece value and produce less wool. Affected 
sheep will often be culled prematurely due to chronic lameness and foot deformities.  The most 
effective treatment is parenteral antibiotics though response to treatment is often poor if infection is 
well established.  Resolution usually occurs in about eight weeks.  Typical prevalence data is not well 
documented in the Australian sheep flock (McGrath 2013, Sentinel Flock 2013). 
Unknown aetiology Known aetiology 
       X   
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Prevention 
Strategies to effectively prevent foot abscess are not well defined. Risk factors are well known; 
specifically heavily pregnant ewes in lush wet conditions are most at risk.  Practical strategies to 
minimise the risk of foot abscess are difficult to adopt.  Managing body weight of ewes must be 
balanced with reproductive performance and risk of pregnancy toxaemia. Apart from removing at 
risk mobs to dry paddocks, foot bathing has limited value and usually not a practical outcome. No 
vaccine is available to prevent foot abscess. 
Low efficacy/ unproven preventives available Effective preventives available 
   X    X   
 
Treatment 
Early treatment of foot abscess with parenteral antibiotics, anti-inflammatory therapeutics and land 
drainage are moderately effective in early cases and poor in more advanced cases. Footbathing with 
zinc sulphate in early stages is of uncertain value and may in fact induce more issues with mustering 
and handling late pregnant ewes. 
Low efficacy/ unproven treatments available Effective treatments available 
    X      
 
Distribution 
Distribution is considered to be stable and dependant on climatic conditions. 
Distribution contracting Distribution stable Distribution increasing 
     X     
 
Prevalence 
Prevalence is generally stable.  Intensification of pasture systems in high rainfall regions may, with 
time, increase the prevalence of foot abscess as could the expanded use of grazing cereals and 
fodder crops in medium to high rainfall regions.  Increasing the Australian sheep flock’s fecundity 
and body size will increase the risk of foot abscess. Exotic breeds run in high rainfall regions appear 
at high risk of foot abscess. Good data to determine the prevalence of foot abscess is not available 
apart from some local surveys. 
Prevalence decreasing Prevalence increasing 
     X     
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Economics 
Assumptions: Foot abscess 
Table 5-37 Assumptions: foot abscess in sheep 
Variable Value adopted Confidence 
Regional 
Extent 
High risk high rainfall zone 41% sheep, wheat sheep moderate risk 
47% sheep, pastoral zone low risk 12% sheep 
*** 
% flocks 
infected 
 Adult ewes   2 yo ewes 
Pastoral low risk 0.2% 0% 
Wheat sheep medium risk 1.5% 0.3% 
HRZ high risk 3% 0.5% 
British breeds 67% of prevalence in Merinos. Rams 50% higher 
* 
Mortalities 5% of affected sheep * 
Weight loss 6.7% Merinos 5% meat breeds (Symons 1978) * 
Fleece 
Fleece weigh reduction 2.5% Merinos, 1.7% meat breed (Symons 
1978) 
* 
Wool price 
Due to staple strength declines: -15 N/kTex merinos, -10N/kTex 
meat breeds  (Nolan 2012) 
** 
Fertility 20% affected ewes fail to rear lamb * 
Market 
avoidance 
Nil *** 
Movement 
restrictions 
Nil *** 
Treatment 
25% affected ewes in high risk zone and 20% in moderate risk zone 
@ $10/ewe 
* 
Prevention Footbath 2% of flocks in high risk zone @ $0.10/sheep * 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of foot abscess in sheep in Australia at $10M (Table 5-38). The annual 
cost of foot abscess to the sheep industry varies widely and could be three times higher in very wet 
years.   
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Table 5-38 Economic cost of foot abscess in sheep 
  Treatment Prevention Production Losses Total 
  H M L H M L H M L H M L 
Per Sheep $0.12 $0.06 $0 $0.01 $0 $0 $0.51 $0.33 $0.03 $0.63 $0.40 $0.04 
Per Flock $196 $105 $1 $10 $5 $0 $842 $552 $58 $1,048 $662 $58 
Total $1.81M $0.09M $8.52M $10.42M 
 
Due to the sporadic nature of the disease the net gain from moving all flocks experiencing foot 
abscess to the lowest level of disease is difficult to calculate. 
 
5.19 Bacterial enteritis 
The disease 
Bacterial enteritis is a combination of several bacterial diseases commonly observed in high rainfall 
regions in weaned Merino lambs and hoggets and occasionally first cross hoggets but is rarely seen 
in second cross lambs.  The disease in winter is usually caused by Yersinia pseudotuberculosis. About 
30-90% of weaners shed bacteria with 30-50% having diarrhoea with mortality rates ranging from 0-
9% and averaging 3% (K Stanger pers com 2014).  Yersinia enterocolitica occurs year round with 17% 
of flocks shedding bacteria.  Mortality rates are lower with Y. enterocolitica at 1% with up to 30% 
shedding bacteria although with no clinical disease.  Estimated morbidity rates range from 1 - 90% 
(18% average) and mortality 0 - 6.9% (1.8% average) due to unspecified Yersinia sp.  Morbidity and 
mortality rates of the disease in summer are less well documented though equally important. 
Weaner colitis in winter is often caused by Yersinia sp and is better understood than the disease in 
summer which seems to be associated with Campylobacter sp though this is uncertain. 
Unknown aetiology Known aetiology 
     X     
 
Prevention 
No vaccines are available. General flock management to improve nutrition and reduce stress of 
concurrent disease such as worms is recommended. 
Low efficacy/ unproven preventives available Effective preventives available 
   X       
 
B.AHE.0010 Final Report: Priority list of endemic diseases for the red meat industries 
Page 167 of 282 
Treatment 
Antibiotic therapy commonly with oral sulphadimidine or injectable oxytetracyclines appears to 
control Yersinia outbreaks well.  Response to treatment of summer outbreaks of campylobacter is 
not as effective. Antibiotic resistance is emerging as an issue in flocks that have had a long term 
history of outbreaks of Yersiniosis. 
Low efficacy/ unproven treatments available Effective treatments available 
      X    
 
Distribution 
The disease predominantly occurs in high rainfall regions mostly affecting Merino weaners where 
50% of flocks are considered at risk. 
Distribution contracting Distribution stable Distribution increasing 
    X      
 
Prevalence 
Slee and Skilbeck (1992) estimated 5% of flocks (mostly in winter) have Y. pseudotuberculosis and 
17% of flocks have Y. enterocolitica (present throughout the year). Prevalence of disease fluctuates 
between years. Yersinia appears to be less severe in favourable years with good feed, whereas 
summer colitis is more severe in wet summers regardless of nutrition.  
Prevalence decreasing Prevalence increasing 
    X      
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Economics 
Assumptions: Bacterial enteritis in sheep 
Table 5-39 Assumptions: bacterial enteritis in sheep 
Variable Value adopted Confidence 
Regional 
Extent 50% of high rainfall zone is at risk ** 
% Flocks 
affected  
10% of Merino weaner mobs affected, 5% of first cross 
weaner mobs 
40% of weaners have clinical disease: 10% severe, 30% 
mild. 
* 
Mortalities Average 3% of affected mob (K. Stanger pers com 2014) * 
Weight loss  5 kg severe, 1kg mild  (temporary) * 
Fertility Nil  ** 
Fleece weight 
% 5% lower severe, 1% lower mild * 
Wool price 
discounts 
Reduction in FD associated with lower wool production. 
Staple strength 15 N/kTex lower severe, 10 N/kTex lower 
mild (Sackett et al. 2006). 
** 
Market 
avoidance 
Nil  *** 
Movement 
restrictions 
Nil *** 
Treatment 
Antibiotic treatment to affected mob $0.70/sheep. 50% treat 
but 50% also drench for worms 
** 
Prevention  Nil  *** 
Other costs 
Additional crutching costs for 50% flocks @ $0.35/sheep. 
Loss of wool due to dags $0.25/sheep. 
Summer outbreak - jet for fly control (20%, cost 
$0.50/sheep) 
** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of weaner bacterial enteritis in sheep in Australia at $10M (Table 5-40). 
This estimate is highly uncertain due to lack of data about prevalence of disease and the subclinical 
production losses.  
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Table 5-40 Economic cost of bacterial enteritis in sheep 
  Treatment Prevention Production Losses Total 
  H M L H M L H M L H M L 
Per Sheep $0.21 $0 $0 $0 $0 $0 $4.36 $0 $0 $4.57 $0 $0 
Per Flock $347 $0 $0 $0 $0 $0 $7,247 $0 $0 $7,595 $0 $0 
Total  $0.47M $0M $9.80M $10.27M 
 
The net gain from moving all flocks experiencing bacterial enteritis is estimated to be $10.27M. This 
completely offsets the estimated cost of bacterial enteritis.  
 
5.20 Pyrrolizidine alkaloidosis 
The disease 
Pyrrolizidine alkaloid poisoning of sheep is caused by toxins called pyrrolizidine alkaloids (PA). Two 
plants, heliotrope (Heliotropium europaeum) and Paterson’s curse (Echium plantagineum), are the 
most common sources of PA toxicity, with less common poisoning the result of grazing Senecio sp 
and other plants containing PAs. PAs are hepatotoxins but can also cause damage to the brain, 
kidney and lungs (Salmon 2011).  Two disease syndromes are common: liver failure with PA 
poisoning; and chronic copper poisoning when stored copper is suddenly released from the liver.  In 
a review undertaken by Seaman (1987), Heliotrope and Paterson’s curse were equally important in 
causing PA poisoning whereas Paterson’s curse was more important in association with copper 
poisoning (Seaman 1987). However Salmon (2011) reported that heliotrope was more important in 
causing disease.  When sheep ingest toxic pasture, liver damage occurs within weeks of ingestion. 
Liver damage is irreversible and cumulative.  Chronic copper poisoning usually occurs after several 
years of ingesting toxic plants, particularly in clover dominant pastures at the end of spring when 
pastures are senescing and copper becomes more available.  
The disease is most common in southern NSW and along the northern fringe of northern Victoria, 
but is present in all regions where heliotrope and Paterson’s curse and other plants that contain PA 
grow. Seaman (1987) reported over a seven year period from 1978-84 mortality rates of 2.4% from 
PA poisoning and 2.5% from chronic copper poisoning.  At the time in NSW, 64% of sheep were 
Merinos, 27% crossbred and 9% other breeds though 25% of losses were in Merinos and 52% in 
crossbreds.  Merinos appear more resistant to disease and it appears crossbred sheep are more 
likely to eat heliotrope.  Dorpers appear to readily ingest heliotrope, though their resistance to PA is 
unknown. 
There is no treatment of clinically affected sheep.  Control is based on control of weeds.  In recent 
years the release of a number of biological control agents has reduced the distribution of Paterson’s 
curse.  In addition heliotrope is better controlled on cropping properties with the more strategic use 
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of herbicides to preserve moisture over summer fallows. In permanent pastures, perennials such as 
lucerne compete well with both weeds.  The removal of stored copper in high risk sheep has been 
successfully achieved using a loose lick (or drench) of sodium molybdite and sodium sulphate. 
Unknown aetiology Known aetiology 
     X     
 
Prevention 
Prevention is achieved by preventing livestock from having access to toxic plants.  Herbicide control 
in cropping land is now better achieved to preserve moisture for cropping.  Biological control of 
Paterson’s Curse is reducing the importance of this weed. Supplying at risk sheep with sodium 
molybdate and sodium sulphate reduces the risk of chronic copper poisoning. Whilst known 
preventive measures are available for livestock management, heliotrope in particular is a widespread 
and important weed that poses challenges for alkaloid poisoning. 
Low efficacy/ unproven preventives available Effective preventives available 
      X    
 
Treatment 
No treatment of affected animals is available; the peracute nature of the disease renders treatment 
ineffective. 
Low efficacy/ unproven treatments available Effective treatments available 
X          
 
Distribution 
The distribution of PA poisoning is linked to the distribution of toxic weeds.  In particular PA 
poisoning is most common in central and southern NSW and the northern border of Victoria though 
is present in most areas within the wheat-sheep zones in particular. 
Distribution contracting Distribution stable Distribution increasing 
    X      
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Prevalence 
PA risk is ever present though often higher risk in situations of lush pasture or intensive feeding.   
Prevalence decreasing Prevalence increasing 
    X      
 
Economics 
Assumptions: Pyrrolizidine alkaloidosis 
Table 5-41 Assumptions: pyrrolizidine alkaloidosis in sheep 
Variable Value adopted Confidence 
Regional 
Extent 
The high risk regions include southern NSW and northern 
Victoria (14% sheep), moderate risk includes remaining 
wheat-sheep zones and adjoining regions (46% sheep) with 
remaining regions considered low/nil risk 
** 
% Flocks 
affected  
High risk:   10% flocks, 10% of sheep affected 
Moderate impact:  1% flocks, 2% of sheep affected 
Double clinical cases in prime lamb flocks 
* 
Mortalities 50% of clinical cases  * 
Weight loss  5 kg permanent weight loss of clinical cases adults and 2 kg 
for weaner sheep. 
** 
Fertility 1.5% decline per kg bodyweight loss ** 
Fleece weight 
% 
5.5% decline for adults affected and 2% for weaners 
** 
Wool price 
discounts 
Nil 
** 
Market 
avoidance 
Approximately 0.03% of sheep condemned due to jaundice 
** 
Movement 
restrictions 
Nil 
*** 
Treatment Nil  *** 
Prevention  1% flocks provide sodium molybdate and sodium sulphate to 
reduce the risk of chronic copper poisoning at a cost of 
$1/sheep  
* 
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Variable Value adopted Confidence 
Other costs  
 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD has 
calculated the annual cost of pyrrolizidine alkaloidosis in sheep in Australia at $6.78M (Table 5-42). 
 
Table 5-42 Economic cost of pyrrolizidine alkaloidosis in sheep 
  Treatment Prevention Production Losses Total 
  H M L H M L H M L H M L 
Per 
Sheep $0 $0 $0 
$0.0
2 $0 $0 
$1.9
9 
$0.0
4 $0 
$2.0
1 
$0.0
4 $0 
Per Flock 
$0 $0 $0 $32 $0 $0 
$3,2
99 $66 $0 
$3,3
31 $66 $0 
Total $0M $0.06M $6.71M $6.78M 
 
The net gain from moving all flocks to the lowest level of pyrrolizidine alkaloidosis disease is 
estimated to be $6.78M.  
 
5.21 Sheep measles (Taenia ovis) 
The disease 
Sheep measles is caused by the intermediate stage of Taenia ovis, a tapeworm that infects dogs.  
Sheep grazing pasture ingest eggs that hatch and larvae migrate to muscle tissue, most commonly 
heart or diaphragm though potentially any muscle in the body.  Cysts develop in muscle and if eaten 
by dogs (or to a lesser degree foxes) will develop into adult tapeworms (Jenkins 2014).  In infected 
sheep, cysts die and develop into small pus-filled abscesses that eventually become mineralised 
nodules which are not acceptable in meat for human consumption.   The financial impact of sheep 
measles relates to offal (heart) condemnation, carcase trimming and condemnation.  There are no 
health or production impacts in dogs or sheep.  Based on abattoir monitoring (NSHMP), sheep 
measles was detected in 3.65% of carcases Australia wide. 
Unknown aetiology Known aetiology 
         X 
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Prevention 
An effective vaccine to prevent sheep measles has been developed though is not yet registered in 
Australia.  The only effective control at present is to avoid dogs gaining access to uncooked sheep 
meat and regularly worming dogs (preferably monthly). This is not an option for fox or wild dog 
control but control of foxes and wild dogs will presumably reduce exposure to sheep. Based on 
surveys (Jenkins 2014) farmers do not treat dogs regularly and many dogs have access to uncooked 
meat. 
Low efficacy/ unproven preventives available Effective preventives available 
      X    
 
Treatment 
The only treatment available is to treat dogs to control tapeworms. 
Low efficacy/ unproven treatments available Effective treatments available 
X          
 
Distribution 
Distribution seems to be widespread and stable across sheep growing regions. 
Distribution contracting Distribution stable Distribution increasing 
    X      
 
Prevalence 
Prevalence decreasing Prevalence increasing 
    X      
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Economics 
Assumptions: Sheep measles 
Table 5-43 Assumptions: sheep measles 
Variable Value adopted Confidence 
Regional 
Extent 
Distributed across all sheep rearing regions of Australia. *** 
% flocks 
infected 
Based on abattoir surveillance (NSHMP) about 3.65% of sheep 
were infected with sheep measles. Prevalence appears to be 
slightly higher in southern regions though is averaged across all 
sheep growing regions. 
*** 
Mortalities Nil *** 
Weight loss Nil *** 
Fleece Nil *** 
Wool Nil *** 
Fertility Nil *** 
Market 
avoidance 
Carcase condemnation: 
a. Condemnation: 0.019% of adults, 0.012% lambs (DAFF 2014, 
Animal Health Australia 2014a)  
b. Carcase trim and offal condemnation 0.58% of adults, 0.35% 
lambs average 0.4 kg cw/carcase (GHD 2009, Hernandez-Jover 
M et al. 2013) 
c. Offal value $0.61/offal condemnation (GHD 2009) 
** 
Movement 
restrictions 
Nil *** 
Treatment 
No treatment is available. However the cost of tapeworm 
treatment of dogs is considered. On average dogs are treated 
twice yearly. Assume 3 dogs/farm treated with Droncit @ $12/dog 
(cost split with hydatids control). 
* 
Prevention As for treatment of dogs *** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of sheep measles in sheep in Australia at $2.4M (Table 5-44).  
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Table 5-44 Economic cost of sheep measles  
  Treatment Prevention Production Losses Total 
  H M L H M L H M L H M L 
Per Sheep $0 $0 $0 $0 $0 $0 $0.04 $0 $0 $0.04 $0 $0 
Per Flock $0 $0 $0 $0 $0 $0 $64 $0 $0 $64 $0 $0 
Total $0M $0M $0.86M $2.44M 
Reducing prevalence by 50% without extra costs considered would reduce the cost to industry by 
$0.4M. 
 
5.22 Campylobacter abortion 
The disease 
Campylobacteriosis (vibriosis) is the most common cause of abortion in sheep.  It causes sporadic 
abortion in the high rainfall regions of southern Australia, particularly Victoria and Tasmania but has 
been reported in all states except Queensland.  The two major abortigenic campylobacter species 
are Campylobacter fetus subsp fetus (probably the most common) and Campylobacter jejuni subsp 
jejuni which is also commonly isolated (Clough 2003).  Both campylobacter species are commensal 
organisms of the gastrointestinal tract.  Susceptible ewes are infected by ingestion of contaminated 
pasture, water or feed that has been contaminated by aborted foetal fluids, foetuses, placenta or 
contaminated faeces.  Carrier sheep are an important source of maintenance and transmission, but 
other animals including foxes, crows and other birds have been implicated in the spread of infection, 
although their importance is unclear compared with carrier ewes.  High risk factors for spread 
include high stocking rates, specifically associated with rotational grazing or feeding grain in a trail 
that promotes heavy bacterial exposure. 
Abortion storms in the last six weeks of pregnancy are the most obvious outcome and typically affect 
10-20% of ewes in a mob, although occasional higher levels of up to 50% of ewes aborted are 
reported.  On endemically infected farms, abortion storms typically occur every 5-7 years due to the 
rise and fall of flock immunity (Clough 2003).  Maiden ewes and pregnant ewe lambs tend to be most 
at risk because they have less immunity.  In the absence of the use of vaccines, a common 
recommendation in endemically infected flocks is to ensure maidens ewes are combined with 
mature ewes well before mating to ensure they are exposed to campylobacter and develop 
immunity before pregnancy, thus reducing the risk of abortion storms.   
The extent of perinatal lamb losses from stillbirths and congenitally infected lambs that are weak and 
die within a day of birth is less clear.  In New Zealand, Anderson (2001) demonstrated endemically 
infected flocks suffer ongoing perinatal lamb losses of 9-10% regardless of whether abortions are 
detected, with losses being reduced by vaccination.  Very little evidence of this phenomenon exists 
in Australia although one trial (5 flocks only) using “Guardian” campylobacter vaccine resulted in a 
6.8% increase in lamb marking percentage for vaccinated ewes (Thompson 2011). In this same trial, 
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if the one mob of adults in which no response was recorded was removed from the analysis, the 
increased lamb marking percentage in the four remaining maiden flocks was 8.6%, i.e. similar to the 
New Zealand experience.   
A new vaccine has recently been released (Coopers Ovilus Campyvax®) that protects against the 
most common strains of campylobacter present in Australia. 
Unknown aetiology Known aetiology 
       X   
 
Prevention 
There are two method of prevention in endemic flocks.  A new vaccine Coopers Ovilus Campyvax® 
which protects against Campylobacter fetus subsp fetus and Campylobacter jejuni subsp jejuni is 
available though not yet widely used (assumed partly due to the fact it is relatively new and partly 
because many producers do not perceive the disease is a problem). The vaccine is most commonly 
used in maiden ewes. Producers can also reduce the risk of abortion storms by ensuring young ewes 
are mixed with older ewes well before mating so they develop immunity before they become 
pregnant.  Other factors that may reduce the risk of exposure are to avoid intense stocking rate 
rotational grazing (this may not be practical or cost effective) with late pregnant ewes and avoid 
grain feeding on the same trail to minimise bacterial contamination. 
Low efficacy/ unproven preventives available Effective preventives available 
      X    
 
Treatment 
In the face of abortion outbreaks, antibiotic therapy for exposed pregnant ewes is the only option to 
reduce the impact, though the efficacy of this procedure is not clear and in any case rarely adopted. 
No proven treatment is available to reduce the impact of an abortion storm caused by 
campylobacter apart from antibiotic therapy of at risk ewes with uncertain efficacy. 
Low efficacy/ unproven treatments available Effective treatments available 
X          
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Distribution 
The distribution of campylobacter abortion appears stable. Campylobacter abortion is observed 
most commonly in high rainfall regions, especially cool moist climates such as Tasmania and 
southern Victoria, although has been observed in the pastoral zone under intensive feeding 
conditions. 
Distribution contracting Distribution stable Distribution increasing 
    X      
 
Prevalence 
There is no good data available about the prevalence of campylobacter abortion. Clough (2003) 
summarised surveys investigating causes of abortion and perinatal lamb loss and of five surveys, 13% 
of farms investigated were positive to campylobacter and of samples submitted from eight surveys, 
15% were positive to campylobacter.  In the wider industry there are no estimates of the prevalence 
of campylobacter, however, industry expert opinion considers about 5% of Tasmanian flocks have 
noticeable abortions due to campylobacter and possibly 1% of flocks in high rainfall regions in NSW, 
Victoria, South Australia and Western Australia with outbreaks with an estimated 10% of maidens 
and 5% of adults aborting.  No estimates are available of subclinical losses.  
Prevalence is generally stable, although with widespread industry recommendations that promote 
rotational grazing and mating of ewe lambs, the prevalence of campylobacter abortion will almost 
certainly increase. 
Prevalence decreasing Prevalence increasing 
      X    
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Economics 
Assumptions: Campylobacter abortion 
Table 5-45  Assumptions: campylobacter abortion in sheep 
Variable Value adopted Confidence 
Regional 
Extent 
Tasmania is considered the highest risk region (3.2% 
sheep), followed by high rainfall regions of mainland states 
excluding Queensland (37.2% sheep). The wheat sheep 
zone is low risk (45.9% sheep). 
** 
% Flocks 
affected  
High risk: 5% flocks 
Moderate risk: 1.5% flocks 
Low risk: 0.5% flocks 
* 
Mortalities 
Ewes aborting Maidens Adults 
High risk: 15% 5% 
Moderate impact: 12% 2.5% 
Low impact: 5% 0% 
 
* 
Weight loss  Nil *** 
Fertility 
Ewes that abort produce 3% more lambs the following year 
as they are heavier at joining 
** 
Fleece weight 
% Ewes that abort produce 5% more wool  *** 
Wool price 
discounts 
Staple strength reduced: 1% clean discount. ** 
Market 
avoidance 
Nil  *** 
Movement 
restrictions 
Nil *** 
Treatment Nil  *** 
Prevention  
1% at risk flocks vaccinate maidens with Ovilus Campyvax in 
high risk and moderate risk zones and 0.2% adults 
vaccinated 
* 
Other costs Nil  
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of campylobacter abortion in sheep in Australia at $1.63M (Table 5-46).  
This estimate is highly uncertain due to lack of data on prevalence both in terms of frequency of 
abortion storms and impact of subclinical perinatal lamb loss associated with campylobacter. 
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Table 5-46 Economic cost of campylobacter abortion in sheep 
  Treatment Prevention Production Losses Total 
  H M L H M L H M L H M L 
Per Sheep $0 $0 $0 $0.01 $0.01 $0 $14.21 $9.52 $2.70 $14.22 $9.53 $2.70 
Per Flock $0 $0 $0 $21 $21 $0 $21,715 $14,546 $4,129 $21,736 $14,567 $4,129 
Total  $0M $0M $2.73M $1.63M 
 
The net gain from moving all flocks experiencing campylobacter abortion to the lowest level of 
disease is estimated at $1.12M. 
 
5.23 Sarcocystis (Sarcocystis spp) 
The disease 
Sarcocystis (sarcosporidiosis or sheep measles) is caused by a group of protozoon parasites 
(Sarcocystis spp). Infected cats, dogs and foxes (infected from ingesting infected meat) act as the 
definitive host that produce sporocysts that pass in the faeces that are subsequently ingested by 
sheep where the sarcocyst develops in muscle and offal.   Cats, dogs and foxes become reinfected by 
ingesting carcase or when fed uncooked meat. Meat with established Sarcocystis infection is not 
acceptable for human consumption (Munday 1990). The financial impact of sarcosporidiosis relates 
to offal condemnation, carcase trimming and condemnation.  There are no apparent health or 
production impacts in sheep, although experimental infection can cause serious wool and 
bodyweight production losses in previously naive animals and occasional reports of abortions are 
documented (Munday 1986).  Based on abattoir monitoring (Animal Health Australia 2014a), 
Sarcocystis was detected in 0.88% of carcases with southern regions at highest risk, particularly 
Tasmania where Sarcocystis was detected in 13.7% of carcases. 
 
Unknown aetiology Known aetiology 
         X 
 
Prevention 
There is no preventive strategy available to prevent Sarcocystis apart from control of feral cats and 
avoid feeding raw meat to cats and dogs and remove carcases. 
Low efficacy/ unproven preventives available Effective preventives available 
 X         
B.AHE.0010 Final Report: Priority list of endemic diseases for the red meat industries 
Page 180 of 282 
Treatment 
No treatment is available. 
Low efficacy/ unproven treatments available Effective treatments available 
X          
 
Distribution 
Distribution seems to be widespread across sheep growing regions, although more common in 
southern regions. In Tasmania it is noted to be more common around townships presumably due to 
the association with higher cat populations. 
Distribution contracting Distribution stable Distribution increasing 
    X      
 
Prevalence 
Prevalence is generally constant. 
Prevalence decreasing Prevalence increasing 
    X      
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Economics 
Assumptions: Sarcocystis 
Table 5-47 Assumptions: Sarcocystis in sheep 
Variable Value adopted Confidence 
Regional 
Extent Distribution Australia wide *** 
% Flocks 
affected  
Based on abattoir surveillance, about 0.88% of sheep were 
infected with sarcocystis. Prevalence appears to be higher in 
southern regions though is averaged across all sheep 
growing regions. 
** 
Mortalities Nil ** 
Weight loss Nil *** 
Fertility Nil *** 
Fleece weight Nil *** 
Wool price Nil *** 
Market 
avoidance 
Carcase condemnation: 
a. Condemnation: 0.01% of adults, (DAFF 2014) 
b. Carcase trim 0.3% of adults. Average 5.6 kg trim/carcase 
(GHD 2009, Hernandez-Jover M et al. 2013) 
** 
Movement 
restrictions 
Nil *** 
Treatment Nil *** 
Prevention 
Avoid offal feeding to cat, dogs and foxes. 
Control of feral cats, dogs and foxes (no cost considered as 
definitive hosts controlled for other reasons). 
*** 
 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of Sarcocystis in sheep in Australia at $0.89M (Table 5-48).  
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Table 5-48 Economic cost of sarcocystis in sheep 
  Treatment Prevention Production Losses Total 
  H M L H M L H M L H M L 
Per Sheep $0 $0 $0 $0 $0 $0 $0.02 $0 $0 $0.02 $ $0 
Per Flock $0 $0 $0 $0 $0 $0 $35 $0 $0 $35 $0 $0 
Total $0M $0M $0.60M $0.89M 
 
If the prevalence of sarcocystis is reduced by 50% then the cost to industry would reduce by $0.45M. 
Note that no value on potential production losses has been considered as they have not been proven 
in field conditions. 
 
6 Results – Goat diseases 
6.1 Internal parasites  
The disease 
A wide range of gastrointestinal worms can affect goats in Australia but the most important ones are 
the barber’s pole worm and the nodule worm, especially in summer rainfall zones, and the small 
brown stomach worm and the scour worms, especially in the winter rainfall and temperate zones. 
Risk factors for worms include high or summer rainfall, higher stocking rates and co-grazing with 
sheep. Sparing factors are low rainfall, low stocking rates, the presence of browse, and rotational 
grazing with cattle. 
Goats are affected by the same worms as sheep but when grazed with sheep, goats tend to carry 
heavier worm burdens and suffer more pathology than sheep (Sangster 1990). The heavier worm 
burdens of goats compared with sheep when co-grazed are due in part to greater rates of infection 
associated with different grazing patterns as well as susceptibility (Jallow et al. 1994).  
Production costs may be associated with deaths and reduced growth, conception rates and fibre 
production. Processing costs do not apply except perhaps in the very rare case of nodule worm 
damage to intestines that may be used for sausage casings. 
Other costs may be associated with buyer resistance if they are aware of drench resistance being a 
serious problem and animal welfare investigation by authorities concerned about deaths or 
condition of stock. 
Unknown aetiology Known aetiology 
        X  
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Prevention 
Prevention may involve: 
 monitoring worm burdens and drench resistance 
 strategic drenching and grazing management to reduce worm burdens and drench resistance 
 selection of resistant goats 
 using browse and supplements to reduce worm burdens 
 extra nutrition to strengthen immunity  
 quarantine and drenching of introduced goats 
 
Low efficacy/ unproven preventives available Effective preventives available 
        X  
 
Treatment 
Worm affected sheep are treated with a range of chemicals by a range of routes of administration. 
Resistance to worm drenches is making treatments increasingly less effective. 
Low efficacy/ unproven treatments available Effective treatments available 
    X      
 
Distribution 
Lyndal-Murphy et al. (1997) concluded that gastrointestinal parasites present little problem to goats 
run on extensive rangeland properties, however for the 10% of Australian goats grazed on grass and 
improved pastures in the higher rainfall agricultural zones (>380mm annual rainfall), parasitism is a 
frequent occurrence with severe outbreaks of disease linked to rainfall events. 
Distribution contracting Distribution stable Distribution increasing 
    X      
 
Prevalence 
The only data found to assist estimates of prevalence or seriousness of worms in goats was the MLA 
sponsored survey by Lyndal-Murphy et al. (1997) addressing the extent of problems from endo and 
ectoparasites, and control practices that was circulated to 1500 goat producers. Useable responses 
were returned from 195. Gastrointestinal parasites were always or mostly a problem on 26% of 
properties and sometimes a problem on 59% and 15% never experienced a problem. Of those 
enterprises that sometimes had a problem, 3% were extensive rangeland, 28% moderate inputs, 63% 
intensive and 0.9% depots while seven respondents were in the education and hobby sectors. Of the 
15% of producers who never had a problem with worms 28% ran an extensive rangeland type 
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enterprise, 25% a moderate inputs enterprise and 32% ran intensive type enterprise. Three per cent 
were depots and 12% belonged to the education and hobby sectors. 
Eighty-eight percent of respondents used drenches to control worms. Of the 12% of respondents 
who did not use drenches to control worms, 41% ran extensive type enterprises, 36% enterprises 
with moderate inputs, 18% intensive type grazing enterprise while the remaining 5% were from the 
education and hobby sectors. 
The economic cost of worms in goats in Australia is believed to be low because of the small 
proportion of the goat population in high and summer rainfall areas of Australia. However in herds in 
the high or summer rainfall areas, many of which will have higher stocking rates, little browse, co-
grazing with sheep and drench resistance, significant production losses and control and treatment 
costs could be expected especially if barber’s pole worm was involved. 
Prevalence decreasing Prevalence increasing 
    X      
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Economics 
Assumptions: Internal parasites 
Table 6-1 Assumptions: gastrointestinal worms in goats 
Variable Values adopted Confidence 
 
Rangeland 
(n=4M) 
Farmed meat (n=250K), fibre (n=150K)  
Regional 
Extent 
Nil herds 
affected 
All farmed goats other than young kids are at risk ** 
% herds 
affected 
Nil 
100% herds affected with greatest impact on the 30% 
of the farmed goat population residing in the high and 
summer rainfall zone. 
** 
Case fatality 
rate 
Nil Weaners 3%; adults 0.6% * 
BW weight 
loss 
Nil Permanent & temporary: 1.0 kg weaners; 1.0 kg adults * 
Fleece 
weight loss 
Nil 5% in fibre goats * 
Fertility Nil 1.5% reduction in pregnancy rate/kg BW lost * 
Market 
avoidance 
Nil Nil *** 
Movement 
restrictions 
Nil Nil *** 
Treatment Nil Considered as part of prevention program * 
Prevention Nil 
Assumes negligible worm egg counting or drench 
resistance testing being carried out and 100% of goats 
and herds treated at $1.50/goat/yr (includes cost of 
drench and labour) 
* 
 
Total cost of disease 
Based on the prevalence and impacts of the disease on the classes of animal affected, GHD has 
calculated the annual cost of internal parasites in goats in Australia at $2.54M as shown in Table 6-2. 
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Table 6-2 Economic cost of internal parasites in goats 
  Treatment Prevention Production Total 
  H M L H M L H M L H M L 
Per Goat $0 $0 $0 $1.50 $1.50 $1.50 $0 $3.93 $3.60 $5.34 $5.34 $0 
Per Herd $0 $0 $0 $294 $294 $294 $0 $752 $706 $1,046 $1,046 $0 
Total  $0M $0.71M $1.83M $2.54M 
 
6.2 Enterotoxaemia 
The disease 
Enterotoxaemia is a well-known, vaccinable, clostridial disease of goats manifesting as diarrhoea and 
or rapid death. Under favourable conditions, the Clostridium perfringens types involved, normally 
resident in the gut, multiply rapidly and produce toxins. 
Sudden changes onto readily fermentable carbohydrate-rich feeds or overeating will trigger 
outbreaks but are not prerequisite. Rolling outbreaks have occurred where feed, management or 
weather changes have not occurred but a heavily contaminated environment has been suspected. 
Death is likely in affected kids, chronic diarrhoea and illthrift is likely in affected adults. 
Production costs may be associated with deaths, long term illthrift in survivors and reduced growth 
associated with reduced supplementary feeding to reduce incidence. 
Tissue reactions at vaccine injection sites can be a costly aesthetic problem for show goats. 
Unknown aetiology Known aetiology 
     X     
 
Prevention 
Reduced feeding of carbohydrates to herd mates, with associated reduced production, is usually 
recommended when a case occurs. 
More frequent vaccinations than are required for sheep are necessary to protect goats. Vaccination 
is often with the more expensive polyvalent vaccines every 4 months in problem herds and every 6 
months in other herds is often recommended.  
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Some vaccine site reactions develop into abscesses, sometimes sterile, that must be differentiated 
from caseous lymphadenitis. Rarely there is carcase trim or hide damage associated with vaccination 
site reactions and abscesses. 
Low efficacy/ unproven preventives available Effective preventives available 
       X   
 
Treatment 
The prognosis is usually grave and therefore treatment, which is expensive and time consuming 
(usually involving rehydration, antibiotics, analgesics, adsorbents and possibly antitoxins), is not 
normally attempted except in highly valued animals.  
Low efficacy/ unproven treatments available Effective treatments available 
      X    
 
Distribution 
All goat populations are susceptible however the risk factors of overfeeding, supplementary feeding, 
introduction to lush feed and heavily contaminated environments from previous diarrhoeic cases 
would probably only be present in the estimated 10% of the Australian goat population that is 
farmed. 
Distribution contracting Distribution stable Distribution increasing 
    X      
 
Prevalence 
Enterotoxaemia does cause death and illthrift in farmed goat herds in Australia however no data was 
found upon which to confidently estimate losses.  
Although enterotoxaemia is often raised in discussions as a serious disease of goats there is little 
documentation of this in the literature; most mention is related to intensively managed dairy goats. 
Logically, the incidence in rangeland goats is likely to be close to zero given the absence of risk 
factors. The incidence in farmed goats is likely to be similar to the incidence in farmed sheep. 
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A clue to the incidence is offered by the published comments of Uzal et al. (1998) from a 1995 survey 
of 397 mainly fibre goat owners and four state diagnostic laboratories. The owners attributed 2% of 
deaths to enterotoxaemia and the laboratories suspected enterotoxaemia in 6.8% of goat autopsies. 
Uzal et al. (1998) also found that 40% of goat owners did not vaccinate and more than half of goat 
owners only gave one dose of vaccine. 
Prevalence decreasing Prevalence increasing 
    X      
 
Economics 
Assumptions: Enterotoxaemia 
Table 6-3 Assumptions: enterotoxaemia in goats 
Variable Values adopted Confidence 
 
Rangeland 
(N=4M) 
Farmed goats (N=250K meat, 150K fibre)  
Regional Extent Nil 
5% herds low incidence; 95% herds nil 
incidence 
* 
% herds affected Nil 0.2% * 
Mortalities Nil 100% case fatality rate * 
Weight loss Nil Nil *** 
Fertility Nil No fertility reduction with 100% mortality * 
Market avoidance Nil Nil *** 
Movement 
restrictions 
Nil Nil *** 
Treatment Nil Nil ** 
Prevention Nil 
95% herds vaccinate all animals at cost of 
$0.3/yr (5:1) 
* 
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Total cost of disease 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of enterotoxaemia in goats in Australia to be $0.35M as shown in 
Table 6-4. 
Table 6-4 Economic cost of enterotoxaemia 
  Treatment Prevention Production Total 
  H M L H M L H M L H M L 
Per Goat $0 $0 $0 $0.71 $0.71 $00 $0.19 $0.00 $0.00 $0.89 $0.71 $0.00 
Per Herd $0 $0 $0 $141 $141 $0 $37 $0 $0 $176 $141 $176 
Total  $0M $0.34M $0.00M $0.35M 
 
6.3 Lice 
The disease 
Lice, depending on species, cause disease in goats by irritating the skin and causing them to scratch, 
or by sucking blood causing illthrift. In rare cases massive infestations cause death.  
The lice of goats are generally specific to goats, and sheep lice although known to transfer to Angora 
goats are not a significant pest of goats except under rare conditions.  
The production costs of lice are associated with illthrift from sucking lice, and reduced quantity and 
quality of mohair production from biting lice (that bite through mohair fibres).  
The review by Lyndal-Murphy et al. (2007) mentioned notations in the literature of reductions in 
mohair clips of as much as 10% to 25% and reductions of 230g/animal attributed to biting lice.  
Deaths associated with massive infestations of sucking lice in kids do occur, but probably very rarely. 
Processing costs may be associated with downgrading of matted and stained mohair or cashmere 
from fibre goats and of rubbed and scratched skins from meat goats though the impact of this is not 
considered due to lack of information. 
Unknown aetiology Known aetiology 
         X 
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Prevention 
Preventive costs may be associated with efforts to avoid purchasing infested goats, increasing 
boundary security to prevent strays and monitoring the existing herd for lice. 
Low efficacy/ unproven preventives available Effective preventives available 
        X  
 
Treatment 
The review by Lyndal-Murphy et al. (2007) which included a survey, indicates that a wide range of 
chemicals including some that are unregistered for use in goats are administered by backline pour-
on, injection, spray, dip and dusting. Organic methods and nutritional supplementation methods are 
used sometimes with unknown efficacy. There may be costs associated with treatments to meet live 
export, interstate movement or show entry protocols even if goats are free of lice. 
In the survey by Lyndal-Murphy et al. (2007), fifty seven percent of respondents indicated they had 
treated for lice in the past two years; most producers indicated they treated once per year, 36% 
indicated they treated more than once per year and some indicated they treated three times. 
Approximately 36% and 64% used registered and unregistered products respectively. The survey 
indicated the most common method of application was by backline pour-on, used by 66% of those 
treating lice.  Based on survey results it appears prevention is adopted in meat and dairy herds even 
though the direct economic impact is likely to be mostly in fibre herds.  The justification of this is 
unclear given the uncertain economic cost of lice in non-fibre herds. 
Low efficacy/ unproven treatments available Effective treatments available 
        X  
 
Distribution 
Species of biting and sucking lice, with the potential for economic impact, are present in all sectors of 
the goat industry including in rangeland goats (Lyndal-Murphy et al. 2007). 
Distribution contracting Distribution stable Distribution increasing 
    X      
 
Prevalence 
Lyndal-Murphy et al. (2007) in their review of the lice situation in Australian goats for MLA, found 
there was little data on the prevalence or economic impact of lice in goats in Australia. 
In their producer survey of 1500 goat producer where there were 195 useful responses, 30% of 
respondents produced fibre for the fibre market with 6% going into the domestic market, 14% to the 
export market and 10% not sure of the final market. Of the 195 useful responses, lice were always or 
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mostly a problem for 9% of producers, sometimes a problem for 53% and never a problem for 37% 
of respondents. However, 56% of producers treated for lice and 9% of respondents had needed to 
treat for lice within six weeks of sale. 
 
Prevalence decreasing Prevalence increasing 
    X      
 
Economics 
Assumptions: Lice  
Table 6-5 Assumptions: Lice in goats 
Variable Values adopted Confidence 
 Rangeland 
(N=4M) 
Farmed goats (N=250K meat, 150K fibre)  
Regional 
Extent 
All rangeland 
populations 
exposed 
All farmed populations exposed ** 
% animals in 
infected 
herds 
affected 
30% prevalence 30% prevalence in meat and fibre herds * 
Case fatality 
rate 
Nil Nil *** 
Weight loss Nil Nil *** 
Fertility Nil Nil *** 
Downgrading 
hides or 
mohair 
Nil 
Nil reported 
7% reduced fleece weight and 10% reduced 
fleece value for affected fibre goats 
* 
Market 
avoidance 
Nil Negligible *** 
Movement 
restrictions 
Nil (all 
slaughtered) 
Negligible *** 
Treatment Nil Refer to prevention * 
Prevention Nil 
Average prevention cost of $1.00/adult 
(slightly higher than sheep); 43% of meat 
goat herds and 57% of fibre herds actively 
prevent 
* 
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Total cost of disease 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of lice in goats in Australia at $0.34M as shown in Table 6-6. 
Table 6-6 Economic cost of Lice 
  Treatment Prevention Production Total 
  H M L H M L H M L H M L 
Per Goat $0 $0 $0 $0.43 $0.57 $0.00 $0.20 $0.34 $0.00 $0.63 $0.85 $0.00 
Per Herd $0 $0 $0 $85 $113 $0 $39 $56 $0 $125 $169 $0 
Total $M $0.00M $0.23M $0.11M $0.34M 
 
The net gain from moving all herds experiencing lice to the lowest level of disease is estimated at 
$30,000. 
 
6.4 Pregnancy toxaemia 
The disease 
Pregnancy toxaemia is a highly fatal metabolic disease of older does associated with under-nutrition 
in late pregnancy. 
Obesity, large or multiple foetuses, sudden dietary changes or illness during late pregnancy are 
predisposing factors as is being of an “improved” higher-producing breed.  
Production costs may be associated with deaths of affected does and loss of the pregnancy and 
lowered production of surviving does (they are prone to dystocia, do not milk well and have higher 
kid mortality). 
Processing costs do not apply. There may be other costs to the business associated with animal 
welfare investigation if a confronting outbreak occurs. 
Unknown aetiology Known aetiology 
        X  
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Prevention 
Careful management of nutrition can reduce the incidence. Management costs may be associated 
with monitoring and supplementary feeding to prevent cases in higher risk does. 
Low efficacy/ unproven preventives available Effective preventives available 
     X     
 
Treatment 
Treatment is rarely successful once clinical signs are evident. Treatment of valuable animals may 
involve inducing parturition, caesarean section and oral propylene glycol. 
Low efficacy/ unproven treatments available Effective treatments available 
  X        
 
Distribution 
Pregnancy toxaemia is thought not to occur in rangeland goats. Farmed goats in the higher rainfall 
areas are likely to be most affected.  
Distribution contracting Distribution stable Distribution increasing 
    X      
 
Prevalence 
No solid data was found upon which to base estimates of incidence or morbidity or mortality rates. 
Seasonal variation in pasture conditions and managers’ acumen will have a bearing on incidence 
from year to year. 
Prevalence decreasing Prevalence increasing 
    X      
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Economics 
Assumptions: Pregnancy toxaemia 
Table 6-7 Assumptions: pregnancy toxaemia in goats 
Variable Values adopted Confidence 
 Rangeland 
(N=4M) 
Farmed goats (N=250K meat, 150K fibre)  
Regional Extent Nil occurrence All farmed herds at risk * 
% herds affected Nil 0.3% of mature breeding does affected * 
Case fatality rate Nil 80%  * 
Weight loss Nil Temporary weight loss of 2 kg * 
Fertility Nil 
80% surviving does fail to wean a kid in next 
12 mo 
* 
Fleece weight Nil 10% reduction in affected fibre does * 
Market avoidance Nil Negligible *** 
Movement 
restrictions 
Nil Negligible *** 
Treatment Nil 
80% cases treated at $15/case (proplyene 
glycol, nursing) 
* 
Prevention Nil 
20% herds supplementary feed high-risk does 
at $1.00/hd 
* 
 
Total cost of disease 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of pregnancy toxaemia in goats in Australia to be $0.10M as shown in 
Table 6-8. 
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Table 6-8 Economic cost of pregnancy toxaemia 
  Treatment Prevention Production Total 
  H M L H M L H M L H M L 
Per Goat $0.01 $0.01 $0.01 $0.07 $0.07 $0.00 $0.12 $0.12 $0.00 $0.21 $0.21 $0 
Per Herd $3 $3 $3 $15 $15 $0 $24 $24 $0 $41 $42 $0 
Total  $0.01M $0.04M $0.06M $0.10M 
 
There is no apparent net gain from moving all affected herds experiencing pregnancy toxaemia to 
the lowest level of disease. 
 
6.5 Caseous lymphadenitis (CLA) 
The disease 
Caseous lymphadenitis (CLA) is a slowly developing, contagious, abscessating, incurable, vaccinable 
disease that has been reported in dairy and feral goats in Australia. Infection from goats can infect 
humans. 
The causative bacterium, after entering the body through breaks in the skin or mucous membranes, 
disseminates and multiplies to cause abscesses in the drainage pattern of regional lymph nodes and 
beyond. Most abscesses are under the skin of the head and neck and in the chest; infrequently 
abscesses are in other locations such as the abdomen, udder and limbs.  
The abscesses can range from the size of a golf ball to a large grapefruit. The production effects on 
an animal are presumed related to inappetance associated with toxaemia and sometimes from local 
physical interference to organ function to do with compression or space occupation. This will mainly 
occur in adult goats and then mainly toward the end of their expected productive life. 
Rupture of skin and lung abscesses contaminate the environment and skin creating a source of 
infection for herd mates that can last for months. Moisture and shade support environmental 
persistence. 
Congregating goats for husbandry reasons such as feeding, shearing, dipping predisposes to spread. 
The potential for cross infection is present for co-grazing sheep and goats. Production costs may be 
associated with: 
 mortalities, as some goats will die on farm or be euthanased 
 premature culling of sick goats with breathing difficulty or wasting 
 infertility from lower conception rates in illthrifty does, usually older does 
 slower growth and fibre production over the lifetime of goats infected at a young age. 
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Processing costs may be associated with condemnation and trim of infected carcasses and offal, and 
downgrading of hides damaged by burst or surgerised abscesses 
Other costs may be associated with zoonotic infection if workers or contractors become infected. 
Surgery, antibiotics, time off work and compensation may be required. 
Unknown aetiology Known aetiology 
        X  
 
Prevention 
Prevention may involve implementing hygiene and disinfection measures at shearing and dipping, 
removing hazards that cause skin breaks, handling infected animals last, vaccination of young stock, 
preferential culling of higher risk older animals and separation of newborn kids from infected dams.  
Bioexclusion of CLA may involve avoiding introductions from infected herds, and applying hygiene 
and disinfection procedures to contractors and their equipment 
Low efficacy/ unproven preventives available Effective preventives available 
       X   
 
Treatment 
CLA is considered incurable however treatment involving isolation, surgical drainage and antibiotics 
may be attempted to achieve temporary reprieve in animals with peripheral abscesses.  
Low efficacy/ unproven treatments available Effective treatments available 
X          
 
Distribution 
CLA abscesses can be found in all populations of goats including in rangeland goats. 
Distribution contracting Distribution stable Distribution increasing 
    X      
 
Prevalence 
In Australia, prevalence of CLA in feral goats determined by presence of lesions found at abattoir 
slaughter has ranged from 0.3% to 18.8% (Williams 1978; McKenzie et al. 1979; Hein and Cargill 
1981; Anderson and Nairn 1985, Batey 1986).  
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Anderson and Nairn (1985) found a prevalence of 3.1% in 900 feral goats in WA. Most goats (~61%) 
had just peripheral abscesses, 25% had internal abscesses and 15% had peripheral and internal 
abscesses. A similar distribution was found by Hein and Carghill (1981) in feral goats from western 
NSW. 
Batey (1986) found a prevalence of 7.8% in 2920 feral goats in WA with head, body and visceral 
lesions present in 49.5%, 46.7% and 12.3% of affected goats respectively. 
In abattoir surveillance data gathered as part of the National Sheep Health Monitoring Program in 
the years 2008 to 2014 inclusive (Animal Health Australia 2014a), CLA was detected in 7% of the 
nearly 400,000 goats inspected, and 96% of the 1653 lines inspected. Prevalences were up to 20% in 
some lines. 
In abattoir data collected by DAFF (2014) over three years from 2011 to 2013 inclusive, there were 
1465 goat carcasses wholly condemned out of 5.6 million goats slaughtered. The number trimmed or 
partially condemned was not available. 
No specific data was found on prevalence in farmed goats in Australia. 
Outbreak prevalence decreasing Outbreak prevalence increasing 
    X      
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Economics 
Assumptions: Caseous lymphadenitis 
Table 6-9 Assumptions: caseous lymphadenitis in goats 
Variable Values adopted Confidence 
 Rangeland (N=4M) Farmed goats (N=250K meat, 150K fibre)  
Regional 
Extent 
Rangeland and farmed goats affected equally; all populations at risk ** 
% herds 
affected 
7% of goats at abattoir inspection detected with CLA lesions across all 
populations; all herds affected 
* 
Mortalities Nil Nil *** 
Weight 
loss 
Nil Nil *** 
Fleece 
weight 
Nil 
5% reduction in fleece weight in year of 
infection (same as sheep) 
* 
Fertility Nil Nil *** 
Market 
avoidance 
0.03% carcasses wholly condemned at $3.50/kg x 17 kg carcass weight 
3% have offal sets condemned at net loss of $3.00/set 
3% have carcase trim at 1 kg trimmed x $3.50/kg carcass BW (margin after 
consigned to pet food) 
* 
Movement 
restrictions 
Nil Nil *** 
Treatment Nil Nil *** 
Prevention Nil 
5% of farmed goats use CLA 6 in 1 or 3 in1 
vaccine 
** 
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Total cost of disease 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of CLA in goats in Australia to be $0.11M as shown in Table 6-10. 
Table 6-10 Economic cost of caseous lymphadenitis 
  Treatment Prevention Production Total 
  H M L H M L H M L H M L 
Per Goat $0 $0 $0 $0 $0.02 $0 $0.02 $0.02 $0 $0.02 $0.04 $0 
Per Herd $0 $0 $0 $0 $4 $0 $4 $4 $0 $4 $9 $0 
Total  $0M $0.01M $0.11M $0.11M 
 
6.6 Liver fluke 
The disease 
For part of their lifecycle, liver fluke live in the liver where they cause local injury and feed on blood. 
Infections manifest as illthrift or sudden death including from black disease caused by Clostridium 
novyi in unvaccinated goats. Risk factors for disease from liver fluke are associated with the presence 
of its partner snail which it depends on to complete its life cycle. 
Risk factors for disease from liver fluke are associated with the presence of its partner snail which it 
depends on to complete its life cycle. 
The snail is largely confined to the tablelands, coastal regions and irrigation areas of south eastern 
Australia. The habitat of the snail on farms is limited to marshes and swamps, springs, water courses 
and irrigated pastures. Goats are at risk if they graze these habitats.  
The production costs of liver fluke are associated with deaths from anaemia, the massive damage 
from migrating immature fluke and black disease, and in chronic fluke infections, illthrift, and 
reduced conception rates and fibre production. 
There are processor costs associated with damaged livers which are unfit for human consumption 
yet suitable for pet food. Other costs may be associated with restrictions on interstate movements to 
WA and investigations by authorities if animal welfare is threatened. 
Unknown aetiology Known aetiology 
         X 
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Prevention 
Prevention involves avoiding introduction of infected animals including infected sheep, cattle, horses 
and alpacas, fencing-off flukey areas, monitoring fluke status using faecal egg counts, strategic 
drenching and rotational grazing. 
Low efficacy/ unproven preventives available Effective preventives available 
        X  
 
Treatment 
Treatment involves drenching or injecting with a flukicide.  
Low efficacy/ unproven treatments available Effective treatments available 
       X   
 
Distribution 
For lifecycle completion, liver fluke are dependent on certain snails which determine the distribution 
of the disease. The main snail involved, Austropeplea tomentosa, is largely confined to the 
tablelands, coastal regions and irrigation areas of south eastern Australia. The habitat of this snail on 
farms is limited to marshes and swamps, springs, water courses and irrigated pastures. Goats are at 
risk if they graze these habitats. Some introduced snail species, escapees from the aquarium 
industry, are less fastidious than A. tomentosa which creates the potential for liver fluke to become 
more widely distributed. The distribution may be slowly widening with spread of introduced snail 
species. 
Distribution contracting Distribution stable Distribution increasing 
    X      
 
Prevalence 
In abattoir surveillance data gathered as part of the National Sheep Health Monitoring Program in 
the years 2008 to 2014 inclusive (Animal Health Australia 2014a), liver fluke was detected in 4% of 
nearly 400,000 goats slaughtered.  Of 1653 lines slaughtered, 21% were positive for liver fluke, an 
average of 28% goats were affected per positive line, and up to 100% of goats were infected in some 
lines. 
Prevalence decreasing Prevalence increasing 
    X      
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Economics 
Assumptions: Liver fluke 
Table 6-11 Assumptions: Liver fluke in goats 
Variable Values adopted Confidence 
 Rangeland 
(N=4M) 
Farmed meat (n=250K) and fibre (n=150K)  
Regional 
Extent 
Nil herds 
affected 
Mainly a problem of herds in south eastern Australia *** 
% herds 
affected 
Nil 
10% of farmed herds infected (20% of goat lines in 
NSHMP data had fluke) 
* 
Case fatality 
rate 
Nil 3% in all age classes * 
Weight loss Nil 
Permanent: 1 kg weaners and 3 kg adults 
Temporary: 1 kg weaners and 3 kg adults 
* 
Fleece weight 
& value 
Nil 
In fibre goats only, reduced fleece weight of 5% in 
weaners and 10% in adults; and reduced fleece value 
of 10% in all fibre goat age classes 
* 
Fertility Nil 1.5% reduction in pregnancy rate/kg BW lost * 
Market 
avoidance 
Nil 
28% livers in goats from affected herds are 
downgraded to pet food or meat meal at cost of 
$2.00/liver 
* 
Movement 
restrictions 
Nil 
May occur occasionally but considered negligible 
because of other readily available selling options 
* 
Treatment Nil All costs assigned to prevention ** 
Prevention Nil 
Prevention/control costs of $1/goat in infected herds 
for fencing, monitoring, rotational grazing. 
* 
 
Total cost of disease 
Based on the prevalence and impacts of the disease on the classes of animal affected, GHD has 
calculated the annual cost of liver fluke in goats in Australia at $0.11M as shown in Table 6-12. 
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Table 6-12 Economic cost of liver fluke in goats 
  Treatment Prevention Production Total 
  H M L H M L H M L H M L 
Per Goat $0 $0 $0 $1 $1 $0 $1.28 $1.31 $0.00 $2.28 $2.31 $2.31 
Per Herd $0 $0 $0 $197 $197 $0 $253 $258 $0 $450 $455 $455 
Total  $0M $0.05M $0.06M $0.11M 
There is negligible net gain from moving all affected herds experiencing liver fluke to the lowest level 
of disease.  
 
6.7 Footrot 
The disease 
Footrot is a highly contagious bacterial disease affecting the ruminant foot that can cause serious 
lameness in goats from interdigital infection and under-running of the horn of the claw. Most 
problems are seen in high rainfall areas in spring in association with warmer temperatures and wet 
conditions underfoot. Footrot is not a problem in arid regions. 
Cross transmission between goats and sheep is possible. Goats are believed to be less susceptible to 
footrot than sheep, and prevalence in goats is believed to be lower than in sheep.  
The legal requirements for notification and management of footrot, and thus compliance costs 
imposed, vary between states.  
Production costs may be associated with premature culling of goats with obstinate chronic infections 
or that are not worthwhile treating. There are also costs associated with the reduced growth, 
conception rates and fibre production that are a consequence of inability to graze freely. 
Processing costs do not apply. 
Restrictions on interstate movements, buyer resistance, ineligibility for shows, business relationships 
and if an animal welfare investigation is launched by authorities are other areas where costs may 
apply. 
Unknown aetiology Known aetiology 
        X  
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Prevention 
Footbathing introduced goats (and sheep), additionally securing of boundary fencing and efforts 
involved to avoid sourcing introductions from infected herds and sheep flocks are biosecurity 
measures used. 
Low efficacy/ unproven preventives available Effective preventives available 
        X  
 
Treatment 
Footbathing, inspections using footparing, and antibiotics are used to attempt to suppress or 
eradicate footrot. 
Low efficacy/ unproven treatments available Effective treatments available 
        X  
 
Distribution 
Problems with footrot are largely restricted to goats grazing in higher rainfall areas. Distribution is 
considered to be stable.  
Distribution contracting Distribution stable Distribution increasing 
    X      
Prevalence 
No data was found on prevalence, morbidity and mortality rates associated with footrot in goats in 
Australia however anecdotal evidence suggests these rates are very low and prevalence is stable. 
Prevalence decreasing Prevalence increasing 
    X      
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Economics 
Assumptions: Footrot 
It is estimated from ABS data, that there are about 50,000 goats in about 1000 herds in the high 
rainfall areas. 
The proportions of meat, fibre and dairy goats in the high rainfall zone are unknown but the majority 
are believed to be dairy and fibre goats.  
The economic cost of footrot in goats in Australia is believed to be very low because of the small 
proportion of the farmed and fibre goat population in high rainfall areas and the greater resistance 
of goats to footrot compared to sheep. Notwithstanding a low prevalence are the significant 
production losses or considerable control and treatment costs or both in some individual goat herds 
in very wet years in the high rainfall area.  
Table 6-13 Assumptions: footrot in rangeland and farmed goats 
Variable Values adopted Confidence 
 Rangeland 
(N=4M) 
Farmed goats (N=250K meat, 150K fibre)  
Regional Extent Nil 
The 6% of farmed goats resident in medium and 
high rainfall areas are most affected 
* 
% herds 
affected 
Nil Assumed 6% of farmed goat herds infected  * 
Case fatality 
rate 
Nil 1% due to secondary problems * 
Weight loss Nil 
Average of 0.2 kg permanent and 0.2 kg 
temporary per clinical case 
* 
Fertility Nil 
1.5% reduction in pregnancy rate per kg of 
permanent weight loss 
* 
Fibre Nil 
2% fleece weight loss and 10% value loss in 
clinical cases 
* 
Market 
avoidance 
Nil Not applied * 
Movement 
restrictions 
Nil 
Occurs occasionally but considered negligible 
because of other disposal options 
* 
Treatment Nil 
1% of goats treated $2/case (antibiotics, 
footbathing) 
* 
Prevention Nil 
3% of herds implement control measures at 
$0.30/animal 
* 
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Total cost of disease 
Based on the prevalence and impacts of the disease on the classes of animal affected, GHD has 
calculated the annual cost of footrot in goats Australia at $70,000 as shown in Table 6-14. 
Table 6-14 Economic cost of footrot in farmed goats 
  Treatment Prevention Production Total 
  H M L H M L H M L H M L 
Per Goat $0.02 $0.02 $0.00 $0.01 $0.01 $0.00 $2.41 $2.44 $0.00 $2.44 $2.47 $0.00 
Per Herd $4 $4 $0 $2 $2 $0 $475 $481 $197 $481 $487 $0 
Total  $0M $0M $0.07M $0.07M 
 
6.8 Johne’s disease 
The disease 
Johne’s disease in goats, should it become clinically apparent (which is rarely), is slowly fatal after a 
period of several weeks or few months of wasting. The clinical disease is usually only seen in adult 
goats, many of which are already reaching the end of their productive life. 
The causal mycobacterium can survive outside the animal for extended periods, which can be a year 
or more in cooler, wetter, shadier environments, and be the main source of infection for goats by 
the ingestion of pasture or water contaminated with faeces from infected goats (and other infected 
ruminants such as cattle, deer and alpacas). 
Production costs may be associated with reduced or lost production for a period of weeks or months 
before a relatively slightly premature death in an occasional older goat. 
Processing costs may include carcase trim from unsightly, injuring or abscessating lumps caused by 
vaccination. 
Other costs may include: 
 Restrictions on interstate movements, live export and access to shows, and buyer resistance. 
 Participation in voluntary testing and culling programs in infected herds 
 Participation in the GoatMAP. Free herds may want to promote their status by participating 
in the Johne’s disease market assurance program for goat herds (GoatMAP). Currently there 
are 30 goat herds participating in the GoatMAP of which 7 are meat goat herds and the 
remainders are dairy goat herds. 
Unknown aetiology Known aetiology 
        X  
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Prevention 
Vaccination is available to prevent or reduce new infections and delay the clinical effects of existing 
infections in infected herds. Grazing management can be used to reduce within herd transmission. 
Low efficacy/ unproven preventives available Effective preventives available 
       X   
 
Treatment 
Effective treatments are unavailable. The disease is considered incurable in livestock. 
Low efficacy/ unproven treatments available Effective treatments available 
 X         
 
Distribution 
Climate and stocking rate are likely to be strong determinants of the distribution of the disease, as 
they are known to be for Johne’s disease in sheep and cattle. 
Logically, fibre and meat goats are most likely to become infected if co-grazing with infected sheep 
and cattle, especially dairy cattle, however they may be spared if significant browse is available given 
the preference of goats to browse rather than graze.  
The extent to which meat and fibre goats closely co-graze with infected sheep or cattle is unknown 
but is thought to be rare. 
Distribution contracting Distribution stable Distribution increasing 
    X      
 
Prevalence 
According to National Animal Health Information System (NAHIS) (Animal Health Australia 2014b) 
reports, there are currently 19 infected goat herds in Australia; all are believed to be dairy goat 
herds. 
In Australia the disease is well known in the dairy goat industry but is little known in the goat meat 
and fibre industry; solid estimates of prevalence are absent. 
Prevalence decreasing Prevalence increasing 
    X      
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Economics 
Assumptions: Johne’s disease 
Table 6-15 Assumptions: Johne’s disease in rangeland goats, and farmed meat, fibre and dairy goats 
Variable Values adopted Confidence 
 Rangeland 
(N=4M) 
Farmed goats (N=250K meat, 150K fibre)  
Regional Extent Nil 
Probably restricted to the higher rainfall zone 
where 10% of farmed goats reside 
* 
% herds 
infected 
Nil 
5% of the 10% herds in high rainfall zone infected 
with 0.2% annual incidence of clinical cases 
* 
Case mortality 
rate 
Nil 100% *** 
Weight loss Nil 0% (100% mortality captures this loss already) * 
Fertility Nil Negligible due to low prevalence * 
Market 
avoidance 
Nil Occurs occasionally but considered negligible * 
Movement 
restrictions 
Nil Occurs occasionally but considered negligible * 
Treatment Nil Nil *** 
Prevention Nil 
Vaccination and grazing management in 1%  of 
herds costing $2.50/animal 
* 
 
Total cost of disease 
Based on the adopted prevalence and impacts of the disease on the classes of animals affected, GHD 
has calculated the annual cost of Johne’s disease in goats in Australia to be $20,000 as shown in Table 
6-16. 
Table 6-16 Economic cost of Johne’s disease in farmed goats 
  Treatment Prevention Production Total 
  H M L H M L H M L H M L 
Per Goat $0 $0 $0 $0.01 $0.01 $0.00 $0.03 $0.03 $0 $0.04 $0.05 $0 
Per Herd $0 $0 $0 $1 $3 $0 $7 $7 $0 $8 $9 $0 
Total  $0M $0.00M $0.02M $0.02M 
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6.9 Caprine arthritis-encephalitis (CAE) 
The disease 
Caprine arthritis encephalitis is a viral disease of goats manifesting as one or more of arthritis, 
pneumonia or mastitis, mainly in adult goats, and nervous disease, mainly in kids. Only 10% of 
infected goats will ever show signs of disease. It is one of the Small Ruminant Lentivirus (SRLV) group 
of diseases. 
Transmission is mainly trans-mammary, sometimes respiratory and sometimes via fomites such as 
shared feed and water troughs. 
Risk factors are those associated with intensive management including periods of close confinement 
of groups of goats, feeding pooled milk and colostrum, sharing unsterilised equipment and co-
mingling of goats from different farms. Reduced risk is associated with more extensive management, 
where single doe-kid units are the norm and close congregation of units less frequent.  
Production costs may be associated with premature culling of illthrifty adults, and mortalities in kids 
with neurological disease. Processing costs do not apply. Other costs may be associated with CAE 
being a legally notifiable disease in some but not all states with restrictions on interstate movements 
and eligibility for live export and shows. Buyers may avoid purchasing from herds where CAE is 
suspected. 
Unknown aetiology Known aetiology 
        X  
Prevention 
Preventing or controlling CAE can involve: 
 participation in voluntary accreditation schemes for which there are annual laboratory, 
veterinary and accreditation costs 
 participation in control programs involving blood testing and culling of positive animals, 
removal of kids at birth and organising and providing virus free feeding,  
 hygiene precautions to prevent within herd spread  
 hygiene measures to prevent entry of virus on fomites 
 precautions to avoid introducing infected animals 
Low efficacy/ unproven preventives available Effective preventives available 
        X  
 
Treatment 
Treatment costs do not apply – CAE is untreatable 
Low efficacy/ unproven treatments available Effective treatments available 
X          
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Distribution 
CAE is thought to be mainly confined to dairy goat herds, and to be very rare in meat, fibre and 
rangeland goats. 
Distribution contracting Distribution stable Distribution increasing 
    X      
 
Economics 
CAE is not considered to be an economic cost in non-dairy goats. 
 
7 Discussion / conclusions 
This report has considered a range of diseases and disease conditions that are impacting on the red 
meat industries (cattle, sheep and goats) in Australia and has estimated the economic costs of 
selected priority diseases. Initial lists of priority diseases were obtained from surveys of livestock 
producers, state governments, livestock veterinarians, processors, Animal Health Australia and 
animal health companies (see Appendix for the lists compiled from each group). The surveys 
captured a wide cross section of stakeholders with knowledge of disease costs, and while the sample 
sizes may not have been sufficient form a statistical perspective, they provided an invaluable starting 
point to the consultants to further refine the priority lists. 
The process adopted by the consultants in refining the lists has been explained earlier in this report. 
In summary, the list compiled from producer surveys was accepted as the starting point. The list was 
then modified considering the priorities of the other survey groups and the professional knowledge 
and experience of the team members in consultation with MLA staff. 
For each disease, a literature review was completed by the consultants to identify current knowledge 
of distribution, prevalence, costs of prevention/treatment and impacts on production. In many 
instances such information is incomplete or unknown, and where these gaps occurred the project 
team members used professional judgement to estimate the various parameters. The key 
assumptions for each disease were then used to populate an Excel model spreadsheet template of 
the red meat industries to calculate the economic costs of the disease. The spreadsheet template 
was then adapted as required in order to better fit the disease being studied. 
As such, the outputs from the study are estimates only as the confidence in the assumptions used 
are variable. In addition, the calculations rely on modelling a “typical” herd/flock for the various 
livestock regions in Australia and extrapolating these across the assumed distribution extent of the 
disease. The calculated disease costs therefore show the average cost of the disease per year but do 
not show the complexity of disease expression that often occurs, for example with latency in a 
number of years followed by a disease “storm” with catastrophic consequences to the livestock 
enterprise. Also, the averaging approach may not fully capture the regional-specific impacts of 
certain diseases which may be impacting local producers but are not reflected at the national level. 
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Further research would be required to better understand these situations, especially where there is 
substantial variance between the report and general industry perceptions; examples of this are 
BVDV and vibriosis in beef cattle. 
This section summarises the estimated disease costs and the gives consideration to implications for 
the future management of the priority diseases for cattle, sheep and goats. It should be read in full 
knowledge of the limitations described above. Despite these limitations, the results provide valuable 
guidance to the industries on the need for future expenditure to improve knowledge of the diseases 
to reduce their impacts and increase profitability.   
7.1 Cattle 
Figure 3 and Figure 4 show the annual cost of the 17 priority cattle diseases for the northern and 
southern cattle industries respectively. Cattle tick has the highest estimated economic impact in the 
north ($156 million) while internal parasites has the highest impact in the south ($82 million). As 
shown in Figure 3, the majority of the economic costs for diseases in the north are due to impacts 
related to production losses. 
 
Figure 3 Estimated economic cost of priority diseases in cattle (northern only) 
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Figure 4 Estimated economist cost of priority diseases in cattle (southern only) 
 
Figure 4 shows there are four diseases with annual economic impacts ranging from $82 to $60 million 
(Internal parasites, bloat, BVDV and dystocia). For internal parasites, bloat and dystocia, prevention 
costs contribute significantly to the total costs of each disease. Table 7-1 and Table 7-2 show each of 
the diseases in cost order and with an additional analysis that provides an overall rating of the 
disease with respect to current knowledge (aetiology, distribution and prevalence) and the ability to 
manage the disease (availability of effective preventive and treatment agents). The scores are 
sourced from the ratings provided by the consultants for each of these attributes in section 0. This 
information is important because it provides guidance on those aspects of the diseases that will most 
benefit from future research, development and/or extension.  
For aetiology, effective preventives and effective treatments, the scores are as provided in the 
summary score table for each disease (i.e. 1 to 10 on the green/orange scale). For distribution and 
prevalence confidence, the confidence ratings in the assumptions table for each disease is used 
based on multiplying each star rating by three (i.e. three stars = 9, two stars = 6 and one star  = 3). An 
overall rating is calculated using the summation of each rating score and expressing this as a 
percentage out of a possible score of 50. For example, cattle tick is 39/50 = 78%. Table 7-1 shows 
that while cattle ticks cost $156 million per year, the industry’s knowledge of the disease and tools 
available for management are quite high, as represented by the overall rating score of 78%. This 
indicates that there may be a reduced need for further disease surveys to get a better understanding 
of distribution and prevalence, and that extension could be the most effective approach to reducing 
costs. 
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Each disease can be considered in a similar manner. For example, vibriosis has an estimated cost of 
$12.7 million per year but has an overall rating of 48% as a result of low rating for each attribute. 
This signals the potential for further research to improve knowledge of the disease (aetiology, 
distribution and prevalence) and its effective management (preventives and treatments).  For BJD, 
while there is a similarly low overall rating (44%) that demonstrates lack of understanding of 
distribution, prevalence, prevention and treatment, the annual cost is $0.3 million (not including 
regulatory impacts) and thus the cost of further research may not be justified by the potential 
benefits.  
Note that the calculation of the overall rating score is largely based on subjective opinions of the 
authors to assist in guiding future investment decisions. As such it should be used with caution – as a 
qualitative ranking score – and combined with other methods of decision making with regard to 
expenditure on future research, development and extension.    
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Table 7-1 Northern cattle cost of diseases and knowledge ratings 
Disease Cost  
($M) 
Rating of knowledge of disease and control mechanisms  
(out of 10) 
Overall 
rating 
  Aetiology Effective 
preventives 
Effective 
treatments 
Distribution 
confidence 
Prevalence 
confidence 
 
Cattle Tick 156 9 8 7 9 6 78% 
Buffalo fly 95 8 4 8 6 6 64% 
Bovine Ephemeral Fever 60 8 4 8 9 3 64% 
Neonatal Calf Mortality 54 2 2 5 9 9 54% 
BVDV 50.9 10 7 1 6 6 60% 
Dystocia 38.1 9 9 8 9 1 72% 
Botulism 22 7 10 1 9 3 60% 
Vibriosis 12.7 4 4 7 6 3 48% 
Internal Parasites 11.6 8 7 7 9 6 74% 
Tick Fever 4.3 9 9 7 3 3 62% 
Pinkeye 2.4 10 8 8 6 3 70% 
Theileria 1.7 6 3 3 6 6 48% 
BJD 0.3 7 2 1 6 6 44% 
 
Table 7-2  provides similar information for the southern cattle industry, with internal parasites being 
estimated to have the highest annual cost ($82 million per year) but this is combined with a 
relatively high overall rating of the knowledge of the disease and the availability of control 
mechanisms. Diseases and conditions with relatively high annual costs (> $5 million) and lower 
overall ratings of knowledge and available controls (< 50%) include neonatal calf mortality, vibriosis 
and theileria. 
While the analyses provided in Table 7-1 and Table 7-2 provides useful guidance on potential future 
research, development and extension activities required, the consultants considered that further 
inputs are required before finalising such decisions. In the first instance, a workshop of selected 
research and industry personnel would be useful to explore opportunities in more detail.   
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Table 7-2 Southern cattle cost of diseases and knowledge ratings 
Disease Cost  
($M) 
Rating of knowledge of disease and control mechanisms 
(out of 10) 
Overall 
rating 
  Aetiology Effective 
preventives 
Effective 
treatment 
Distribution 
confidence 
Prevalence 
confidence 
 
Internal Parasites 82 8 7 7 9 6 74% 
Bloat 77 9 7 2 6 6 60% 
BVDV 63 10 7 1 6 6 60% 
Dystocia 59.6 9 9 8 9 6 82% 
Neonatal Calf 
Mortality 
42 2 2 5 6 3 36% 
Grass Tetany  24 9 8 6 9 6 76% 
Calf Scours 23 7 6 7 9 6 70% 
Theileria 18 6 3 3 6 6 48% 
Pinkeye 11 10 8 8 6 6 76% 
Vibriosis 8.3 4 4 7 3 3 42% 
Clostridial Diseases 6.7 9 8 2 9 6 68% 
Botulism 6.0 7 10 1 9 3 60% 
Cattle Tick 5.0 9 9 7 9 9 86% 
Buffalo fly 4.1 8 4 8 6 6 64% 
Bovine Johne’s 
Disease 
2.5 7 2 1 6 6 44% 
Bovine Ephemeral 
Fever 
0.1 8 4 8 9 6 70% 
 
7.2 Sheep 
Figure 5 shows the annual cost of the 23 priority sheep diseases and conditions. Neonatal mortalities 
($540 million) and internal parasites ($436 million) have the highest estimated annual economic 
impacts. It should be noted that neonatal mortality losses also include some costs that are also 
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included separately in dystocia and mastitis. The contribution of these two diseases is explained in 
section 5.1 and should be referred to in order to avoid the risk of double counting. 
Figure 5 also shows that the majority of the economic costs for all diseases are due to impacts related 
to production losses, except for lice where prevention costs are higher. Other diseases also have 
significant prevention costs (neonatal mortalities, internal parasites, dystocia and flystrike). 
 
Figure 5 Estimated economic cost of priority diseases in sheep 
 
Similarly for cattle diseases above, Table 7-3 shows each of the diseases in cost order and with an 
additional analysis that provides an overall rating of the disease with respect to current knowledge 
(aetiology, distribution and prevalence) and the ability to manage the disease (availability of 
effective preventive and treatment agents). The scores are sourced from the ratings provided by the 
consultants for each of these attributes in section 5. This information is important because it 
provides guidance on those aspects of the diseases that will most benefit from future research, 
development and/or extension.  
Of the seven highest cost sheep diseases, six have an overall rating score with respect to current 
knowledge and the ability to manage the disease of 80% or higher. The exception is perennial 
ryegrass toxicity with a rating of 68% which is largely due to the fact there is no therapeutic 
compound available to treat PRGT, with the only option being to remove clinically affected stock 
from toxic pasture and provide supportive husbandry (food and water) whilst they recover.  
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As discussed for cattle above, while the analysis provided in Table 7-3 provides useful guidance on 
potential future research, development and extension activities required, the consultants considered 
that further inputs are required before finalising such decisions. In the first instance, a workshop of 
selected research and industry personnel would be useful to explore opportunities in more detail.   
Table 7-3 Sheep cost of diseases and knowledge ratings 
Disease Cost 
($M) 
Rating of knowledge of disease and control mechanisms 
(out of 10) 
Overall 
rating 
  Aetiology Effective 
preventives 
Effective 
treatments 
Distribution 
confidence 
Prevalence 
confidence 
 
Neonatal Mortalities 540 8 7 7 9 9 80% 
Internal Parasites 436 10 7 8 9 9 86% 
Dystocia 219 7 7 8 9 9 80% 
Weaner Illthrift & 
mortality 
188 8 7 8 9 9 82% 
Flystrike 173 9 8 8 9 6 80% 
PRGT 105 9 8 2 9 6 68% 
Lice 81 10 8 7 9 9 86% 
Mastitis 52 7 1 6 6 3 46% 
Footrot 44 9 8 8 6 3 68% 
Arthritis 39 6 5 5 9 6 62% 
OJD 35 10 8 1 9 6 68% 
Clostridial Disease 31.7 8 8 1 6 3 52% 
Liver Fluke 25 10 7 8 9 6 80% 
Pneumonia 20 7 2 7 3 3 44% 
Caseous 
Lymphadenitis 
18 10 7 1 6 6 60% 
Pregnancy Toxaemia 16 9 7 4 6 3 58% 
Hypocalcaemia 11 8 7 9 6 3 66% 
Foot Abscess 10 8 4 5 9 3 58% 
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Disease Cost 
($M) 
Rating of knowledge of disease and control mechanisms 
(out of 10) 
Overall 
rating 
  Aetiology Effective 
preventives 
Effective 
treatments 
Distribution 
confidence 
Prevalence 
confidence 
 
Bacterial Enteritis 10 6 4 7 6 3 52% 
Pyrrolizidine 
alkaloidosis 
6.8 6 7 1 6 3 46% 
Sheep Measles 2.4 10 7 1 9 9 72% 
Campylobacter 
abortion 
1.6 8 7 1 6 3 50% 
Sarcocystis 0.9 10 2 1 9 6 56% 
 
7.3 Goats 
Figure 6 shows the annual cost of the nine priority goat diseases and conditions. Internal parasites 
($2.5 million) have the highest estimated annual economic impact. Figure 6 also shows that the 
majority of the economic cost for internal parasites is due to impacts related to production losses, 
although prevention costs are substantial. The costs of the next two diseases in priority order, 
enterotoxaemia and lice, are associated more with prevention costs and not production losses.  
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Figure 6  Estimated economic cost of priority diseases in goats 
 
Table 7-4 shows each of the diseases in cost order and with an additional analysis that provides an 
overall rating of the disease with respect to current knowledge (aetiology, distribution and 
prevalence) and the ability to manage the disease (availability of effective preventive and treatment 
agents). The scores are sourced from the ratings provided by the consultants for each of these 
attributes in section 6. This information provides guidance on those aspects of the diseases that will 
most benefit from future research, development and/or extension.  
A notable feature in Table 7-4 is the fact that confidence levels for distribution and prevalence are 
generally low. This most likely reflects the fact that the majority of goats are located in rangelands 
which increases the difficulty of obtaining data on diseases. While surveys could provide more 
accurate data, the cost of conducting the surveys would need to be weighed against the gains 
provided. 
As previously discussed, while the analysis provided in Table 7-4 provides useful guidance on 
potential future research, development and extension activities required, the consultants considered 
that further inputs are required before finalising such decisions. In the first instance, a workshop of 
selected research and industry personnel would be useful to explore opportunities in more detail.   
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Table 7-4 Goat cost of diseases and knowledge ratings 
Disease Cost 
(M) 
Rating of knowledge of disease and control mechanisms 
(out of 10) 
Overall 
rating 
  Aetiology Effective 
preventives 
Effective 
treatments 
Distribution 
confidence 
Prevalence 
confidence 
 
Internal Parasites 2.54 9 9 5 3 6 64% 
Enterotoxaemia 0.34 6 8 7 3 3 54% 
Lice 0.34 10 9 9 6 3 74% 
Pregnancy Toxaemia 0.11 9 6 3 3 3 48% 
CLA 0.11 9 8 1 6 3 54% 
Liver Fluke 0.1 10 9 8 9 3 78% 
Footrot 0.07 9 9 9 3 3 66% 
Johne’s Disease 0.02 9 8 2 3 3 50% 
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1 Questionnaires  
1.1 Producer questionnaire 
1.2 Cattle and Sheep Vets questionnaire 
1.3 Chief Veterinary Officer questionnaire 
1.4 Animal Health Companies 
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1.1 Producer questionnaire 
Livestock disease survey - producers 
Introduction –  
Hello – I am (John Smith) and we have been contracted by Meat & Livestock Australia (MLA) to 
do a survey of producers on what are the most important livestock diseases to determine 
priorities for future research.  
Are you available to do a short (10 minute) survey of livestock diseases you think are important 
in your area? If not, can I phone at a more suitable time? 
We are interested in what you consider the important diseases and conditions affecting stock..... 
in your district ....during the past 5 years. We are not covering droughts, floods and feed 
shortages.  
Can we start by getting an idea of the type of enterprise you run? 
(Note that phone lists will be split into the following categories so the interviewer will know they 
are talking with one of the following – and also possibly by state): 
 Cattle  
 Sheep and goats 
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Question 1. Establish enterprise type, location etc. (for cattle, sheep, goats) 
Enterprise types Which 
livestock 
enterprises 
are 
present? 
Could be 
more than 
one 
 
 
Total number of 
animals? 
1. 0-50 
2. 50-500 
3. 500-1,000 
4. > 1,000 
State? (may be 
available) 
1. Vic 
2. NSW / ACT 
3. WA 
4. Tas 
5. NT 
6. SA 
7. Qld 
 
Location within state? 
1. North 
2. North-east 
3. North-west 
4. South 
5. South-east 
6. South-west 
7. East 
8. West  
9. Central 
10. Central-west 
Average 
annual 
rainfall 
(mm)? 
 
Comments 
Cattle stud        
Cattle commercial - breeding       
Cattle commercial - 
backgrounding/finishing/trading 
      
Cattle live exports       
Sheep wool stud        
Sheep wool commercial       
Sheep meat stud       
Sheep meat commercial       
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Enterprise types Which 
livestock 
enterprises 
are 
present? 
Could be 
more than 
one 
 
 
Total number of 
animals? 
1. 0-50 
2. 50-500 
3. 500-1,000 
4. > 1,000 
State? (may be 
available) 
1. Vic 
2. NSW / ACT 
3. WA 
4. Tas 
5. NT 
6. SA 
7. Qld 
 
Location within state? 
1. North 
2. North-east 
3. North-west 
4. South 
5. South-east 
6. South-west 
7. East 
8. West  
9. Central 
10. Central-west 
Average 
annual 
rainfall 
(mm)? 
 
Comments 
Sheep live export       
Goats meat       
Goats wool (cashmere, angora)       
Goats live export       
Sheep or goat dairies       
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Question 2: What specific diseases or conditions do you consider important ...with respect to their affect on herd/flock profitability... in your district... in 
the past five years? (for each enterprise type). This might be in terms of expenditure to control or prevent the disease/condition, .... or losses from reduced 
performance, value of the animal or its products.  
 We ask for conditions affecting ‘the district’ and not the producer’s own herd as this may reduce bias in answering (embarrassed to admit X,Y,Z) 
and allows diseases perceived to be present in the district but not necessarily in the herd to be captured. Five years to prevent a ‘last year’ bias. 
No limit to number of diseases – producer may list zero to whatever number they think relevant or pertinent. For each disease/condition 
nomination by the producer the interviewer captures how important this disease is, how it impacts on herds and the capacity to control/reduce 
production 
A B C D E 
Disease 
record 
number 
Disease / 
condition 
/syndrome 
name 
(See lists of 
diseases by 
enterprise 
below) 
How much cost or other effort does it take to control or 
prevent the disease/condition .... affecting the profitability 
... of the herd/flock? 
By cost and effort we mean the amount of money, time, 
and energy spent to keep the disease under control or to 
prevent it entering the herd/flock. (It may include costs of 
labour, medicines, vaccines, biosecurity measures etc) 
Would you rate the overall cost and effort to be: 
1. Negligible 
2. Minor 
3. Moderate 
4. High 
5. Very high 
How much do losses from this disease/ condition ... 
affect profitability... of the herd/flock? 
By losses we mean production losses or reduced value 
of the animal or its products. 
(It may include sickness, deaths, reduced growth, 
reproduction, reduced value of carcass, offal, hides, 
wool etc) 
Would you rate the overall losses to be: 
1. Negligible 
2. Minor 
3. Moderate 
4. Severe 
5. Catastrophic 
Can you rank  each of the 
diseases/conditions you 
mentioned - from most 
important  
to least important 
1->N 
Disease 1 X 2 3 1 
     
     
Disease 2 Y 3 2 2 
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Disease lists 
A comprehensive disease lists will be made available to the interviewer. The interviewer will not be reading out the list to the producer. Rather, the 
interviewer will be searching the list (in alphabetical order) in response to a disease/condition/syndrome nominated by the producer. The interviewer will 
then ask questions for columns C, D and E for each disease nominated.   
General 
Is there any other information you would like to add on disease control or treatment for livestock. 
Thank you - Smartaskers to add typical closing. Perhaps state that report will be publicly available on MLA website when finalised. 
 
Disease lists 
The following disease lists will be available to the interviewer. The interviewer will not be reading out the list to the producer. Rather, the interviewer will 
be searching the list (in alphabetical order) in response to a disease/condition/syndrome nominated by the producer. The interviewer will then ask 
questions for columns C, D and E for each disease nominated.   
Combined cattle disease, condition and syndrome list 
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1.2 Cattle and Sheep Vets questionnaire 
B.AHE.0010: 
Assessing the most economically damaging endemic diseases for cattle, sheep and goats 
 
Dear Cattle and Sheep Vets, 
 
GHD and a consortium of vets is completing a project for MLA on the most economically damaging 
endemic diseases for cattle, sheep and goats (project number: B.AHE.0010).  
The consortium is seeking feedback from members of the Australian Cattle Veterinarians (ACV) and 
Australian Sheep Veterinarians (ASV) to assist in developing a list of priority diseases or conditions. 
GHD is asking ACV and ASV members to complete a survey of diseases/conditions/syndromes 
covering four main areas: 
1) The economic importance of each disease (high, medium or low) from the list provided in 
the link below (NB: there is one list of cattle diseases and one list of sheep & goat diseases) 
2) The extent to which more extension (awareness) of currently available treatment and 
prevention options could reduce economic impact 
3) The extent to which more research is required to identify better treatment and control 
options to reduce economic impact 
4) Any comments about the disease/condition/syndrome especially if it relates to any 
emerging trends that will require attention in the near future 
 
Once the following survey is completed please post to: 
Attn: Paul Dellow 
GHD Pty Ltd 
Level 15, 133 Castlereagh St 
Sydney NSW 2000 
 
Alternatively, this survey can be scanned and emailed to diseasesurvey@ghd.com  
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Please note all responses will be treated confidentially and will remain anonymous. All information 
will be collated at a regional or state level.  
 
If you have any questions or would like to expand on any aspects of specific endemic diseases, 
please contact a member of the consortium from the list below: 
 
Dr Tristan Jubb.  Email: tristan@livestockhealthsystems.com.  Mobile: 0448 403 600 
Dr Richard Shephard.  Email: richard@herdhealth.com.au.   Mobile: 0418 515 498 
Dr John Webb-Ware.  Email: j.webbware@unimelb.edu.au.   Mobile: 0418748600 
Dr Geoffry Fordyce.  Email: g.fordyce@uq.edu.au.    Mobile: 0428 109 062 
Joe Lane (GHD). Email: joe.lane@ghd.com.    Mobile: 0415269934 
 
B.AHE.0010 Final Report: Priority list of endemic diseases for the red meat industries 
Page 242 of 282 
A. LIVESTOCK DISEASE SURVEY (ENDEMIC DISEASES) - CATTLE. MLA Project B.AHE.0010 
Your Location – State________________________
 Region:________________________________ 
List of endemic 
diseases, 
conditions, 
syndromes 
Q1. Economic 
importance 
Q2. Need for 
extension 
Q3. Need for 
research 
Q4. Other comments 
  Against each 
disease or 
condition, in 
your 
experience 
please rate 
their economic 
importance as 
low (L), 
medium (M) or 
high (H). If the 
disease is not 
relevant to 
your area or 
experience 
please leave 
blank. This may 
be in terms of 
production or 
product losses, 
or costs of 
control and 
prevention, or 
both.  
For the 
diseases and 
conditions you 
have ranked 
as Medium 
and High, 
indicate on a 
scale of 1-5 
the 
importance of 
more 
extension 
(awareness) of 
currently 
available 
treatment and 
prevention 
options to 
reduce 
economic 
impact. 
1. Not 
important 
2. Low 
importance 
3. Moderately 
important 
4. Highly 
important 
5. Crtically 
important 
For the 
diseases and 
conditions 
you have 
ranked as 
Medium and 
High, 
indicate on a 
scale of 1-5 
the 
importance 
of more 
research to 
identify 
better 
treatment 
and control 
options to 
reduce 
economic 
impact. 
1. Not 
important 
2. Low 
importance 
3. 
Moderately 
important 
4. Highly 
important 
5. Crtically 
important 
Any comments about this 
disease/condition/syndr
ome especially if it 
relates to any emerging 
trends that will require 
attention in the near 
future. 
3D syndrome         
Abortion -         
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List of endemic 
diseases, 
conditions, 
syndromes 
Q1. Economic 
importance 
Q2. Need for 
extension 
Q3. Need for 
research 
Q4. Other comments 
stillbirths 
Abortion dt 
Neospora 
        
Abscesses - liver         
Abscesses - 
neck/lymphnode/g
rass seed 
        
Abscesses - skin         
Abscesses - 
vaccination/injecti
on site 
        
Acidosis (grain 
poisoning) 
        
Akabane virus 
(Crooked calf 
disease) 
        
Alopecia - hair loss         
Annual ryegrass 
toxicity (ARGT) 
        
Anthelmintic 
resistance  (Drench 
resistance) 
        
Anthrax         
Acaricide 
Resistance 
        
Atypical interstitial 
pneumonia 
        
Balanitis         
Balanoposthitis         
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List of endemic 
diseases, 
conditions, 
syndromes 
Q1. Economic 
importance 
Q2. Need for 
extension 
Q3. Need for 
research 
Q4. Other comments 
Barbers Pole Worm        
BJD - Bovine 
Johne's Disease 
(Johne's disease) 
        
Black livers - 
melanosis, mulga 
livers, bore water 
livers 
       
Blackleg         
Bloat        
Bone chewing         
Botulism        
Bovine respiratory 
disease (BRD) 
        
Bracken fern 
poisoning 
       
Broken pizzle         
Bruising        
Buffalo fly skin 
lesions 
        
Buffalo fly worry        
Calf pneumonia         
Calf scours - 
Cryptosporidia 
       
Calf scours - 
General 
        
Calf scours - E coli        
Calf scours -         
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List of endemic 
diseases, 
conditions, 
syndromes 
Q1. Economic 
importance 
Q2. Need for 
extension 
Q3. Need for 
research 
Q4. Other comments 
Rotavirus 
Calf scours - 
Salmonella 
       
Campylobacteriosis 
- vibriosis 
        
Cast (eg on 
irrigation 
checkbank) 
       
Castration losses         
Chemical residues - 
meat 
       
Chemical residues - 
offal 
        
Clostidial infection        
Cobalt deficiency         
Coccidiosis        
Copper deficiency         
Deformed calves 
(congenital 
defects) 
       
Dehorning losses         
Dog bites - dog 
attack 
       
Downers - downer 
cows 
        
Drooling        
Dystocia (calving 
problems) 
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List of endemic 
diseases, 
conditions, 
syndromes 
Q1. Economic 
importance 
Q2. Need for 
extension 
Q3. Need for 
research 
Q4. Other comments 
Ear infection - head 
tilt 
       
Ephemeral fever 
(Three-day 
sickness) 
        
Eye cancer (Cancer 
eye) 
       
Eye problems         
Facial eczema        
Feet problems         
Fluke (Internal 
parasites/worms) 
       
Footrot         
Grass seed 
abscesses 
       
Grass tetany         
Haemorrhage 
(blood loss, 
bleeding) 
       
Heat stress         
IBR - infectious 
bovine 
rhinotracheitis 
       
Illthrift         
Illthrift weaners        
Infectious pustular 
vulvovaginitis (IPV) 
        
Infertility - Vibriosis 
- 
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List of endemic 
diseases, 
conditions, 
syndromes 
Q1. Economic 
importance 
Q2. Need for 
extension 
Q3. Need for 
research 
Q4. Other comments 
Campylobacteriosis 
Infertility bulls         
Infertility cows        
Infertility heifers         
Iodine deficiency        
Joint ill         
Lameness        
Laminitis         
Lantana poisoning        
Lead poisoning         
Leptospirosis        
Lice         
Listeriosis         
Liver abscesses         
Liver fluke 
(Fascioliasis) 
        
Lumpy jaw         
Lungworm         
Malignant 
catarrhal fever 
(MCF) 
        
Mastitis         
Milk fever 
(Hypocalcaemia) 
        
Navel infections         
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List of endemic 
diseases, 
conditions, 
syndromes 
Q1. Economic 
importance 
Q2. Need for 
extension 
Q3. Need for 
research 
Q4. Other comments 
Necrobacillosis  - 
oral, laryngeal 
        
Nitrate-nitrite 
poisoning 
        
Onion grass balls         
Oral necrobacillosis         
Overgrown claws 
(overgrown feet) 
        
Penile/penis 
haematoma/swolle
n/injured 
        
Perennial ryegrass 
staggers 
        
Pestivirus (Bovine 
viral diarrhoea) 
        
Phalaris staggers         
Phosphorus 
deficiency 
        
Photosensitisation         
Pinkeye (Moraxella 
bovis) 
        
Plant poisoning         
Pneumonia         
Pneumonia in 
calves 
        
Pregnancy 
toxaemia (fatty 
liver disease) 
        
B.AHE.0010 Final Report: Priority list of endemic diseases for the red meat industries 
Page 249 of 282 
List of endemic 
diseases, 
conditions, 
syndromes 
Q1. Economic 
importance 
Q2. Need for 
extension 
Q3. Need for 
research 
Q4. Other comments 
Prepuce 
injury/infection - 
posthitis 
        
Pulpy kidney 
(enterotoxaemia) 
        
Red nose  
(Infectious bovine 
rhinotracheitis) 
        
Red water - red 
urine 
        
Retained foetal 
membranes - RFMs 
        
Rickets         
Ringworm         
Salmonellosis         
Sand impaction - 
sand in rumen, 
sand in paunch 
        
Sarcocystis         
Selenium 
deficiency 
        
Shipping fever         
Sporadic Bovine 
Encephalomyelitis 
(SBE) 
        
Starvation ketosis         
Stephanofilariasis         
Sudden death         
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List of endemic 
diseases, 
conditions, 
syndromes 
Q1. Economic 
importance 
Q2. Need for 
extension 
Q3. Need for 
research 
Q4. Other comments 
Swollen joints         
Tetanus         
Theiliera         
Tick fever         
Tick worry         
Trace element 
deficiency 
       
Transit tetany         
Trichomoniasis        
Umbilical hernia         
Urea poisoning        
Urolithiasis 
(waterbelly) 
        
Vaginal prolapse - 
prolapsed vagina 
       
Vaginitis - 
vulvovaginitis 
        
Vibriosis - 
Campylobacteriosis 
       
Warts - 
papillomatosis 
        
Weaner illthrift        
Woody tongue - 
Actinobacillosis 
        
Worms (Internal 
parasites) 
       
Yersiniosis         
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List of endemic 
diseases, 
conditions, 
syndromes 
Q1. Economic 
importance 
Q2. Need for 
extension 
Q3. Need for 
research 
Q4. Other comments 
Zamia poisoning        
Any Others? 
(Please specify 
below) 
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B. LIVESTOCK DISEASE SURVEY (ENDEMIC DISEASES) - SHEEP & GOATS. MLA Project 
B.AHE.0010 
List of endemic diseases, 
conditions, syndromes 
Q1. 
Economic 
importance 
Q2. Need for 
extension 
Q3. Need for 
research 
Q4. Other comments 
  Against 
each 
disease or 
condition, 
in your 
experience 
please rate 
their 
economic 
importance 
as low (L), 
medium 
(M) or high 
(H). If the 
disease is 
not 
relevant to 
your area 
or 
experience 
please 
leave 
blank. This 
may be in 
terms of 
production 
or product 
losses, or 
costs of 
control and 
prevention, 
or both.  
For the 
diseases and 
conditions you 
have ranked as 
Medium and 
High, indicate 
on a scale of 1-
5 the 
importance of 
more 
extension 
(awareness) of 
currently 
available 
treatment and 
prevention 
options to 
reduce 
economic 
impact. 
1. Not 
important 
2. Low 
importance 
3. Moderately 
important 
4. Highly 
important 
5. Critically 
important 
For the 
diseases and 
conditions 
you have 
ranked as 
Medium and 
High, indicate 
on a scale of 
1-5 the 
importance 
of more 
research to 
identify 
better 
treatment 
and control 
options to 
reduce 
economic 
impact. 
1. Not 
important 
2. Low 
importance 
3. 
Moderately 
important 
4. Highly 
important 
5. Critically 
important 
Any comments about this 
disease/condition/syndrome 
especially if it relates to any 
emerging trends that will 
require attention in the near 
future. 
Abortion - still birth         
Abscesses – vaccination 
injection site 
        
Acidosis (grain poisoning)         
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List of endemic diseases, 
conditions, syndromes 
Q1. 
Economic 
importance 
Q2. Need for 
extension 
Q3. Need for 
research 
Q4. Other comments 
Actinobacillosis of 
epididymis/infertility 
        
Actinobacillosis of 
muzzle/head 
        
Agalactia (Mastitis/hard 
udder)  
        
Anaemia from Mycoplasma 
infection (formerly 
Eperythrozoonosis) 
        
Annual ryegrass toxicity         
Anthelmintic resistance  
(Drench resistance) 
        
Anthrax         
Arthritis of lambs         
Bacterial enteritis         
Bacterial enteritis – 
Campylobacter 
        
Bacterial enteritis – 
Salmonella 
        
Bacterial enteritis – 
Yersiniosis 
        
Barbers Pole Worm         
Benign footrot         
Bent leg         
Black livers – melanosis, 
mulga livers, bore water 
livers 
        
Black mastitis         
Blue-green algae poisoning         
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List of endemic diseases, 
conditions, syndromes 
Q1. 
Economic 
importance 
Q2. Need for 
extension 
Q3. Need for 
research 
Q4. Other comments 
Brucella ovis (Brucellosis)         
Campylobacter         
Cancer ears         
Cancer vulva         
Caprine arthritis-encephalitis 
(CAE) 
        
Caseous lymphadenitis 
(‘CLA’, ‘Cheesy gland’) 
        
Chemical residues – meat         
Chemical residues – wool         
Chorioptic mange         
Clostridial disease -  big 
head, malignant oedema 
        
Clostridial disease  (Black 
disease) 
        
Clostridial disease  (Pulpy 
kidney, enterotoxaemia) 
        
Clostridial disease – Tetanus         
Clover disease infertility         
Cobalt deficiency         
Coccidiosis         
Cold stress post shearing         
Copper deficiency         
Copper poisoning         
Dead lambs – cold stress         
Dead lambs – difficult birth         
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List of endemic diseases, 
conditions, syndromes 
Q1. 
Economic 
importance 
Q2. Need for 
extension 
Q3. Need for 
research 
Q4. Other comments 
Dead lambs – mismothering         
Dead lambs – predation         
Dermotophilosis (‘Dermo’, 
‘Lumpy wool’) 
        
Diarrhoea - scours         
Downers         
Dystocia (Difficult birth)         
Facial eczema         
Fleece rot         
Flystrike – Body & breech         
Foot abscess         
Footrot – benign         
Footrot – intermediate         
Footrot – Virulent         
Fox attack         
Fractured ribs         
Gastrointestinal Parasites         
Goitre         
Grass seeds        
Heat stress – hyperthermia         
Heliotrope poisoning        
Hydatids         
Hypocalcaemia        
Infertility -  female: Ewe, Doe         
Infertility – male: Ram, buck        
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List of endemic diseases, 
conditions, syndromes 
Q1. 
Economic 
importance 
Q2. Need for 
extension 
Q3. Need for 
research 
Q4. Other comments 
Iodine deficiency         
Itch mite        
Jaundice – yellows         
Balanitis/posthitis        
Lameness         
Lameness post dipping        
Lice         
Listeriosis        
Liver disease         
Liver Fluke         
Lungworm         
Lupinosis        
Mismothering         
OJD – ovine Johne’s disease        
Perennial ryegrass staggers         
Periodontal disease        
Phalaris poisoning - sudden 
death 
        
Phalaris staggers        
Photosensitisation         
Pinkeye        
Pizzle rot         
Plant poisoning – uncertain 
or other than specified 
       
Pneumonia         
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List of endemic diseases, 
conditions, syndromes 
Q1. 
Economic 
importance 
Q2. Need for 
extension 
Q3. Need for 
research 
Q4. Other comments 
Polioencephalomalacia – 
PEM 
       
Post weaning mortality         
Pregnancy toxaemia        
Prolapsed rectum         
Prolapsed uterus        
Prolapsed vagina         
Pyrrolizidine alkaloid 
poisoning 
       
Redgut         
Rickets        
Salmonellosis         
Sarcocystis        
Scabby mouth         
Scald - foot scald        
Scrotal mange         
Selenium deficiency        
Sheep measles         
Shelly toe        
Teeth wear         
Toxoplasma        
Trace element deficiencies         
Trachymene poisoning        
Twin lamb disease         
Urolithiasis - water belly        
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List of endemic diseases, 
conditions, syndromes 
Q1. 
Economic 
importance 
Q2. Need for 
extension 
Q3. Need for 
research 
Q4. Other comments 
Vitamin D deficiency         
Vitamin E deficiency        
Weaner ill-thrift         
White muscle disease        
Wild dog attack         
Worms / Internal Parasites         
Yersiniosis         
Any Others? (Please specify 
below) 
        
         
         
         
         
         
 
Thank your for your participation 
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1.3 Chief Veterinary Officer questionnaire 
 
A. LIVESTOCK DISEASE SURVEY (ENDEMIC DISEASES) - CATTLE. MLA Project B.AHE.0010
List of endemic diseases, conditions, syndromes Q1. Economic importance Q2. Need for extension Q3. Need for research Q4. Other comments
Against each disease or condition, please 
rate their economic importance in your 
jurisdiction as low (L) medium (M) or high 
(H). This may be in terms of production or 
product losses, or costs of control and 
prevention, or both.
For the diseases and conditions you 
have ranked as Moderate and High, 
indicate on a scale of 1-5 the importance 
of more extension (awareness) of 
currently available treatment and 
prevention options to reduce economic 
impact.
1. Not important
2. Low importance
3. Moderately important
4. Highly important
5. Crtically important
For the diseases and conditions 
you have ranked as Moderate and 
High, indicate on a scale of 1-5 the 
importance of more research to 
identify better treatment and 
control options to reduce economic 
impact.
1. Not important
2. Low importance
3. Moderately important
4. Highly important
5. Crtically important
Any comments about this 
disease/condition/syndrome
3D syndrome
Abortion
Abortion dt Neospora
Abscesses - liver
Abscesses - neck/lymphnode/grass seed
Abscesses - skin
Abscesses - vaccination/injection site
Acidosis (grain poisoning)
Actinobacillosis - woody tongue
Akabane virus (Crooked calf disease)
Alopecia - hair loss
Annual ryegrass toxicity (ARGT)
Anthelmintic resistance  (Drench resistance)
Anthrax
Atypical interstitial pneumonia
Balanitis
Balanoposthitis
BJD - bovine Johne's disease (Johne's disease)
Black livers - melanosis, mulga livers, bore water livers
Blackleg
Bleeding (blood loss, haemorrhage)
Bloat
Bogged - stuck
Bone chewing
Botulism
Bovine respiratory disease (BRD)
Bovine viral diarrhoea  (Pestivirus)
Bracken fern poisoning
Broken pizzle
Bruising
Buffalo fly skin lesions
Buffalo fly worry
Calf pneumonia
Calf scours - Cryptosporidia
Calf scours - E coli
Calf scours - Rotavirus
Calf scours - Salmonella
Campylobacteriosis - vibriosis
Cancer eye
Cast (eg on irrigation checkbank)
Castration losses
Chemical residues - meat
Chemical residues - offal
Circling
Clostidial infection
Cobalt deficiency
Coccidiosis
Constipation
Copper deficiency
Cryptosporidiosis - (calf scours complex)
Deformed calves (congenital defects)
Dehorning losses
Diarrhoea (Scours)
Dog bites - dog attack
Downers - downer cows
Drooling
Dystocia (calving problems)
Ear infection - head tilt
Enterotoxaemia (pulpy kidney)
Ephemeral fever (Three-day sickness)
Eye cancer (Cancer eye)
Eye problems
Facial eczema
Fascioliasis (Liver fluke)
Feet problems
Fluke (Internal parasites/worms)
Footrot
Grass seed abscesses
Grass tetany
Gut problems
Haemorrhage (blood loss, bleeding)
Hair loss - alopecia
Head tilt - ear infection
Heat stress
Hit by vehicle - road accident, road trauma
Horn damage
Hypocalcaemia (Milk fever)
IBR - infectious bovine rhinotracheitis
Illthrift
Illthrift weaners
Infectious pustular vulvovaginitis (IPV)
Infertility - Vibriosis - Campylobacteriosis
Infertility bulls
Infertility cows
Infertility heifers
Internal parasites (worms)
Iodine deficiency
IPV - infectious pustular vulvovaginitis
Joint ill
Lameness
Laminitis
Lantana poisoning
Lead poisoning
Leptospirosis
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Listeriosis
Liver abscesses
Liver fluke (fascioliasis)
Lumpy jaw
Lung problems
Lungworm
Malignant catarrhal fever - MCF
Mastitis
MCF (Malignant catarrhal fever)
Milk fever (Hypocalcaemia)
Moraxella bovis (Pinkeye)
Navel infections
Necrobacillosis  - oral, laryngeal
Nervous signs
Nervous signs (neurological disease)
Neurological disease (nervous signs)
Nitrate-nitrite poisoning
Onion grass balls
Oral necrobacillosis
Other
Overgrown claws (overgrown feet)
Papillomatosis - warts
Paralysis
Penile/penis haematoma/swollen/injured
Penis injury
Perennial ryegrass staggers
Perennial ryegrass toxicosis
Pestivirus (Bovine viral diarrhoea)
Phalaris staggers
Phalaris toxicity
Phosphorus deficiency
Photosensitisation
Pinkeye (Moraxella bovis)
Plant poisoning
Pneumonia
Pneumonia in calves
Poisoning
Posthitis - prepuce injury/infection
Pregnancy toxaemia (fatty liver disease)
Prepuce injury/infection - posthitis
Pulpy kidney (enterotoxaemia)
Red nose  (Infectious bovine rhinotracheitis)
Red urine - red water
Red water - red urine
Retained foetal membranes - RFMs
RFMs - retained foetal membranes
Rickets
Ringworm
Road accidents- road trauma - hit by vehicle
Ryegrass staggers
Salmonellosis
Sand impaction - sand in rumen, sand in paunch
Sarcocystis
Selenium deficiency
Septic wounds
Shipping fever
Skin problem
Snake bite
Sporadic bovine encephalomyelitis (SBE)
Staggers
Starvation ketosis
Stephanofilariasis
Stillbirths
Stuck - bogged
Sudden death
Swollen joints
Tetanus
Theiliera
Three-day sickness (Ephemeral fever)
Tick fever
Tick resistance
Tick worry
Trace element deficiency
Transit tetany
Trichomoniasis
Umbilical hernia
Urea poisoning
Urolithiasis (waterbelly)
Vaginal prolapse - prolapsed vagina
Vaginitis - vulvovaginitis
Vibriosis -Campylobacteriosis
Warts - papillomatosis
Weaner illthrift
Woody tongue - Actinobacillosis
Worms (Internal parasites)
Wound infections
Yersiniosis
Zamia poisoning
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B. LIVESTOCK DISEASE SURVEY (ENDEMIC DISEASES) - SHEEP & GOATS. MLA Project B.AHE.0010
List of endemic diseases, conditions, syndromes Q1. Economic importance Q2. Need for extension Q3. Need for research Q4. Other comments
Against each disease or condition, please rate their 
economic importance in your jurisdiction as low (L) 
medium (M) or high (H). This may be in terms of 
production or product losses, or costs of control and 
prevention, or both.
For the diseases and conditions you have ranked as 
Moderate and High, indicate on a scale of 1-5 the 
importance of more extension (awareness) of 
currently available treatment and prevention 
options to reduce economic impact.
1. Not important
2. Low importance
3. Moderately important
4. Highly important
5. Crtically important
For the diseases and conditions you have ranked as 
Moderate and High, indicate on a scale of 1-5 the 
importance of more research to identify better 
treatment and control options to reduce economic 
impact.
1. Not important
2. Low importance
3. Moderately important
4. Highly important
5. Crtically important
Any comments about this 
disease/condition/syndrome
Abortion
Abscesses – vaccination injection site
Acidosis (grain poisoning)
Actinobacillosis of epididymis/infertility
Actinobacillosis of muzzle/head
Agalactia (Mastitis/hard udder) (Goats)
Anaemia from Mycoplasma infection (formerly Eperythrozoonosis)
Annual ryegrass toxicity
Anthrax
Arthritis of lambs
Bacterial enteritis
Bacterial enteritis – Campylobacter
Bacterial enteritis – Salmonella
Bacterial enteritis – Yersiniosis
Barbers pole worm
Benign footrot
Bent leg
Bird attack (crow pick)
Black livers – melanosis, mulga livers, bore water livers
Black mastitis
Blue-green algae poisoning
Bottle jaw
Brucella ovis (Brucellosis)
Campylobacter
Cancer
Cancer ears
Cancer vulva
Caprine arthritis-encephalitis (CAE)
Caseous lymphadenitis (‘CLA’, ‘Cheesy gland’)
Cast
Chemical residues – meat
Chemical residues – wool
Chorioptic mange
Circling
Clostridial disease -  big head, malignant oedema
Clostridial disease  (Black disease)
Clostridial disease  (Pulpy kidney, enterotoxaemia)
Clostridial disease – Tetanus
Clover disease infertility
Cobalt deficiency
Coccidiosis
Cold stress
Cold stress post shearing
Copper deficiency
Copper poisoning
Dead lambs – cold stress
Dead lambs – difficult birth
Dead lambs – mismothering
Dead lambs – predation
Dermotophilosis (‘Dermo’, ‘Lumpy wool’)
Diarrhoea
Dog bites
Downers
Drooling
Dystocia (Difficult birth)
Eperythrozoonosis (Anaemia from Mycoplasma infection)
Facial eczema
Fleece damage – wool loss
Fleece rot
Flystrike – Body & breech
Foot abscess
Footrot – benign
Footrot – intermediate
Footrot – Virulent
Fox attack
Fractured ribs
Goitre
Grass seeds
Gut problems
Hard udder (Agalactia/Mastitis)
Heat stress – hyperthermia
Heliotrope poisoning
Hydatids
Hypocalcaemia
Hypothermia
Illthrift
Infertility -  female: Ewe, Doe
Infertility – male: Ram, buck
Internal parasites (worms  - liver fluke separate)
Iodine deficiency
Itch mite
Itching/rubbing
Jaundice – yellows
Knob rot – balanitis/posthitis
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Lamb marking losses
Lameness
Lameness post dipping
Lice
Listeriosis
Liver disease
Liver fluke (worms – Internal parasites)
Lung problems
Lungworm
Lupinosis
Mastitis
Melanosis
Mismothering
Nervous disease
Neurological problems
OJD – ovine Johne’s disease
Osteoporosis
Other
Perennial ryegrass staggers
Perennial ryegrass toxicosis
Periodontal disease
Phalaris poisoning
Phalaris staggers
Photosensitisation
Pinkeye
Pizzle rot
Plant poisoning – uncertain or other than specified
Pneumonia
Polio
Polioencephalomalacia – PEM
Post weaning mortality
Pregnancy toxaemia
Prolapsed rectum
Prolapsed uterus
Prolapsed vagina
Pyrrolizidine alkaloid poisoning
Redgut
Rib fractures
Rickets
Rubbing/itching
Ryegrass staggers
Salmonellosis
Sarcocystis
Scabby mouth
Scald
Scours
Scrotal mange
Selenium deficiency
Sheep measles
Shelly toe
Skin cancer
Skin problems
Snake bite
Staggers
Still birth
Sudden death
Teeth problems
Teeth wear
Tender wool
Toxoplasma
Trace element deficiencies
Trachymene poisoning
Twin lamb disease
Urinary tract blockage
Urolithiasis
Vitamin D deficiency
Vitamin E deficiency
Water belly
Weaner ill-thrift/ post weaning mortality
White muscle disease
Wild dog attack
Wool loss - fleece damage
Worms (Internal parasites - Liver fluke)
Wound infections
Yersiniosis
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C. LIVESTOCK DISEASE SURVEY (ENDEMIC DISEASES) - LABORATORY DIAGNOSES. MLA Project B.AHE.0010
Year 2009 (Cattle)
List of laboratory diagnoses (name 
of disease)
Date of the index submission Number of animals 
affected
Number of animals 
exposed
Program under which the submission was made ie NSDIP; 
NTSESP, VSDIP (Victorian Sudden Death Investigation 
Program), general surveillance (GS) etc.
a
b
c
d
etc
Year 2009 (Sheep)
List of laboratory diagnoses (name 
of disease)
Date of the index submission Number of animals 
affected
Number of animals 
exposed
Program under which the submission was made ie NSDIP; 
NTSESP, VSDIP (Victorian Sudden Death Investigation 
Program), general surveillance (GS) etc.
a
b
c
d
etc
Year 2009 (Goats)
List of laboratory diagnoses (name 
of disease)
Date of the index submission Number of animals 
affected
Number of animals 
exposed
Program under which the submission was made ie NSDIP; 
NTSESP, VSDIP (Victorian Sudden Death Investigation 
Program), general surveillance (GS) etc.
a
b
c
d
etc
Year 2010 (Cattle)
List of laboratory diagnoses (name 
of disease)
Date of the index submission Number of animals 
affected
Number of animals 
exposed
Program under which the submission was made ie NSDIP; 
NTSESP, VSDIP (Victorian Sudden Death Investigation 
Program), general surveillance (GS) etc.
a
b
c
d
etc
Year 2010 (Sheep)
List of laboratory diagnoses (name 
of disease)
Date of the index submission Number of animals 
affected
Number of animals 
exposed
Program under which the submission was made ie NSDIP; 
NTSESP, VSDIP (Victorian Sudden Death Investigation 
Program), general surveillance (GS) etc.
a
b
c
d
etc
Year 2010 (Goats)
List of laboratory diagnoses (name 
of disease)
Date of the index submission Number of animals 
affected
Number of animals 
exposed
Program under which the submission was made ie NSDIP; 
NTSESP, VSDIP (Victorian Sudden Death Investigation 
Program), general surveillance (GS) etc.
a
b
c
d
etc
Repeat for years 2011, 2012, 2013
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1.4 Animal Health Companies questionnaire 
 
 
B.AHE.0010     Assessing the most economically damaging endemic diseases for cattle, sheep and goats
Dear Animal Health Company Technical Manager,
GHD and a consortium of vets is completing a project for MLA on the most economically damaging endemic diseases for cattle, sheep and 
goats (project number: B.AHE.0010). 
The consortium is seeking feedback from Animal Health Company representatives to assist in developing a list of priority diseases or 
conditions.
GHD is asking you to complete a survey of diseases/conditions/syndromes covering six (6) main areas:
1.       The economic importance of each disease (high, medium or low) from the lists in the two worksheets provided (NB: there is one list of 
cattle diseases and one list of sheep & goat diseases)
2.       The extent to which more extension (awareness) of currently available treatment and prevention options could reduce economic 
impact
3.       The extent to which more research is required to identify better treatment and control options to reduce economic impact
4.       For the diseases and conditions listed, please state what product(s) your company has available for use in Australia.
5.       For the products you provided in Question 4, what is the standard price per animal of the recommended dose or application rate?
6.       Any comments about the disease/condition/syndrome especially if it relates to any emerging trends that will require attention in the 
near future
Completing the survey:
There are two excel tabs after this page containing a list of damaging endemic diseases for cattle and another tab for sheep and goats.
Please complete each worksheet with your responses.
diseasesurvey@ghd.com 
Please note all responses will be treated confidentially and will remain anonymous. All information will be collated at a regional or state level. 
If you have any questions or would like to expand on any aspects of specific endemic diseases, please contact a member of the consortium 
from the list below:
Dr Tristan Jubb. Email: tristan@livestockhealthsystems.com. Mobile: 0448 403 600
Dr Richard Shephard. Email: richard@herdhealth.com.au. Mobile: 0418 515 498
Dr John Webb-Ware. Email: j.webbware@unimelb.edu.au. Mobile: 0418748600
Dr Geoffry Fordyce. Email: g.fordyce@uq.edu.au. Mobile: 0428 109 062
Joe Lane (GHD). Email: joe.lane@ghd.com. Mobile: 0415269934
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A. LIVESTOCK DISEASE SURVEY (ENDEMIC DISEASES) - CATTLE. MLA Project B.AHE.0010
Your location: 
State
Region
You can type the response directly into the cell (e.g. L, M or H or 1-5) or select from the drop down list
List of endemic diseases, conditions, syndromes Q1. Economic importance Q2. Need for extension Q3. Need for research Q4. Your company's product(s) Q5. Product price Q6. Other comments
Against each disease or condition, in your 
experience please rate their economic 
importance as low (L), medium (M) or high 
(H). If the disease is not relevant to your 
area or experience please leave blank. This 
may be in terms of production or product 
losses, or costs of control and prevention, 
or both. 
For the diseases and conditions you 
have ranked as Medium and High, 
indicate on a scale of 1-5 the importance 
of more extension (awareness) of 
currently available treatment and 
prevention options to reduce economic 
impact.
1. Not important
2. Low importance
3. Moderately important
4. Highly important
5. Crtically important
For the diseases and conditions 
you have ranked as Medium and 
High, indicate on a scale of 1-5 the 
importance of more research to 
identify better treatment and 
control options to reduce economic 
impact.
1. Not important
2. Low importance
3. Moderately important
4. Highly important
5. Crtically important
For the diseases and conditions 
listed, please state what product(s) 
your company has available for use 
in Australia.
For the products you provided in 
Question 4, what is the standard 
price per animal of the 
recommended dose or application 
rate?
Any comments about this disease/condition/syndrome especially if 
it relates to any emerging trends that will require attention in the 
near future.
3D syndrome
Abortion - stillbirths
Abortion dt Neospora
Abscesses - liver
Abscesses - neck/lymphnode/grass seed
Abscesses - skin
Abscesses - vaccination/injection site
Acidosis (grain poisoning)
Akabane virus (Crooked calf disease)
Alopecia - hair loss
Annual ryegrass toxicity (ARGT)
Anthelmintic resistance  (Drench resistance)
Anthrax
Acaricide Resistance
Atypical interstitial pneumonia
Balanitis
Balanoposthitis
Barbers Pole Worm
BJD - Bovine Johne's Disease (Johne's disease)
Black livers - melanosis, mulga livers, bore water livers
Blackleg
Bloat
Bone chewing
Botulism
Bovine respiratory disease (BRD)
Bracken fern poisoning
Broken pizzle
Bruising
Buffalo fly skin lesions
Buffalo fly worry
Calf pneumonia
Calf scours - Cryptosporidia
Calf scours - General
Calf scours - E coli
Calf scours - Rotavirus
Calf scours - Salmonella
Campylobacteriosis - vibriosis
Cast (eg on irrigation checkbank)
Castration losses
Chemical residues - meat
Chemical residues - offal
Clostidial infection
Cobalt deficiency
Coccidiosis
Copper deficiency
Deformed calves (congenital defects)
Dehorning losses
Dog bites - dog attack
Downers - downer cows
Drooling
Dystocia (calving problems)
Ear infection - head tilt
Ephemeral fever (Three-day sickness)
Eye cancer (Cancer eye)
Eye problems
Facial eczema
Feet problems
Fluke (Internal parasites/worms)
Footrot
Grass seed abscesses
Grass tetany
Haemorrhage (blood loss, bleeding)
Heat stress
IBR - infectious bovine rhinotracheitis
Illthrift
Illthrift weaners
Infectious pustular vulvovaginitis (IPV)
Infertility - Vibriosis - Campylobacteriosis
Infertility bulls
Infertility cows
Infertility heifers
Iodine deficiency
Joint ill
Lameness
Laminitis
Lantana poisoning
Lead poisoning
Leptospirosis
Lice
Listeriosis
Liver abscesses
Liver fluke (Fascioliasis)
Lumpy jaw
Lungworm
Malignant catarrhal fever (MCF)
Mastitis
Milk fever (Hypocalcaemia)
Navel infections
Necrobacillosis  - oral, laryngeal
Nitrate-nitrite poisoning
Onion grass balls
Oral necrobacillosis
Overgrown claws (overgrown feet)
Penile/penis haematoma/swollen/injured
Perennial ryegrass staggers
Pestivirus (Bovine viral diarrhoea)
Phalaris staggers
Phosphorus deficiency
Photosensitisation
Pinkeye (Moraxella bovis)
Plant poisoning
Pneumonia
Pneumonia in calves
Pregnancy toxaemia (fatty liver disease)
Prepuce injury/infection - posthitis
Pulpy kidney (enterotoxaemia)
Red nose  (Infectious bovine rhinotracheitis)
Red water - red urine
Retained foetal membranes - RFMs
Rickets
Ringworm
Salmonellosis
Sand impaction - sand in rumen, sand in paunch
Sarcocystis
Selenium deficiency
Shipping fever
Sporadic Bovine Encephalomyelitis (SBE)
Starvation ketosis
Stephanofilariasis
Sudden death
Swollen joints
Tetanus
Theiliera
Tick fever
Tick worry
Trace element deficiency
Transit tetany
Trichomoniasis
Umbilical hernia
Urea poisoning
Urolithiasis (waterbelly)
Vaginal prolapse - prolapsed vagina
Vaginitis - vulvovaginitis
Vibriosis - Campylobacteriosis
Warts - papillomatosis
Weaner illthrift
Woody tongue - Actinobacillosis
Worms (Internal parasites)
Yersiniosis
Zamia poisoning
Any Others? (Please specify below)
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B. LIVESTOCK DISEASE SURVEY (ENDEMIC DISEASES) - SHEEP & GOATS. MLA Project B.AHE.0010
Your location: 
State
Region
You can type the response directly into the cell (e.g. L, M or H or 1-5) or select from the drop down list
List of endemic diseases, conditions, syndromes Q1. Economic importance Q2. Need for extension Q3. Need for research Q4. Your company's product(s) Q5. Product price Q6. Other comments
Against each disease or condition, 
in your experience please rate their 
economic importance as low (L), 
medium (M) or high (H). If the 
disease is not relevant to your area 
or experience please leave blank. 
This may be in terms of production 
or product losses, or costs of 
control and prevention, or both. 
For the diseases and conditions you have ranked 
as Medium and High, indicate on a scale of 1-5 
the importance of more extension (awareness) 
of currently available treatment and prevention 
options to reduce economic impact.
1. Not important
2. Low importance
3. Moderately important
4. Highly important
5. Critically important
For the diseases and conditions you have 
ranked as Medium and High, indicate on a 
scale of 1-5 the importance of more research 
to identify better treatment and control 
options to reduce economic impact.
1. Not important
2. Low importance
3. Moderately important
4. Highly important
5. Critically important
For the diseases and conditions 
listed, please state what product(s) 
your company has available for use 
in Australia.
For the products you provided in 
Question 4, what is the standard 
price per animal of the 
recommended dose or application 
rate?
Any comments about this disease/condition/syndrome 
especially if it relates to any emerging trends that will 
require attention in the near future.
Abortion - still birth
Abscesses – vaccination injection site
Acidosis (grain poisoning)
Actinobacillosis of epididymis/infertility
Actinobacillosis of muzzle/head
Agalactia (Mastitis/hard udder) 
Anaemia from Mycoplasma infection (formerly Eperythrozoonosis)
Annual ryegrass toxicity
Anthelmintic resistance  (Drench resistance)
Anthrax
Arthritis of lambs
Bacterial enteritis
Bacterial enteritis – Campylobacter
Bacterial enteritis – Salmonella
Bacterial enteritis – Yersiniosis
Barbers Pole Worm
Benign footrot
Bent leg
Black livers – melanosis, mulga livers, bore water livers
Black mastitis
Blue-green algae poisoning
Brucella ovis (Brucellosis)
Campylobacter
Cancer ears
Cancer vulva
Caprine arthritis-encephalitis (CAE)
Caseous lymphadenitis (‘CLA’, ‘Cheesy gland’)
Chemical residues – meat
Chemical residues – wool
Chorioptic mange
Clostridial disease -  big head, malignant oedema
Clostridial disease  (Black disease)
Clostridial disease  (Pulpy kidney, enterotoxaemia)
Clostridial disease – Tetanus
Clover disease infertility
Cobalt deficiency
Coccidiosis
Cold stress post shearing
Copper deficiency
Copper poisoning
Dead lambs – cold stress
Dead lambs – difficult birth
Dead lambs – mismothering
Dead lambs – predation
Dermotophilosis (‘Dermo’, ‘Lumpy wool’)
Diarrhoea - scours
Downers
Dystocia (Difficult birth)
Facial eczema
Fleece rot
Flystrike – Body & breech
Foot abscess
Footrot – benign
Footrot – intermediate
Footrot – Virulent
Fox attack
Fractured ribs
Gastrointestinal Parasites 
Goitre
Grass seeds
Heat stress – hyperthermia
Heliotrope poisoning
Hydatids
Hypocalcaemia
Infertility -  female: Ewe, Doe
Infertility – male: Ram, buck
Iodine deficiency
Itch mite
Jaundice – yellows
Balanitis/posthitis
Lameness
Lameness post dipping
Lice
Listeriosis
Liver disease
Liver Fluke 
Lungworm
Lupinosis
Mismothering
OJD – ovine Johne’s disease
Perennial ryegrass staggers
Periodontal disease
Phalaris poisoning - sudden death
Phalaris staggers
Photosensitisation
Pinkeye
Pizzle rot
Plant poisoning – uncertain or other than specified
Pneumonia
Polioencephalomalacia – PEM
Post weaning mortality
Pregnancy toxaemia
Prolapsed rectum
Prolapsed uterus
Prolapsed vagina
Pyrrolizidine alkaloid poisoning
Redgut
Rickets
Salmonellosis
Sarcocystis
Scabby mouth
Scald - foot scald
Scrotal mange
Selenium deficiency
Sheep measles
Shelly toe
Teeth wear
Toxoplasma
Trace element deficiencies
Trachymene poisoning
Twin lamb disease
Urolithiasis - water belly
Vitamin D deficiency
Vitamin E deficiency
Weaner ill-thrift
White muscle disease
Wild dog attack
Worms / Internal Parasites
Yersiniosis
Any Others? (Please specify below)
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2.1 Cattle 
  Producers (Northern)   Producers (Southern)   Cattle and Sheep Vets   
Responses 70   110   12   
1 Bovine ephemeral fever 28 Internal parasites (worms) 40 Pestivirus (Bovine viral 
diarrhoea) 
6 
2 Botulism 20 Pinkeye (Moraxella bovis) 20 Acidosis (grain poisoning) 5 
3 Tick fever 17 Other 19 Anthelmintic resistance  
(Drench resistance) 
4 
4 Leptospirosis 14 Liver fluke (fascioliasis) 14 Feet problems 4 
5 Blackleg 10 Pestivirus (Bovine viral 
diarrhoea) 
14 Heat stress 4 
6 Buffalo fly worry 10 Enterotoxaemia 13 Infertility cows 4 
7 Vibriosis -
Campylobacteriosis 
9 Blackleg 12 Mastitis 4 
8 Tick worry 8 Grass tetany 10 Pinkeye (Moraxella bovis) 4 
9 BJD - bovine Johne's disease 
(Johne's disease) 
6 Bovine ephemeral fever 10 Bovine respiratory disease 
(BRD) 
3 
10 Other 6 Bloat 7 Calf pneumonia 3 
11 Internal parasites (worms) 5 Footrot 7 Calf scours - E coli 3 
12 Pestivirus (Bovine viral 
diarrhoea) 
5 BJD - bovine Johne's disease 
(Johne's disease) 
6 Calf scours - Rotavirus 3 
13 Buffalo fly skin lesions 4 Buffalo fly worry 5 Campylobacteriosis - vibriosis 3 
14 Pinkeye (Moraxella bovis) 4 Clostridial infection 5 Clostidial infection 3 
15 Plant poisoning 3 Calf scours - E coli 4 Downers - downer cows 3 
16 Tetanus 3 Diarrhoea (Scours) 4 Illthrift 3 
17 Abortion 2 Mastitis 4 Illthrift weaners 3 
18 Lantana poisoning 2 Tick worry 4 Infertility - Vibriosis - 
Campylobacteriosis 
3 
19 Acaracide resistance 2 Vibriosis -Campylobacteriosis 4 Infertility bulls 3 
20     Buffalo fly skin lesions 3 Theiliera 3 
21     Leptospirosis 3 Vibriosis - Campylobacteriosis 3 
22     Milk fever (Hypocalcaemia) 3 Worms (Internal parasites) 3 
23     Tetanus 3     
24     Tick fever 3     
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  CVOs (Southern)   Laboratory Results CVOs    Processors 
Responses 4   4   1 
1 Bovine respiratory disease 
(BRD) 
2 Mastitis 2218 Abscesses - vaccination/injection 
site 
2 Infertility cows 2 Salmonellosis 953 Abscesses - liver 
3 Infertility heifers 2 Johne's Disease 599 Eye cancer (Cancer eye) 
4 Mastitis 2 Pestivirus (Bovine viral 
diarrhoea) 
594 Worms (Internal parasites) 
5 Pinkeye (Moraxella bovis) 2 Unknown (exotic disease 
excluded) 
584 Anthelmintic resistance  (Drench 
resistance) 
6 Circling 2 Cryptosporidiosis - (calf 
scours complex) 
534 Anthrax 
7 Perennial ryegrass toxicosis 2 Pneumonia 316 Downers - downer cows 
8 Calf scours - Rotavirus 1 Streptococcus infection 293 Acaricide Resistance 
9 Acute Bovine Liver Disease 1 Staphylococcus infection 273 Black livers - melanosis, mulga 
livers, bore water livers 
10 Calf scours - Cryptosporidia 1 Selenium deficiency 219 Chemical residues - offal 
11 Calf scours - E coli 1 Hypocalcaemia 217 Lumpy jaw 
12 Annual ryegrass toxicity 
(ARGT) 
1 Clinical pathology 
abnormality 
206 Bovine respiratory disease (BRD) 
13 Dehorning losses 1 Other 206 Eosinophillic Myositis 
14 Facial eczema 1 Salmonellosis Clinical  203 Eye problems 
15 Grass seed abscesses 1 Pestivirus exposure 178 Shipping fever 
16 Lameness 1 Coronavirus 158 Bracken fern poisoning 
17 Pestivirus (Bovine viral 
diarrhoea) 
1 Copper deficiency 138 Atypical interstitial pneumonia 
18 Anthrax 1 Bovine viral 
diarrhoea/pestivirus (not 
type 2) 
135 Calf scours - General 
19 Milk fever (Hypocalcaemia) 1 Calf scours - Rotavirus 131 Calf scours - E coli 
20 Phalaris staggers 1 Calf scours - E coli 130 Calf scours - Salmonella 
21 Phosphorus deficiency 1 Hard udder 
(Agalactia/Mastitis) 
127 Pregnancy toxaemia (fatty liver 
disease) 
22 Woody tongue - 
Actinobacillosis 
1 Salmonellosis (general) 127 Woody tongue - Actinobacillosis 
23     Hepatic abnormality 119   
24     Worms (Internal parasites) 111   
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2.2 Sheep and Goats 
  Producers (Sheep)   Producers (Goats)   Cattle and Sheep Vets   
Responses 90   30   11   
1 Internal parasites (worms) 37 Liver fluke 14 Barbers Pole Worm 7 
2 Lice 35 Barbers pole worm 10 Flystrike – Body & breech 6 
3 Flystrike - Body & breech 26 Footrot 5 OJD – ovine Johne’s disease 6 
4 Johne's disease 23 Worms  5 Weaner ill-thrift 6 
5 Pulpy kidney (Clostridial diseases) 18 Cheesy gland (Caseous 
lymphadenitis - CLA) 
4 Worms / Internal Parasites 6 
6 Footrot 9 Caprine arthritis-encephalitis 
(CAE) 
3 Clostridial disease  (Pulpy 
kidney, enterotoxaemia) 
5 
7 Pregnancy toxaemia 8 Johne's disease 3 Footrot – Virulent 5 
8 Arthritis of lambs 7 Lice 2 Mismothering 5 
9 Barbers pole worm 7 Pregnancy toxaemia 2 Dead lambs – predation 4 
10 Brucella ovis (Brucellosis) 4 Pulpy kidney (Clostridial 
diseases) 
2 Abortion - still birth 3 
11 Cheesy gland (Caseous 
lymphadenitis - CLA) 
3     Dead lambs – cold stress 3 
12 Foot abscess 3     Dead lambs – mismothering 3 
13 Footrot - benign 3     Diarrhoea - scours 3 
14 Footrot - Virulent 3     Foot abscess 3 
15 Other 3     Lameness 3 
16 Scabby mouth 3     Post weaning mortality 3 
17 Cancer 2     Pregnancy toxaemia 3 
18 Copper deficiency 2     Wild dog attack 3 
19 Hypocalcaemia 2     Lice 2 
20 Liver fluke 2     Brucella ovis (Brucellosis) 2 
21 Mastitis 2     Caseous lymphadenitis 
(‘CLA’, ‘Cheesy gland’) 
2 
22 Pinkeye 2         
23 Perennial Ryegrass Staggers 2         
24 Twin lamb disease 2         
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  CVO's   Laboratory Results 
- CVOs (SHEEP) 
  Laboratory Results - 
CVOs (Goats) 
  Processors 
Responses 4   4   4   1 
1 Internal parasites 
(worms) 
2 Brucella ovis 
(Brucellosis) 
6587 Caprine arthritis-
encephalitis (CAE) 
342 Sheep measles 
2 Footrot – Virulent 2 Worms (Internal 
parasites) 
1107 Unknown (exotic 
disease excluded) 
101 Caseous lymphadenitis 
(‘CLA’, ‘Cheesy gland’) 
3 Dead lambs – cold 
stress 
2 Unknown (exotic 
disease excluded) 
600 Helminth parasites 91 Grass seeds 
4 Dead lambs – difficult 
birth 
2 Helminth parasites 413 Internal parasitism 61 Wild dog attack 
5 Abortion 2 Hypocalcaemia 267 Johne's disease  46 Abscesses – vaccination 
injection site 
6 Barbers pole worm 2 Other 234 Worms (Internal 
parasites) 
38 Anthelmintic resistance  
(Drench resistance) 
7 Caseous 
lymphadenitis (‘CLA’, 
‘Cheesy gland’) 
1 Footrot – Virulent 229 Haematological 
abnormality 
35 Anthrax 
8 Flystrike – Body & 
breech 
1 Paratuberculosis 
(Johnes disease) 
213 Internal parasites-
protozoa 
32 Gastrointestinal Parasites  
9 Brucella ovis 
(Brucellosis) 
1 Johne's Disease 204 Other 29 Worms / Internal 
Parasites 
10 Dead lambs – 
mismothering 
1 Liver disease 180 Anaemia 21 Barbers Pole Worm 
11 Lice 1 Internal parasitism 173 Coccidiosis 19 Fox attack 
12 Post weaning 
mortality 
1 Copper deficiency 160 Clinical pathology 
abnormality 
18 Fractured ribs 
13 Sheep measles 1 Trauma 152 Mastitis 18 OJD – ovine Johne’s 
disease 
14 Weaner ill-thrift/ 
post weaning 
mortality 
1 Cobalt Deficiency 132 Staphylococcus 
infection 
16 Hydatids 
15 Liver Fluke 1 Coccidiosis 120 CAE 14 Sarcocystis 
16 Bacterial enteritis – 
Campylobacter 
1 Footrot – benign 111 Trauma 14 Chemical residues – meat 
17 Bacterial enteritis – 
Salmonella 
1 Pregnancy 
toxaemia 
111 Enterotoxaemia 
(pulpy kidney) 
13 Chemical residues – wool 
18 Foot abscess 1 Johnes untyped !$ 105 Corynbacteria 12 Bacterial enteritis – 
B.AHE.0010 Final Report: Priority list of endemic diseases for the red meat industries 
Page 272 of 282 
  CVO's   Laboratory Results 
- CVOs (SHEEP) 
  Laboratory Results - 
CVOs (Goats) 
  Processors 
Salmonella 
19 Footrot – 
intermediate 
1 Pneumonia 96 Salmonellosis 
(general) 
11   
20 Perennial ryegrass 
staggers 
1 Selenium deficiency 81 Hypocalcaemia 9   
21 Sarcocystis 1 OJD – ovine Johne’s 
disease 
79 Copper deficiency 8   
22 Twin lamb disease 1 Mastitis 76 Nematodirus 8   
23     Toxicity - phalaris 72 Nervous system 
abnormality 
8   
24     Enterotoxaemia 
(pulpy kidney) 
70 Ostertagiasis 8   
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2.3 Carcase condemnations 2011-2013 - Cattle 
Cattle by Total 
Condemnations 
        Total 
Slaughtered 
  21,509,537    
  2011 2012 2013 Total ACT NSW Qld SA Tas Vic WA 
ABSCESS 119 120 241 480 0 33 253 2 14 172 6 
ACTINO 24 20 32 76 0 17 6 2 8 43 0 
ANAEMI 12 11 14 37 0 7 10 2 3 13 2 
ARTHRITIS 14 8 3 25 0 3 4 0 1 16 1 
AT ANTEMORTEM 75 101 84 260 0 15 16 0 8 212 9 
BRUISING 276 280 390 946 0 304 174 25 24 392 27 
C.BOVIS 6 0 0 6 0 3 0 0 0 2 1 
CANCER EYE 1167 920 756 2843 25 1110 318 96 76 1120 98 
CELLULITIS 2 2 2 6 0 0 0 0 0 5 1 
COMPANY CONDEMN 25 21 37 83 0 0 0 0 4 79 0 
ECCHYMOSIS 1 4 5 10 0 1 2 1 2 4 0 
EMACIATION 192 299 328 819 0 119 88 2 33 571 6 
EOSINOPHILS MYOSITIS 131 128 116 375 0 151 120 62 2 33 7 
FEVER 1690 1742 1961 5393 0 187 501 29 142 4473 61 
GANGRENE 147 198 236 581 0 123 187 16 7 142 106 
GROSS 
CONTAMINATION 
45 82 267 394 0 13 5 2 6 368 0 
HYDATIDS 5 2 2 9 0 1 8 0 0 0 0 
IMMATURITY 28 20 26 74 0 0 0 0 23 51 0 
JAUNDICE 311 403 724 1438 0 136 463 0 106 725 8 
MALIGNANC 1831 2077 2347 6255 0 1111 4054 78 102 799 111 
MELANOSIS 33 36 34 103 0 31 37 12 3 16 4 
METRITIS 107 114 125 346 0 14 121 1 15 183 12 
NAVEL 19 56 76 151 0 0 0 0 0 151 0 
NEUROFIBROMA 46 60 53 159 0 15 43 36 17 48 0 
OTHER CAUSES 118 237 293 648 0 188 138 9 55 254 4 
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Cattle by Total 
Condemnations 
        Total 
Slaughtered 
  21,509,537    
PERITONITIS 79 63 86 228 0 9 62 4 5 142 6 
POLYARTHRITIS 117 157 128 402 0 130 60 0 35 170 7 
PYAEMIA 285 211 282 778 0 329 98 0 27 310 14 
SEPTIC PNEUMONIA 229 199 273 701 0 107 376 23 8 151 36 
SEPTICAEMIA 322 385 588 1295 0 207 570 38 29 398 53 
TOXAEMIA 40 40 49 129 0 119 6 1 0 2 1 
URAEMIA 109 98 105 312 0 49 105 4 8 144 2 
WOUNDS 1 4 2 7 0 2 2 0 0 3 0 
XANTHOSIS 8 18 21 47 0 16 10 0 0 21 0 
                 
Total 7614 8116 9686 25416 25 4550 7837 445 763 11213 583 
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2.4 Carcase condemnations 2011-2013 - Sheep 
Sheep by Total 
Condemnations 
        Total Slaughtered                    17,940,514    
Reason 2011 2012 2013 Total ACT NSW Qld SA Tas Vic WA 
ANAEMI 76 64 69 209 0 0 9 86 4 49 61 
AT ANTEMORTEM 485 458 781 1724 0 506 53 5 4 47 1109 
BRUISING 468 485 1043 1996 2 486 73 406 15 879 135 
C.OVIS 770 862 1834 3466 0 887 97 331 44 784 1323 
CLA 1516 1424 2115 5055 0 1307 78 112 139 2582 837 
COMPANY CONDEMN 3306 3229 5998 12533 0 5493 2525 1534 19 2748 214 
DOG BITE 0 100 33 133 0 0 132 0 0 1 0 
ECCHYMOSIS 27 45 29 101 0 26 1 1 0 63 10 
EMACIATION 6840 8413 14551 29804 0 1927 1354 2251 495 22009 1768 
FEVER 1639 1455 2446 5540 0 817 476 649 19 3143 436 
GANGRENE 11 55 55 121 0 12 31 6 5 48 19 
GROSS 
CONTAMINATION 
2409 2914 5619 10942 0 1464 978 1269 147 6823 261 
HYDATIDS 16 8 7 31 0 13 3 6 0 9 0 
JAUNDICE 1709 1737 2479 5925 0 1278 386 1315 67 2406 473 
MALIGNANC 5282 6886 10827 22995 0 8840 1516 1853 94 7810 2882 
METRITIS 118 370 454 942 0 0 3 787 6 93 53 
MUSCLE CONDITIONS 7 3 3 13 0 0 1 1 1 0 10 
OTHER CAUSES 585 669 1116 2370 0 67 338 159 497 909 400 
PERITONITIS 1 32 68 101 0 4 8 13 4 69 3 
POLYARTHRITIS 1129 1599 3569 6297 0 3578 220 553 51 1686 209 
PYAEMIA 36 58 331 425 0 1 8 23 16 316 61 
SARCOSPORIDIA 231 627 951 1809 0 520 18 28 814 385 44 
SEPTIC PNEUMONIA 947 904 1104 2955 0 5 14 268 3 157 2508 
SEPTICAEMIA 1231 1471 2807 5509 0 2379 565 1923 42 359 241 
WOUNDS 11 16 9 36 0 0 21 9 0 4 2 
                 
Total 28850 33884 58298 121032 2 29610 8908 13588 2486 53379 13059 
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2.5 Carcase condemnations 2011-2013 - Lambs 
Lambs by Total 
Condemnation 
        Total 
Slaughtered 
    39,086,005   
Reason 2011 2012 2013 Total ACT NSW Qld SA Tas Vic WA 
AT ANTEMORTEM 174 62 78 314 0 25 0 41 0 25 223 
BRUISING 64 48 76 188 0 30 0 27 0 113 18 
C.OVIS 1416 1285 1880 4581 0 856 23 826 58 2031 787 
CLA 185 92 71 348 0 63 4 9 1 251 20 
COMPANY CONDEMN 1195 934 1174 3303 0 802 117 417 0 1798 169 
DOG BITE 0 32 5 37 0 0 34 0 0 3 0 
ECCHYMOSIS 6 11 1 18 0 1 0 2 0 13 2 
EMACIATION 314 278 296 888 0 61 17 56 0 720 34 
FEVER 700 782 1108 2590 0 533 65 349 3 1143 497 
GANGRENE 6 10 15 31 0 1 2 3 0 21 4 
GROSS 
CONTAMINATION 
677 602 978 2257 0 254 94 387 5 1464 53 
JAUNDICE 3020 3458 2129 8607 0 2354 608 2516 88 2096 945 
MALIGNANC 226 179 213 618 0 241 12 102 2 157 104 
OTHER CAUSES 326 328 258 912 0 47 63 205 15 411 171 
POLYARTHRITIS 2101 1844 1967 5912 0 922 44 579 126 4002 239 
SARCOSPORIDIA 9 2 0 11 0 3 0 0 0 7 1 
SEPTIC PNEUMONIA 219 148 136 503 0 10 2 92 1 66 332 
SEPTICAEMIA 408 385 620 1413 0 455 67 640 4 211 36 
WOUNDS 0 0 0 0 0 0 0 0 0 0 0 
                 
Total 11046 10480 11005 32531 0 6658 1152 6251 303 14532 3635 
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2.6 Carcase condemnations 2011-2013 - Goats 
Goats by Total 
Condemnation 
        Total 
Slaughtered 
    5,593,254   
  2011 2012 2013 Total ACT NSW Qld SA Tas Vic WA 
AT ANTEMORTEM 57 7 28 92 0 0 28 7 0 55 2 
BRUISING 60 84 160 304 0 0 101 29 0 150 24 
C.OVIS 3 5 5 13 0 0 1 6 0 6 0 
CLA 565 386 514 1465 0 0 886 65 0 506 8 
COMPANY CONDEMN 2307 1368 2320 5995 0 0 1593 4 0 4234 164 
DOG BITE 0 19 13 32 0 0 21 0 0 11 0 
ECCHYMOSIS 0 35 16 51 0 0 50 1 0 0 0 
EMACIATION 602 1361 1669 3632 0 0 1728 834 0 957 113 
FEVER 1332 1579 1171 4082 0 0 1152 749 0 2114 67 
GANGRENE 23 33 44 100 0 0 73 6 0 19 2 
GROSS 
CONTAMINATION 
1185 2121 4062 7368 0 0 905 992 0 4951 520 
JAUNDICE 117 169 268 554 0 0 291 35 0 227 1 
MALIGNANC 72 88 76 236 0 0 138 27 0 134 6 
METRITIS 9 8 1 18 0 0 1 14 0 6 1 
OTHER CAUSES 147 241 154 542 0 0 259 26 0 305 11 
POLYARTHRITIS 93 109 153 355 0 0 236 16 0 151 9 
PYAEMIA 13 15 0 28 0 0 6 0 0 27 3 
SARCOSPORIDIA 1 0 0 1 0 0 1 8 0 15 0 
SEPTIC PNEUMONIA 50 127 112 289 0 1 37 203 0 27 23 
SEPTICAEMIA 453 401 389 1243 0 0 1024 50 0 127 42 
WOUNDS 0 0 1 1 0 0 0 1 0 0 0 
                 
Total 7089 8156 11156 26401 0 1 8531 3073 0 14022 996 
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3 Livestock disease modelling 
Example – Buffalo Fly (northern beef) 
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NORTHERN BEEF
No Herds 19,743 High Moderate Low Nil
No Head 15,706,803 10% 50% 30% 10%
(instructions on data entry are located in columns to the right) => No Herds 1,974 9,872 5,923 1,974
Buffalo fly No animals 1,570,680 7,853,402 4,712,041 1,570,680
Cl inica l  prevalence (Al l  age groups) 98.9% 33.0% 10.0% 0.0% 29.39% (regional clinical prevalence)
INPUTS Avg herd size 291 Breeders
HERD Females Bulls Steers
CHARACTERISTICS Calves 0.5-1.5 1.5-2.5 2.5-3.5 Mature >3.5 Mature Calves 0.5-1.5 1.5-2.5 >2.5-3.5 Mature >3.5
Cohort size (as proportion of cow herd) 47% 43% 33% 25% 42% 4% 47% 43% 41% 26% 17%
Calving rate 74% 88% 87%
Avg. no. (high) 136 124 95 74 122 12 136 124 118 76 49
Avg. no. (medium) 136 124 95 74 122 12 136 124 118 76 49
Avg. no. (Low) 136 124 95 74 122 12 136 124 118 76 49
Background Mortality rate 9% 3% 3% 3% 3% 4% 9% 2% 2% 2% 1%
proportion of group sold 0% 20% 19% 12% below 18% 0% 2% 34% 34% below
H 35% H 100%
M 35% M 100%
L 35% L 100%
Animal value $300 $465 $619 $648 $648 $865 $339 $547 $852 $961 $980
number sold (high) 0 25 18 9 43 2 0 3 40 26 33
number sold (med) 0 25 18 9 43 2 0 3 40 26 33
number sold (low) 0 25 18 9 43 2 0 3 40 26 33
DISEASE PREVALENCE
Within-herd prevalence - highly affected 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
Avg. no. 136.0 124.0 95.0 74.0 122.0 0.0 136.0 124.0 118.0 76.0 49.0
Within-herd prevalence - moderately affected 33.0% 33.0% 33.0% 33.0% 33.0% 33.0% 33.0% 33.0% 33.0% 33.0% 33.0%
Avg. no. 44.9 40.9 31.4 24.4 40.3 4.0 44.9 40.9 38.9 25.1 16.2
Within-herd prevalence - lowly affected 10.0% 10.0% 10.0% 10.0% 10.0% 10.0% 10.0% 10.0% 10.0% 10.0% 10.0%
Avg. no. 13.6 12.4 9.5 7.4 12.2 1.2 13.6 12.4 11.8 7.6 4.9
DIRECT COSTS
TREATMENT COSTS
Treatment costs ($ per head treated + handling etc.) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Treatment proportion - highly affected 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Treatment proportion - moderately affected 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Treatment proportion - lowly affected 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
MANAGEMENT AND PREVENTION COSTS APPLIED
Herd control costs - highly affected (applied to each animal in cohort $/head) $3.60 $7.20 $7.20 $7.20 $7.20 $7.20 $3.60 $7.20 $7.20 $7.20 $7.20
Control proportion herds implementing - highly affected 90% 90.0% 90.0% 90.0% 90.0% 90.0% 90.0% 90.0% 90.0% 90.0% 90.0%
Herd control costs - moderately affected (applied to each animal in cohort $/head) $1.19 $2.38 $2.38 $2.38 $2.38 $2.38 $1.19 $2.38 $2.38 $2.38 $2.38
Control proportion herds implementing - moderately affected 70% 70.0% 70.0% 70.0% 70.0% 70.0% 70.0% 70.0% 70.0% 70.0% 70.0%
Herd control costs - lowly affected (applied to each animal in cohort $/head) $0.36 $0.72 $0.72 $0.72 $0.72 $0.72 $0.36 $0.72 $0.72 $0.72 $0.72
Control proportion herds implementing - lowly affected 50% 50.0% 50.0% 50.0% 50.0% 50.0% 50.0% 50.0% 50.0% 50.0% 50.0%
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REGULATORY COSTS
Fixed $0.00
Variable (per cow) $0.00
INDIRECT COSTS
Fixed or one off per herd $0.00
Indirect costs - highly affected $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Indirect costs - moderately affected $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Indirect costs - lowly affected $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Proportion herds implementing/impacted- highly affected 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Proportion herds implementing/impacted - moderately affected 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Proportion herds implementing/impacted - lowly affected 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
PRODUCTION LOSSES
MORTALITY
Mortality value (animal) $300 $465 $619 $648 $648 $865 $339 $547 $852 $961 $980
Mortality rate (% of clinical cases that die) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Total deaths (high) 12.2 4.0 3.0 2.4 3.9 0.5 12.2 2.9 1.9 1.2 0.7
Total deaths (med) 12.2 4.0 3.0 2.4 3.9 0.5 12.2 2.9 1.9 1.2 0.7
Total deaths (low) 12.2 4.0 3.0 2.4 3.9 0.5 12.2 2.9 1.9 1.2 0.7
LIVEWEIGHT
Permanent weight loss (kg) Clinicals High 6.4 12.8 12.8 12.8 12.8 5.0 6.4 12.8 12.8 12.8 12.8
Permanent weight loss (kg) Clinicals Moderate 2.1 4.2 4.2 4.2 4.2 5.0 2.1 4.2 4.2 4.2 4.2
Permanent weight loss (kg) Clinicals Low 0.6 1.3 1.3 1.3 1.3 5.0 0.6 1.3 1.3 1.3 1.3
Permament weight loss value kg (clinicals) $2.00 $1.50 $1.50 $1.50 $1.50 $1.50 $2.00 $2.00 $2.00 $2.00 $2.00
Permanent weight loss - proportion cases affected (clinicals) 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
Temporary weight loss (kg) Clinicals High 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0
Temporary weight loss (kg) Clinicals Moderate 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0
Temporary weight loss (kg) Clinicals Low 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0
Temporary weight loss value kg (clinicals) $1.00 $1.00 $1.00 $1.00 $1.00 $1.00 $1.00 $1.00 $1.00 $1.00 $1.00
Temporary wt loss opportunity interest value 6% 6% 6% 6% 6% 6% 6% 6% 6% 6% 6%
Temporary weight loss Agistment cost ($/week $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Temporary weight loss Time to resume wt loss (weeks) 0 0 0 0 0 0 0 0 0 0 0
Temporary weight loss - proportion cases affected (clinicals) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
REPRODUCTION
Failure to calve cost - - $300 $300 $300 - - - -
Pregnancy rate reduction (clinical) High - - 0.0% 0.0% 0.0% - - - -
Pregnancy rate reduction (clinical) Moderate 0.0% 0.0% 0.0%
Pregnancy rate reduction (clinical) Low 0.0% 0.0% 0.0%
MARKET SPECIFICATIONS
Failure to meet market specifications value $0.10 $0.10 $0.10 $0.10 $0.10 $0.10 $0.10 $0.10 $0.10 $0.10 $0.10
Proportion affected 4.1% 4.1% 4.1% 4.1% 4.1% 4.1% 4.1% 4.1% 4.1% 4.1% 4.1%
REDUCED PRODUCT VALUE
Loss of hide value (clinical) $0.00 $6.00 $7.00 $8.00 $8.00 $8.00 $5.00 $6.00 $7.00 $8.00 $8.00
Damaged hides - proportion clinicals affected 0.0% 4.1% 4.1% 4.1% 4.1% 4.1% 4.1% 4.1% 4.1% 4.1% 4.1%
Loss of meat value (e.g. MSA-downgrade) in clinicals $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
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OUTPUTS Females Bulls Steers
Calves 0.5-1.5 1.5-2.5 2.5-3.5 Mature >3.5 Mature Calves 0.5-1.5 1.5-2.5 >2.5-3.5 Mature >3.5
Cohort size (as proportion of cow herd) 47% 43% 33% 25% 42% 4% 47% 43% 41% 26% 17%
No. Animals (high) 136 124 95 74 122 12 136 124 118 76 49
No. Animals (med) 136 124 95 74 122 12 136 124 118 76 49
No. Animals (low) 136 124 95 74 122 12 136 124 118 76 49
Prevalence Calves 0.5-1.5 1.5-2.5 2.5-3.5 Mature >3.5 Mature Calves 0.5-1.5 1.5-2.5 >2.5-3.5 Mature >3.5
Highly affected herd 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100%
Moderately affected herd 33% 33% 33% 33% 33% 33% 33% 33% 33% 33% 33%
Lowly affedted herd 10% 10% 10% 10% 10% 10% 10% 10% 10% 10% 10%
Treatment and Control costs
Total clinical case treatment costs -  highly affected herd $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total clinical case treatment costs -  moderately affected herd $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total clinical case treatment costs -  lowly affected herd $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Control costs  -  highly affected $440.64 $803.52 $615.60 $479.52 $790.56 $77.76 $440.64 $803.52 $764.64 $492.48 $317.52
Control costs  -  moderately affected $113.10 $206.24 $158.00 $123.08 $202.91 $19.96 $113.10 $206.24 $196.26 $126.40 $81.50
Control costs  -  lowly affected $24.48 $44.64 $34.20 $26.64 $43.92 $4.32 $24.48 $44.64 $42.48 $27.36 $17.64
Indirect costs
Fixed or one off per herd $0.00
Total indirect costs -  high $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total indirect costs - moderate $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total indirect costs - low $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Production/financial losses
Live weight permanent loss - high $1,734.00 $2,371.50 $1,816.88 $1,415.25 $2,333.25 $90.00 $1,734.00 $3,162.00 $3,009.00 $1,938.00 $1,249.50
Live weight permanent loss - moderate $188.83 $258.26 $197.86 $154.12 $254.09 $29.70 $188.83 $344.34 $327.68 $211.05 $136.07
Live weight permanent loss - low $17.34 $23.72 $18.17 $14.15 $23.33 $9.00 $17.34 $31.62 $30.09 $19.38 $12.50
Live weight temporary loss - high $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Live weight temporary loss - moderate $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Live weight temporary loss - low $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total weight loss - highly affected $1,734.00 $2,371.50 $1,816.88 $1,415.25 $2,333.25 $90.00 $1,734.00 $3,162.00 $3,009.00 $1,938.00 $1,249.50
Total weight loss - moderately affected $188.83 $258.26 $197.86 $154.12 $254.09 $29.70 $188.83 $344.34 $327.68 $211.05 $136.07
Total weight loss - lowly affected $17.34 $23.72 $18.17 $14.15 $23.33 $9.00 $17.34 $31.62 $30.09 $19.38 $12.50
Regulatory cost
Fixed $0
Variable $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
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Discount on value of affected animals sold
Discounted value sales - highly affected $0.00 $0.10 $0.07 $0.04 $0.18 $0.01 $0.00 $0.01 $0.16 $0.11 $0.14
Discounted value sales - moderately affected $0.00 $0.03 $0.02 $0.01 $0.06 $0.00 $0.00 $0.00 $0.05 $0.04 $0.04
Discounted value sales - lowly affected $0.00 $0.01 $0.01 $0.00 $0.02 $0.00 $0.00 $0.00 $0.02 $0.01 $0.01
Value of reproductive wastage
Reproductive losses - highly affected $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Reproductive losses - moderately affected $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Reproductive losses - lowly affected $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Value of mortality losses
Mortality losses (direct) - highly affected $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Mortality losses (direct) - moderately affected $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Mortality losses (direct) - lowly affected $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Product devaluation losses
Discount on hide/skin value - highly affected $0.00 $6.15 $5.17 $2.95 $14.10 $0.66 $0.00 $0.74 $11.48 $8.53 $10.82
Discount on hide/skin value - moderately affected $0.00 $2.03 $1.70 $0.97 $4.65 $0.22 $0.00 $0.24 $3.79 $2.81 $3.57
Discount on hide/skin value - lowly affected $0.00 $0.62 $0.52 $0.30 $1.41 $0.07 $0.00 $0.07 $1.15 $0.85 $1.08
Discount on carcase value - highly affected $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Discount on carcase value - moderately affected $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Discount on carcase value - lowly affected $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total indirect costs - highly affected $0.00 $6.25 $5.24 $2.99 $14.28 $0.66 $0.00 $0.75 $11.64 $8.63 $10.96
Total indirect costs - moderately affected $0.00 $2.06 $1.73 $0.99 $4.71 $0.22 $0.00 $0.25 $3.84 $2.85 $3.62
Total indirect costs - lowly affected $0.00 $0.63 $0.52 $0.30 $1.43 $0.07 $0.00 $0.08 $1.16 $0.86 $1.10
TOTAL - AFFECTED HERD Total Per head Gain from better control Total Per head
Highly affected $26,941.19 $33.93 Highly affected $26,383.61 $33.23
Moderately affected $3,857.87 $4.86 Moderately affected $3,300.30 $4.16
Lowly affected $557.58 $0.70
INDUSTRY SECTOR GAIN (PER HERD) $4,288.51 $5.40
TOTAL - INDUSTRY SECTOR LEVEL (PER HERD) $4,790.33 $6.03
TOTAL - REGIONAL SECTOR LEVEL $94,575,455 POTENTIAL INDUSTRY SECTOR GAIN $84,668,070
